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ABSTRACT
GabR is a member of the MocR/GabR subfamily of the GntR family of bacterial
transcription regulators. It regulates the metabolism of γ-aminobutyric acid (GABA), an
important nitrogen and carbon source for many bacteria. The crystal structures reported
here confirmed that this protein has evolved from the fusion of a type I aminotransferase
and a winged helix-turn-helix (wHTH) DNA binding protein to form a chimeric protein
that adopts a dimeric head-to-tail configuration. The pyridoxal 5′-phosphate (PLP)–
binding regulatory domain of GabR is therefore an example of a coenzyme playing a role
in transcription regulation rather than in enzymatic catalysis. Our structural and
biochemical studies have laid solid the mechanistic foundation for understanding the
regulatory functions and mechanism of the MocR/GabR subfamily of transcription
regulators.
GabR is also an intriguing case of molecular evolution, displaying the
evolutionary lineage between aminotransferase and a resulted regulation domain of a
transcription regulator. PLP’s native function is not a catalytic co-enzyme but an effector
of transcription regulation. The stable chemical species of GabR-PLP-GABA
responsible for GabR-mediated transcription activation, has been revealed mechanistic
crystallography, NMR spectroscopy and biological assays using both GABA and a

xviii

GABA analog (S)-4-Amino-5-Fluoropentanoic Acid (AFPA) as a molecular probe. Our
studies provide critical structural and chemical insights for a currently understudied
subfamily of bacterial transcription regulators, MocR/GabR-type regulators in the GntR
family.
In parallel, I also worked on several other projects. Herein, I dedicated 2 full
chapters to demonstrate the progress on the Sucrose Synthase project. We obtained
biochemical and structural evidence of sucrose metabolism in non-photosynthetic
bacteria. Until now, only sucrose synthases from photosynthetic organisms have been
characterized. Here, we provide the crystal structure of the sucrose synthase from the
chemolithoautotroph Nitrosomonas europaea. This supported that the enzyme functions
with an open/close induced fit mechanism. It prefers as substrate adenine-based
nucleotides rather than uredine-based like the eukaryotic counterparts, implying there is a
strong connection between sucrose and glycogen metabolism in these bacteria.
Mutagenesis data showed that the catalytic mechanism must be conserved not only in
sucrose synthases, but also in all other retaining GT-B glycosyltransferases.

xix

CHAPTER ONE
INTRODUCTION
Research Aims: Potential Anti-Virulence Target for Secondary Infections of Cystic
Fibrosis (CF)
Cystic Fibrosis is a life-threatening genetic disorder that causes thick, sticky
mucus to build up in the lungs, digestive tract, and other areas of the body. It is one of the
most common chronic lung diseases among children and young adults. In Caucasian
populations, the carrier frequency for Cystic Fibrosis is approximately one in twenty-five,
with a prevalence of about 1 in 2000 1. Nearly 1,000 CF diagnoses are reported annually,
and the disease caused 3,708 deaths in the United States from 1999-2006. As of 2007,
the medial survival age was 37.4 years, compared to a U.S. life expectancy of 70.7 years
in the same year.
The local environment of the cystic fibrosis lung is unique and results in
characteristic disease patterns and specific spectrum of cystic fibrosis associated lung
pathogens 1. Susceptibility to Staphylococcus aureus, Pseudomonas aeruginosa and other
bacterial infections is significantly higher in patients with CF, as the lungs become
largely ineffective at ridding the body of microbes when mucus build-up begins. Thus, a
large number of deaths from CF are attributed to bacterial secondary infections that lead
to lung disease in patients. With CF affecting 70,000 people across the world, and the
bacteria's high resistance of a wide range of antibacterial agents, the novel antibiotic
1

2
development becomes urgent for the treatment of bacterial infections and for an improved
life quality of CF patients.
The Burkholderia cepacia Complex (Bcc) is a subset of at least nine opportunistic
pathogens that belong to the gram-negative Burkholderia genus associated with
infections in CF patients. In efforts to develop more effective CF treatments, this
complex is of particular interest in antibiotic development because of the welldocumented multi-drug resistance of bacterial strains and the capability of patient-topatient spread. Burkholderia cenocepacia and Burkholderia multivorans are two
members of the Bcc responsible for a majority of the infections seen in CF patients, and
they have been reported in both clinical and environmental settings (soil and water) as
sources of infection.
These two strains are related to Bacillus subtilis by their metabolism of γ-amino
butyric acid (GABA) to produce glutamate, which is an important metabolite in bacterial
nitrogen metabolism. Similarity existing between B. subtilis and Bcc strains in their
glutamate production mechanisms makes B. subtilis an ideal, non-pathogenic model
organism for our study on the inhibition/modulation of GABA/glutamate metabolism in
B. cenocepacia and B. multivorans for therapeutically purposes. It also has been recently
discovered that GABA is an essential cell-to-cell signal in eukaryotes. It acts as a single
signal between eukaryotes and pathogenic bacterial. GABA production has been revealed
to be crucial to bacterial stress response, especially acid resistance. All of which make the
metabolism of GABA in bacteria a potential target for the development of a strategy to
control the virulence of bacterial pathogeneses. GabR is the transcription regulator in B.

3
subtillis that represses the transcription of the gabR gene while also initiating the
transcription of the gabT and gabD genes, which are key enzymes in glutamate
biosynthesis utilizing GABA while responding to the increase of GABA’s concentration
in vivo.
The Transcription and the Transcription Factor
As the first step of gene expression, transcription is a fundamental process that is
often highly conserved and tightly regulated process in bacteria. Bacteria cells rely on
very sophisticated responses to adapt to micro environmental changes, due to the
frequently changing habitats conditions. Though transcription regulation, these responses
most frequently lead to the activation and/or repression of a specific sets of genes to
control metabolic pathway and adapt to the different environmental condition 2.
Transcription is the process of synthesis of mRNA by using a single strand of
DNA as a template; the process is performed by structurally conserved DNA-dependent
RNA polymerase (RNAPs) 3. Transcription is tightly controlled by the transcription
factors (TFs), which are the proteins that bind to specific sequence on the DNA near their
target genes, thereby modulating the transcription initiation. TFs perform this function
alone or with other proteins in a complex (homoprotein), by promoting (as an activator),
or blocking (as a repressor) the recruitment of RNA polymerase to the promoter regions
of specific genes.
Based on contemporary X-ray crystallography and advanced computational
simulation, TFs mostly revealed as the dimerization motif, both heterodimer and homodimer are common. In general, the dimerization of a protein generally results in the
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formation of an enlarged interaction surface, compared to the monomer. The enlarged
surface area of the dimer provides increased potential for various protein-protein or
protein-DNA interactions essential to transcription. Comparing to a monomer, TFs that
dimerize can achieve a higher DNA binding affinity and specificity and twice as many
base pairs can be recognized providing distinct DNA-binding specificities 4.
Taking advantage of the intense and ongoing computationally studies, molecular
and biophysical studies over the past decade, scientists have generated an unprecedented
amount of information describing the location of the binding site/s, described in
Parallelism Weight Matrix (PWM) and further deduced from aligning a set of DNA
sequence that are experimentally known, for the transcription regulators 5. However the
understanding of the binding mechanism is still very preliminary. The major challenge
for our work is to be able to bridge this gap between the molecular description and the
genome-scale overview.
GntR family and the subfamily classification
In 1990, Haydon and Guest first identified and described GntR family of bacterial
transcription regulators, named after the first member identified, the B. subtilis
transcription regulator - GntR - repressor of the gluconate operon 6. Among all the
bacterial transcription regulators, GntR is known as one of the most abundant and widely
distributed groups of Helix-Turn-Helix (HTH) transcription factors. To date, the
metabolite-response GntR family has approximately 8,561 regulatory proteins in Pfam
database (PfaM family GntR: PF00392)7, which spread out among 764 bacteria taxa.
GntR transcription regulators are often located at the chromosome adjacent to the genes
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that they control, which in many cases allows insight into the metabolites that they bind
to as effectors. There are also many cases where GntR-like regulators are not located
close to the gene it regulates but elsewhere. One of the well-studied examples in this
transcription regulator family is orphan regulator FadR/GntR, the fatty acid metabolism
regulator in Escherichia coli. These studies have intensively focused on both the
structural and functional aspects, serving as a critical reference case for our research.
A striking characteristic feature of the GntR family is that the members possess a
highly conserved N-terminal DNA-binding domain (DBD), which evolved in DNA
binding, and an extensive diverse and heterogeneity C-terminal effector binding and / or
oligomerization domain (Eb/O). It was hypothesized that binding of the effector
molecules could trigger the conformational changes in the protein, which modulates the
DNA-binding properties of the regulator resulting in either activation or repression of
transcription. It is not surprising, though, that there are a large number of effector
molecules that have not been identified, given the diversity of molecule that they bind
and relative large number of the GunR-family members itself.
The HTH DNA binding motif in this GntR family is the traditional tri-helical
domain, whose original case demonstrated the critical role in DNA binding within the
bacteirophage Lambda protein, cI and cro and the lac operon repressor, LacI and the
generation of cell-type specific gene expression 8. The there-helical HTH domain is
known as the winged-helix-turn-helix domain. In addition to the core three-helix bundle,
it also contains a wing form by C-terminal beta-hairpin. In some versions of this domain,
the loop between strand elements interacts with the two strands of the wing 9. The “wing”
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feature provides great interactions with the DNA due to the third alpha helix, which can
fit well within the major groove of the DNA. This was suggested by the extensive
sequence analysis and secondary structural analysis throughout 1980s and 1990s 7. It is
being proposed that these domains descend from a common ancestor.
Since the physiological role of these regulators critically depend upon the effector
binding to the operon site of the DNA, therefore analysis based on the alignment of the C
terminus and secondary structural predications were used to classify the members of the
GntR family. The distinct structural topologies reveal seven major subfamilies: FadR,
HutC, MocR, YtrA, and three minor subfamily AraR, DevA, and PlmA (Figure1) 10.
The most abundant GntR sub-family, FadR subfamily, named after the fatty acid
biosynthesis and degradation regulator, functions as a switch that coordinately regulates
the machinery required for fatty acid beta-oxidation and the expression of a key enzyme
in fatty acid biosynthesis. It contains the majority of the GntR-like regulators,
approximately 40 %. The protein in this subfamily contains six or seven-helical Cterminal domain, with the average length of 150-170 amino acid. The crystal structure is
available for FadR of Escherichia coli (Figure2; PDB ID: 1EX1)11.
The HTH domain is fused to a seven alpha helical bundle, which contains a large
internal cavity required for binding its regulator molecule. The RMSD on the alpha
carbons is 0.717 Å between the bound and unbound of the acyl CoA indicated the protein
backbone undergoes conformational shift upon binding to the acyl CoA-its own
regulator, further resulting in 7.2 Å movement of the DNA recognition helix preventing
DNA binding and subsequently repressing the transcription.

7

Figure 1. Unrooted tree of the proteins of GntR family regulators of M. smegmatis
including representatives of all subfamily regulator from different Baterial Genomes with
1000 bootstrap replicates. All the GntR regulators are clustered into six subfamilies.
FadR subfamily is branched again into two groups (FadR and VanR) 10.

8

Figure 2. Quaternary structure of FadR and its corresponding DNA.

The second proposed subfamily is the HutC subfamily, named after the histidine
utilization operon regulator, comprising about 31 % of the GntR regulators. The Cterminal regulatory domain of HutC response to various of the ligands, such as: histidine
12

; long chain fatty acids 13; trehaylose 6-phosphate or alkylphosphonate 14, which makes

it not so surprising to find out that this subfamily regulate processes as diverse as amino
acid uptake and plasmid transfer. The structure of HutC subfamily contains both alphahelical and beta-sheet on C-terminal domain and averages 170 amino acids in length;
Three dimensional crystal structural and analysis of the HutC family member, PhnF from
E. coli shows that the C-terminal domain had a chorismate lyase-like fold, comprising a
six-stranded antiparallel beta-sheets, a two-stranded parallel beta-sheets and four short
alpha-helices (Figure3; PDB ID: 2WV0). A large cavity on the surface of the PhnF C
terminus indicates the putative effector molecule-binding pocket, which suggested to be
conserved in with the other members in the HutC subfamily 15.

9

Figure 3. Quaternary structure of PhnF.
The YtrA sub-family represents only 6 % GntR-like regulators to date, among
which forms part of operons involved in ATP-binding cassette (ABC) transport system.
This sub-family contains the shortest C-terminal domain with about 50 amino acids on
average (Figure 4), increasing certain extents of doubts regarding the efficiency for
binding of the effecter molecule(/s). People hypothesizes that the binding of the small
molecules may impair the dimerization of this particular family of the transcription
regulators, which could cause the loss of DNA binding, thus further repress the
transcription. Combining with the sequence comparison and the secondary structural
predication, it was suggested that dimerization is quite necessary for this subfamily and

could be formed by positively
Figure 4. Quaternary structure of CFL2947 from Corynebacterium glutamicum.
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or negatively charged as well as hydrophobic and aromatic residues16. This hypothesis
soon proved by the X-ray structure of CFL2947 from Corynebacterium glutamicum
(Figure 4; PDB ID: 2EK5)17.
The DevA sub family of GntR transcription regulators has only be found in
bacterium Streptomyces 18. It showed that DevA is required for proper developments in S.
coelicolor, although the exact roles of these proteins have not been highly elucidated. The
C-terminal domain topology is clearly novel comparing to the others subfamilies. The Nterminal domain shares the most similarity with the HutC sub family 18. Since there are
no crystal structures available in this subfamily, the structure-function relationship
remains unclear.
AraR is another minor subfamily, which required for the extracellular degradation
of arabinose-containing polysaccharides, transport of arabinose, arabinose oligomers,
xylose, and galactose, intracellular degradation of arabinose oligomers, and further
catabolism of this sugar in B. subtilis
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. The C-terminal domain shows extensive

homology to the LacI/ GaIR regulator family. The crystal structure of the AraR (Figure 5;
PDB ID: 4EGY) demonstrated a high-level repression by co-ordinarily binding two-inphase 20, which might correlate with different physiological requirements. The high level
of repression is achieved by DNA bending requiring two in-phrase, whereas binding to a
single operator, which autoregulates AraR expression, is 10-fold less effective 21.
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Figure 5. Quaternary structure of DNA binding domain from AraR and its corresponding
DNA fragment.

PlmA subfamiy, the most newly discovered minor subfamily in 2003 that found
in cyanobacterial Anabaena sp. Strain PCC7120. It has been demonstrated that plmA can
affect on a cell’s ability to maintain its relative plasmid content. However, regulation
mechanism of PlmA remains unclear 22. Structurae wise, PlmA also has a novel topology
on the C-terminal domain, and appears to confine to the Cyanobacateria. The N-terminal
DNA binding domain appear to be closely similar to the MocR and YtrA subfamilies
suggesting that the E-b/O domain of PlmA may have been divergently replaced during
the evolution, despite their similarity in the DNA binding domain.
The MocR subfamily’s C-terminal domain is readily distinguishable from others
because of its exceptional average length of about 350 amino acids. It is also capable of
binding to a vitamin B6 derivitive-PLP. The PLP-binding putative aminotransferase
domains are closely related by amino acid sequence to the homodimeric type-I
aminotransferases. Aminotransferases are of the central importance in amino acid
metabolism and in links to carbohydrate and fat metabolism. Type-I aminotransferases
almost excusively exist as dimers in a head-to-tail fashion, and each subunit binds to one
molecule of PLP through an internal aldimine linkage with the amino group of the
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conserved lysine residue in the PLP binding site. This characteristic feature suggests that
the recruitment of such a domain in transcription regulation is likely to facilitate proteinprotein interaction/oligermerization.
MocR/GabR
The representative member of the MocR/GabR subfamily, GabR, is essential for
transcriptional activation of the pathway that controls the GABA degradation

23

. GABA

is an important nitrogen and carbon source in many bacteria. The GABA-inducible
gabTD pathway in B. subtilis allows utilization of extracellular GABA as the sole
nitrogen source to generate glutamate and succinate. The gabR gene in B. subtilis is
located upstream of the gabTD operon and is transcribed divergently. GabR functions as
the PLP- and GABA-dependent transcriptional activator of the gabTD operon and as a
negative autoregulator 3(Figure 6). Mutations in the conserved residues

Figure 6. Schematic of GabR binding sites at the gabR and gabTD promoters. A
schematic of the gabR and gabTD gene loci, as previously elucidated (2), is shown here.
The 47-bp GabR binding site (−63 to −17) within the gabR−gabT regulatory region is
shown in detail, and the two direct repeats (ATACCA) are indicated. The arrows indicate
the transcription start sites and directions for the gabR and gabT genes
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of the putative aminotransferase domain presumed to be crucial for the folding of the
domain and PLP-binding abolished the ability of GabR to activate the gabT promoter in
vivo but did not affect its activity as an autorepressor
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. Therefore, while the ability to

bind DNA may be sufficient for its autorepressor function, GabR is competent to activate
transcription from the gabT promoter only in the presence of PLP and GABA.
The gabT and gabD genes encode the two key enzymes for glutamate
biosynthesis: GABA aminotransferase (GabT) and succinic semialdehyde dehydrogenase
(SSDH or GabD), respectively. GabT is a type-I aminotransferase that catalyzes the PingPong transamination reaction using GABA as amino group donor, α-ketoglutarate as
amino group acceptor and PLP as co-enzyme to form the products, succinic
semialdehyde and glutamate 24. During the first half-reaction, GABA donates its amino
group to PLP, thereby releasing succinic semialdehyde and converting PLP to its
pyridoxamine 5’-phosphate (PMP) form (Figure 7).

In the second half-reaction, α-

ketoglutarate accepts the amino group to become glutamate and regenerate the PLP form
of the enzyme (Figure 7). In the downstream reaction, the NAD-dependent
dehydrogenase, GabD converts succinic semialdehyde (SS) to succinate. Null mutants of
gabR, gabT and gabD in B. subtilis were reported to be incapable of using GABA as the
sole nitrogen source

25

, further demonstrating that the functions of GabR, GabT and

GabD are all essential for GABA utilization.
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Figure 7. The GabT-catalyzed aminotransferase reaction. The first half reaction (GABA
to succinic semialdehyde) of the GabT-catalyzed Ping-Pong transamination is shown in
the boxed area. The second half-reaction is shown outside the boxed area.

CHAPTER TWO
CRYSTAL STRUCTURE OF BACILLUS SUBTILIS GABR, AN AUTOREPRESSOR
AND TRANSCRIPTIONAL ACTIVATOR OF GABT
Research Significance
B. subtilis GabR is a transcription factor that regulates gamma-aminobutyric acid
(GABA) metabolism. GabR is a member of the understudied MocR/GabR subfamily of
the GntR family of transcription regulators. A typical MocR/GabR-type regulator is
a chimeric protein containing a short N-terminal winged-helix-turn-helix DNA-binding
domain and a long C-terminal pyridoxal 5′-phosphate (PLP)-binding putative
aminotransferase domain. In the presence of PLP and GABA, GabR activates the gabTD
operon, which allows the bacterium to use GABA as nitrogen and carbon sources. GabR
binds to its own promoter and represses gabR transcription in the absence of GABA.
Here, we report two crystal structures of full length GabR from B. subtilis: a 2.7-Å
structure of GabR with PLP bound and the 2.55-Å apo structure of GabR without PLP.
The quaternary structure of GabR is a head-to-tail domain-swap homodimer. As
predicted base on sequence similarity, each monomer comprises two domains: an Nterminal winged-helix DNA-binding domain and a C-terminal PLP-binding type I
aminotransferase-like domain. The winged-helix domain contains putative DNA-binding
residues conserved in other GntR-type regulators. Together with sedimentation velocity
and fluorescence polarization assays, the crystal structure of GabR provides insights into
15
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DNA binding by GabR at the gabR and gabT promoters. The absence of GabR-mediated
aminotransferase activity in the presence of GABA and PLP, and the presence of an
active site configuration that is incompatible with stabilization of the GABA external
aldimine suggest that a GabR aminotransferase-like activity involving GABA and PLP is
not essential to its primary function as a transcription regulator.
Introduction
The MocR/GabR subfamily of chimeric proteins is widespread in bacteria and
regulates a variety of biological processes. All members of this subfamily are typically
composed of a 60- to 120-residue N-terminal winged-helix DNA-binding domain
resembling other bacterial transcriptional regulators from the GntR family, and a large Cterminal putative aminotransferase domain, averaging 300 aa in size and capable of
binding to the vitamin B6 coenzyme, pyridoxal 5′-phosphate (PLP) 25. The PLP-binding
putative aminotransferase domains are closely related by amino acid sequence to
homodimeric type I aminotransferases 26,27. GABA is an important nitrogen and carbon
source in many bacteria. The GABA-inducible gabTD pathway in Bacillus subtilis allows
utilization of extracellular GABA as nitrogen and carbon sources. The gabR gene is
located upstream of the gabTD operon and is transcribed divergently. GabR functions as
the PLP- and GABA-dependent transcriptional activator of the gabTD operon and as a
GABA-independent negative autoregulator (figure 6). 24, 25. Mutations in the conserved
residues of the putative aminotransferase domain presumed to be crucial for the folding
of the domain and PLP-binding abolished the ability of GabR to activate the gabT
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promoter in vivo but did not affect its activity as an autorepressor 25.
The gabT and gabD genes encode two enzymes for an alternative route of
glutamate biosynthesis using GABA: GABA aminotransferase (GabT) and succinic
semialdehyde dehydrogenase (GabD), respectively 25. GabT is a type I aminotransferase
28, 29

that catalyzes the Ping-Pong transamination reaction using GABA as an amino

group donor, α-ketoglutarate as an amino group acceptor and PLP as coenzyme to form
the products, succinic semialdehyde (SS) and glutamate. During the first half-reaction,
GABA donates its amino group to PLP, thereby releasing SS and converting PLP
to pyridoxamine 5′-phosphate (PMP) (Figure 7). In the second half-reaction, αketoglutarate accepts the amino group became glutamate and regenerates the PLP form of
the enzyme (Figure 7). In the downstream reaction, the NAD-dependent dehydrogenase,
GabD converts SS to succinate. Null mutants of gabR, gabT, and gabD in B. subtilis were
reported to be incapable of using GABA as the sole nitrogen source 25.
GabR binds specifically to an extended region of DNA that overlaps the −35 and
−10 elements of the gabT and gabR promoters, respectively 24(Figure 7). Using DNase I
foot printing experiments and native gel-shift experiments with purified GabR, a 47-bp
region of DNA (−63 to −17 relative to the gabT transcription start site) was identified as
the GabR binding site. The 47-bp minimal fragment contains two copies of the direct
repeat, ATACCA, which may be essential for GabR binding. Addition of PLP and
GABA did not noticeably alter the DNase I footprints, indicating that GabR is capable of
binding DNA in the absence of these molecules. Based on the extended 47-bp footprint, it
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was proposed that GabR binds to DNA either as a dimer or tetramer 24. It has been
reported that a GabR-catalyzed “partial” aminotransferase- like reaction involving GABA
and PLP may be essential for its transcriptional activator function 24. Interestingly, no
“full” two-step Ping-Pong–type GABA aminotransferase activity for GabR could be
detected in vivo, and overexpression of GabR was unable to restore GABA
aminotransferase activity in strains lacking gabT 24. Here, we report two crystal structures
of the PLP-bound and PLP-free forms of full-length B. subtilis GabR determined to be
2.7 and 2.55 Å, respectively. The crystal structure of GabR reveals a two-domain protein
organized as a distinct head-to-tail domain-swap homodimer. A long linker of 29 aa
separates the N-terminal winged-helix domain from the C-terminal domain, which has
the same overall fold as type I aminotransferases and is hereby called AT-fold domain.
Together with sedimentation velocity and fluorescence polarization data, the GabR
structure provides a model for DNA binding at the gabR-gabT locus by one or more
GabR homodimers. Key amino acid sequence changes in the putative substrate-binding
pocket of GabR relative to those of well-characterized type I aminotransferases suggest
that a GabR catalytic activity involving GABA and PLP is either absent or very poor
under physiological conditions. Our results strongly suggest that the AT-fold domain in
B. subtilis GabR, in a unique combination with the winged-helix domain, is primarily
relegated to a regulatory function at the gabR and gabT promoters.
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GabR is a Head-to-Tail Domain-Swap Homodimer
Sequence alignments of members of the MocR/GabR subfamily show that these
proteins comprise a small N-terminal winged-helix domain and a large C-terminal
putative type I aminotransferase domain

16, 25

. The crystal structure of GabR described

here is
Figure 8. Quaternary structure of GabR. GabR is a head-to-tail domain-swap homodimer.
The AT-fold domains are shown in light gray. The long linkers connecting the N-terminal
winged-helix domains to the C-terminal AT-fold domains are shown in green. The
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winged-helix domains are shown in blue-violet. The HTH motifs (orange) and the wing
motifs are labeled. An orthogonal view of the structure is shown in Figure 10.

the winged-helix subtype

30

and a C-terminal AT-fold domain (residues 110–470)

characteristic of the type I aminotransferase family 31, 32 and containing the signature long
bent α-helix (residues 345–386) connecting two subdomains. A long 29-residue linker
(residues 81–109) connects the winged-helix domain to the AT-fold domain (Figure 8 and
Figure 9).
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Figure 9. Quaternary structure of GabR. The structure is rotated 90° counterclockwise
along the y axis relative to Figure 8.

GabR crystallizes as a homodimer with the two monomers organized in the headto-tail domain-swapped interfaces. The larger interface is composed of two AT-fold
domains, which are also arranged in a head-to-tail manner to form the characteristic
homodimeric type I aminotransferase fold. The interface contains a buried area of 1,695
Å2 with a binding energy of −11.4 kcal/mol, suggesting that this interface stabilizes the
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GabR homodimer and is physiological. This interface of GabR, as seen in all type I
aminotransferases

31

, contains two PLP-binding pockets bound by one molecule of PLP

in each pocket.
The second interface is formed between the winged-helix domain of one
monomer and the AT-fold domain of the other monomer. This interface has a buried area
of 422 Å2 with a relatively low free energy of −3.8 kcal/mol, suggesting that the overall
quaternary structure of GabR may be dynamic in solution and that the winged-helix
domain may undergo large-scale domain movements, especially when bound by DNA.
The large dimer interface between the two AT-domains further suggests that any such
domain movements by the winged-helix domain do not require restructuring of the
AT−AT interface. Interestingly, we note that the extended N-terminal arms of the two
monomers of aspartate aminotransferase (Asp-AT) also reach over and interact with the
other subunit in that homodimer

32

. Because Asp-AT does not have an N-terminal

winged-helix domain, the significance of this “crossing over” of the N-terminal arm to
the other subunit in Asp-AT is not clear. Although there is reasonable electron density for
the long extended linker that connects the winged-helix domain to the AT-fold domain,
the linker does not form any significant contacts with the rest of the protein, suggesting
that it may be flexible in solution and may thereby facilitate the proposed winged-helixed
domain movements upon DNA binding.
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Figure 10. Imidazole is bound in the PLP-binding pocket of apo-GabR. The PLP-binding
site of the crystal structure of apo-GabR is shown. The 2Fo − Fc map (green mesh)
around the imidazole molecule is shown at 1σ level. The imidazole moiety and
surrounding side chains are shown as sticks. Carbon atoms are shown in white, oxygen
atoms in red, and nitrogen atoms in blue.

We also crystallized GabR without exogenous PLP. In the resulting apo-GabR
structure, PLP is no longer bound in the PLP-binding pocket, and instead, a molecule of
imidazole is bound in the same pocket (Figure 10). The purified protein is pale yellow in
color, suggesting that endogenous PLP from Escherichia coli is still bound to GabR
immediately after purification. Because imidazole is present in high concentrations in the
purification and crystallization buffers, the replacement of PLP by imidazole is most
likely a crystallization artifact. The overall similarity between the GabR−imidazole and
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GabR−PLP structures suggests that the AT-fold domain maintains its overall structural
integrity even when PLP is no longer bound.
GabR is a Dimer in Solution
We performed sedimentation velocity analysis to investigate the oligomeric state
of GabR−PLP in solution. In the absence of GABA, the sedimentation velocity plot
shows a predominant peak at 100 kDa, suggesting a dimer of GabR in solution even at
very low protein concentration (Figure 11; GabR molecular weight, 56 kDa). The plot
also shows two minor peaks at about 50 and 10 kDa, which may represent a small
proportion of monomer and degradation products, respectively. The sedimentation
velocity plot of GabR−PLP in the presence of GABA similarly shows a predominant
peak at 100 kDa and two low–molecular-weight peaks (Figure 11), again indicating a
dimer of GabR in solution. Also, during protein purification, GabR elutes as one major
peak on a Superdex 200 gel-filtration column with an apparent molecular weight of a
dimer (Figure 12). Based on the crystal structure, our expectation is that the AT−AT
dimer interface in the solution state of GabR may be similar to that found in the crystal
structure. Our sedimentation velocity data do not reveal tetramers and higher oligomers
in solution; however, further oligomerization of GabR may still occur when
GabR binds to DNA.
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Figure 11. Sedimentation velocity analysis of GabR. (A) Molecular weight of the
GabR−PLP sample determined from the global fitting of sedimentation velocity
data. (B) Molecular weight of the GabR−PLP sample in the presence of 20 mM GABA
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Figure 12. The gel-filtration profile of GabR The major peak for GabR (fractions 7-9) on
Superdex 200 16/60 corresponds to an apparent molecular weight of a dimer. The minor
peak (fractions 9-10) corresponds to that for a monomer.

Conserved Putative DNA-Binding Residues in the N-Terminal Winged Helix
Domain
The GabR N-terminal domain (residues 3–80) contains a canonical winged-helix
domain (α1-β1-α2-T-α3-β2-W- β3), where α2-T-α3 (residues 42–66) form the HTH motif
and W (residues 71–76) is the wing (Figure 13). In the case of GabR, a second wing is
absent. Although many winged-helix proteins contain a second wing, there are several
examples of wingedhelix proteins that bind DNA and in which the second wing is absent
33

. X-ray and NMR structures of winged-helix proteins in complex with DNA show that

the winged-helix domain uses diverse modes of DNA binding, with examples of this
domain binding DNA as a monomer, homodimer, or heterodimer 33.
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Figure 13. The GabR N-terminal winged-helix domain. TheThe GabR N-terminal
winged-helix domain (residues 3–80) is shown in detail. The various secondary structural
elements (α1-β1-α2-T-α3-β2-W-β3) are labeled. The helix-turn-helix (HTH) motif (α2-Tα3) is shown in orange. W is the wing (β2-W-β3).

In general, the most basic or positively charged surface of the winged-helix
domain binds to the negatively charged phosphate backbone or nucleotide side-chain
groups 33. Because the putative DNA-binding domain is conserved among GntR-type
transcriptional regulators, we searched the Conserved Domain Database 34 using the
GabR winged-helix domain sequence as a query. We found several hits, including E. coli
acyl-CoA–responsive transcription factor, FadR, and identified three putative DNAbinding residues in GabR (R43, S52, and K75) based on sequence conservation in FadR
and other GntR family members. Because these three residues (R43 and S52 in the HTH;
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K75 in the wing) also map to the most basic surface on the GabR winged-helix domain
(Figure 14) and are fully exposed in the GabR homodimer (Figure 15), we predict that
they may constitute a major DNA-binding surface.

Figure 14. The most basic surface on the GabR winged-helix domain. The electrostatic
potential surface of the GabR winged-helix domain is shown. The values
−1.000 and 1.000 on the scale bar represent acidic and basic electrostatic potential
surface charges, respectively. The orientation corresponds to the wingedhelix domain
shown on the bottom in Figure 8. The labeled residues denote amino acids that are
conserved between GabR and FadR.
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Figure 15. GabR electrostatic surface potential. The electrostatic surface potential
representation for the GabR homodimer in two different views. The figure on the Left is
in the same orientation as Figure 9. The dotted circle highlights the most basic surface on
the winged-helix domain. The figure on the Right is rotated 90° counterclockwise relative
to the figure on the Left.

To examine the DNA-binding roles of these conserved residues, we generated a
GabR−DNA model by superimposing the structural coordinates of the GabR wingedhelix domain onto those of the FadR−DNA complex [Protein Data Bank (PDB) ID code
1H9T 35]. In the FadR−DNA complex (Figure 16A), two winged-helix domains of a
FadR homodimer bind to a 19-bp operator sequence containing two copies of an inverted
repeat, TCTGGT, separated only by 3 bp 35. In contrast, the 47-bp GabR binding site
contains two copies of the direct repeat ATACCA separated by 34 bp of DNA. Because
we do not know exactly how GabR binds DNA, we only used one copy of the GabR
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winged-helix domain for the structural superposition (Figure 16B). The resulting
GabR−DNA model (Figure 16B) is identical no matter which FadR monomer we use for
the superposition and has several salient features. First, the HTH motif in FadR binds in
the major groove of DNA, whereas the wing invades the minor groove (Figure 16A).
Residue R35 in helix α2 of the FadR HTH motif makes two H-bonds with the first
guanine in the TCTGGT repeat (Figure 16A).
The conserved arginine residue R43 in GabR (Figure 16B)may form similar
sequence-specific contacts with one of the guanines in its direct repeat (double-stranded
sequence, ATACCA•TATGGT). In the turn of the HTH motif, FadR residue T44 (S52 in
GabR) makes H bonds with the phosphate backbone and provides a hydrophobic contact
to the central C−G base pair in the 19-mer, whereas residues in the α3 recognition helix,
which are typically known to bind the major groove of DNA 30, either contact the central
C−G base pair in the 19-mer (T46 in FadR; N54 in GabR) or a phosphate group (T47 in
FadR; S55 in GabR) in the major groove. In the FadR wing, residue K67 points between
two phosphate groups (Figure 16A). The GabR residue K75 (Figure 16B) could similarly
point between two phosphate groups. Because many residues are conserved between
FadR and GabR (Figure 17) and because the FadR and GabR DNA repeats have similar
sequences, we predict that some of the protein−DNA interactions will be similar between
the FadR−DNA and GabR−DNA complexes. However, because the GabR and FadR
repeat sequences are dissimilar in type, direction, and spacing, a crystal structure of the
GabR−DNA complex is required to eludicate all of the individual pairwise protein−DNA
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interactions.

Figure 16. Conserved putative DNA-binding residues in GabR. (A) The crystal structure
of the FadR−DNA complex is shown (PDB ID code 1H9T) (12). FadR binds DNA as a
homodimer. The protein and DNA are shown in cartoon and stick representation,
respectively. Side chains of some of the DNA-binding residues are shown as sticks and
labeled. The corresponding phosphate groups and nucleotides contacted by the protein
side chains are colored in orange. The central base pair in the 19-mer DNA is shown in
pink. Only the winged-helix domains of FadR are shown; the acyl-CoA–binding domains
are hidden for clarity. (B) A model of the GabR winged-helix domain bound to the 19-bp
FadR DNA sequence. Again, the central base pair in the 19-mer is colored in pink,
although only 12 of the 19 bp are shown for clarity. The phosphate groups and
nucleotides putatively contacted by GabR protein side chains are colored in orange. The
GabR protein side chains predicted to be involved in DNA binding are shown as sticks
and are labeled.

Figure 17. Sequence alignment of the winged-helix domain sequences of B. subtilis GabR
and E. coli FadR. A BLAST alignment of the HTH and wing motifs is shown. The green
asterisks highlight DNA-binding residues of FadR that are identical or similar in GabR.
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Second, because the two winged-helix domains of FadR interact with each other
on DNA (Figure 16A) 35, we examined whether such an interface is possible in GabR.
The GabR α3 helix is surface exposed (Figure 8) and has a sequence that is capable of
forming an α3−α3 interface similar to that of FadR (Figure 17 and Figure 18). Thus, two
copies of the GabR winged-helix domain may be able to interact with each other on DNA
under specific circumstances, for instance, when the direct repeats that are 34 bp apart are

brought into close proximity.

Figure 18. Two DNA-binding domains of GabR can interact on DNA through the “α3−α3
dimer interface.” A superposition of two molecules of GabR onto the FadR−DNA
complex is shown. The α3−α3 interface is indicated by the magenta circle. The acylCoA–binding domains of FadR and putative aminotransferase domains of GabR are not
shown for clarity. The protein and DNA are shown in cartoon and stick representation,
respectively. Side chains of some of the DNAbinding residues are shown as sticks and
labeled. The corresponding phosphate groups and nucleotides contacted by the protein
side chains are colored in orange. The central DNA base pair is shown in pink. Only the
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winged-helix domains of FadR are shown. The acyl-CoA–binding domains of FadR are
hidden for clarity.
Third, mutating the CC doublets in either of the two GabR direct repeats to GG led to a
10-fold decrease in DNA-binding affinity. Furthermore, mutating both CC doublets to
GG completely abolished GabR binding 24. These observations are consistent with our
GabR−DNA model, which suggests that residue R43 of GabR may form sequencespecific contacts with one of the guanines in its direct repeat. As is true for FadR (13) 36,
our GabR−DNA model predicts that mutating conserved residues like R43 and K75 may
abrogate or interfere with GabR−DNA interactions
GabR Binds DNA with High Affinity
The binding affinity of GabR for a 49-bp DNA containing the 47-bp GabR
binding site was determined by fluorescence polarization and competitive binding assays.
Previous studies estimated the apparent dissociationExperimental Procedures gabT
fragment to be around 1 nM 24. When a range of GabR protein concentrations were
titrated against the 47-bp carboxytetramethylrhodamine (TAMRA)-labeled DNA, we
observed a dose-dependent increase in polarization (Figure 19A), indicative of the
binding of GabR protein to DNA. The curve was fitted to the modified Hill equation (in
Experiments Procedures) and the dissociation constant of the GabR−DNA complex was
determined to be 70.2 ± 3.7 nM. A Hill coefficient of 2.2 ± 0.2 was obtained, indicating
positive cooperativity in the binding process. To establish specificity of binding and rule
out nonspecific effects from the TAMRA label, a competitive binding assay was
performed with unlabeled oligonucleotides containing the same sequence as the
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TAMRA-labeled DNA (Figure 19B). A preformed mixture of equimolar concentrations
of TAMRA-labeled DNA and GabR was titrated with increasing concentrations of
unlabeled DNA. The fluorescence polarization decreased with increasing amounts of
unlabeled DNA (Figure 19B). The curve was fitted to the Hill equation (Eq. 2 in
Experiments Procedures) and the IE50 of unlabeled DNA for GabR was calculated to be
98.1 nM ± 7.8 nM, which is similar to the dissociation constant of the TAMRA-labeled

DNA−GabR complex (Figure 19B). A Hill coefficient of 1.7 ± 0.4 was obtained,

Figure 19. Fluorescence polarization assays to measure DNA binding by GabR. Each
data point was measured in triplicate. The average values and errors were plotted and
fitted to the Hill equation. The abbreviations used in the figure are as follows: FPFTD,
fluorescence polarization signal of free labeled DNA; FPGTD, fluorescence polarization
signal of the GabR−DNA complex; KD, the dissociation constant; n, the Hill coefficient;
and IE50, the concentration of unlabeled DNA required to bind 50% of protein. (A)
Titration of GabR against 50 nM TAMRA-DNA. The GabR concentrations were varied
from 0 to 1,000 nM. Error bars are too small to be displayed if the errors are less than
1/1,000th of the measured value. (B) Competitive binding assay. Titration of unlabeled
DNA (0–1,000 nM) against a fixed concentration of preformed GabR-labeled DNA
complex (100 nM each of GabR and TAMRA-DNA).
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supporting the same type of positive cooperativity as shown in (Figure 19A). Although
the precise binding stoichiometry of GabR for DNA is still unknown, the dissociation
constants that we determined suggest a high-affinity GabR−DNA complex. The Hill
coefficients in both titrations indicate positive cooperativity in the binding of GabR
dimers to DNA.
PLP is bound in the C-terminal AT-Fold Domain
Like in other type I aminotransferases 31, 32, the AT-fold domain of GabR has two
subdomains, the large subdomain containing the invariant lysine (K312) that forms the
Schiff base with PLP and the small subdomain that typically interacts with the αcarboxylate group of the substrate. One molecule of PLP is bound per GabR monomer as
an internal aldimine at K312. We next compared the PLP-binding pocket of B. subtilis
GabR (Figure 20) with those of E. coli Asp-AT (PDB ID: 2AAT), the best-characterized
member of the type I aminotransferase family; and pig liver GABA-AT bound to the
substrate analog, γ-ethynyl GABA (GEG) (PDB ID: 1OHY) 32, 37. The active site residues
that facilitate PLP binding are conserved in all three cases. For example, the phosphate
group of PLP is situated very close to the N terminus of a nearby helix in all cases and is
stabilized by hydrogen bonds from polar residues (T181, T309, and S311 in the case of
GabR) to the phosphate oxygens. The salt bridge between an arginine residue (residue
R319) and the phosphate group is also conserved in GabR, although the phosphate group
has a different orientation compared with those in Asp-AT and GABA-AT. The primary
function of PLP is to stabilize the negative charge generated at the Cα atom of the
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transition state or external aldimine (Schiff base between an amino acid substrate and
PLP) by delocalizing the negative charge through the π-electron system of the cofactor. A
conserved aspartate residue [D279 in GabR, D222 in E. coli Asp-AT, D223 in chicken
mitochondrial Asp-AT 27, and D298 in GABA-AT; Figs. 5A and 6A] promotes this
electron sink nature of PLP by maintaining PLP in the protonated state through
interaction with the pyridinium nitrogen.

Figure 20. The PLP-binding pocket of B. subtilis GabR. The GabR residues that interact
with PLP are labeled.
Is GabR an enzyme?
We were currently unable to obtain crystals of a GabR−PLP−GABA complex, and
therefore, we examined the putative GABA-binding site in GabR−PLP to understand
whether GabR might catalyze an aminotransferase reaction involving GABA.
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Transamination reactions are ping-pong reactions that require two different amino acids
to be able to bind in the active site (GABA and glutamate, if GabR were an αketoglutarate– dependent GABA aminotransferase). Most aminotransferases use either
two conserved arginines or an extended hydrogenbonding network to recognize and bind
two amino acids with different shapes and properties 31. We superimposed the crystal
structures of B. subtilis GabR, pig liver GABA-AT−GEG 37, and E. coli Asp-AT 32 to
elucidate how different amino acids might bind in the active site of GabR. Even though
GabR, GABA-AT, and Asp-AT share the overall type I aminotransferase fold, their
polypeptide sequences are highly divergent. Also, the lengths of their secondary structural

Figure 21. PLP binding in aminotransferases and the arginine switch. (A) A schematic of
the interactions of the phenolic ring of PLP with surrounding protein side chains. The
corresponding residue numbers for Asp-AT (D223, N195, K258) and GABA-AT (D298,
Q301, K329) are indicated. The precise locations of the hydrogen atoms have not been
observed or measured so far. The H-atom positions indicated in the schematic are
therefore only inferred from reaction chemistry. (B) A schematic model for the arginine
switch in GABA-AT. The model is inferred from the crystal structure of pig liver GABAAT−GEG complex and adapted. The positions of the two conserved arginine residues in
the active site of GABA-AT and their interactions with the α- and γ-carboxylate groups of
glutamate are indicated.

elements vary significantly and contain insertions of α-helices and β-strands in different
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parts of the structures, making it difficult to obtain secondary structure-based
superposition. Therefore, we manually superimposed the pyridine ring of PLP to compare
the putative substrate- binding pockets in all cases.
If GabR were a bona fide aminotransferase, then the active site must be able to
interact with a keto acid such as α-ketoglutarate. In the active sites of Asp-AT and
GABA-AT, two conserved arginines stabilize such a keto acid to subsequently form the
related amino acid (Figure 21A)31. However, we found two key differences in the “active
site” of GabR, compared with these aminotransferases, which may compromise its ability
to transaminate GABA. First, the GabR active site may contain only one structurally
conserved arginine (R207) that is, however, not conserved by sequence. In Asp-AT and
GABA-AT, the equivalent arginine residue (R292* in the other subunit of the dimer in
Asp-AT and R192 in GABAAT(Figure 21B), is known to form a bidentate hydrogen
bond/ion pair with the γ-carboxylate of a dicarboxylate substrate such as glutamate,
whereas the second arginine (R386 in Asp-AT and R445 in GABA-AT; Figure 21B)
makes a similar direct contact with the α-carboxylate of the glutamate. Furthermore,
GABA-AT employs an arginine switch to distinguish between GABA and glutamate 31, 37.
When GABA binds, R192 stays in place to contact the carboxylate of GABA (Figure 22),
which is located in the same position as the γ-carboxylate of glutamate, while R445
moves away to accommodate GABA and engages instead in a salt bridge with a nearby
glutamate residue (E270; Figure 22A). Because only the first arginine residue in GabR
may be structurally conserved (R207; Figure 22B) while the second arginine is not, this
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suggests that GabR may bind GABA but not glutamate or other dicarboxylate substrates.
In the absence of conserved arginines, aromatic amino acid aminotransferases and
branched-chain aminotransferases use large-scale rearrangements of the active site
hydrogen-bond network or hydrophobic cavities lined with polar residues to
accommodate two different amino acids in the same site (refs. 9 and 15, and references
therein). However, because these features are not preserved in GabR, these alternative
substrate-binding mechanisms are unlikely for GabR. The second key difference in the
active site of GabR is related to its ability to stabilize the GABA external aldimine. When
the amino acid substrate forms an external aldimine, the imine N atom of the amino acid
and phenolic O atom of PLP could share an H-atom. Therefore, the phenolic O must be
optimally oriented to accept the hydrogen from the imine N during reprotonation and
hydrolysis to form PMP and release the deaminated substrate (Figure 21A). In Asp-AT,

Figure 22. PLP is bound in the AT-fold domain of GabR. (A) The substrate-binding
pocket in the GABA-AT−GEG structure. The secondary structure elements are shown in
cartoon form. Side chains of the key residues that interact with PLP and substrate analog,
GEG, are shown in stick representation and labeled. Hydrogen bonds are shown as dotted
green lines. (B) The putative substrate-binding pocket in the crystal structure of GabR.
The figure is drawn as described in A. The 2Fo − Fc map (blue mesh) around PLP is
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shown at 1.2σ level.

an asparagine (N195; Figure 21A) interacts with the phenolic O to hold it in place, and in
GABA-AT, a glutamine residue (Q301; Figure 21A) and a water molecule perform the
same function. In GabR, there is no such interaction with the phenolic O, implying that
the GABA external aldimine might not be optimally oriented for catalysis.
A sequence alignment of 10 MocR/GabR protein sequences from different strains
of B. subtilis, E. coli, Pseudomonas aeruginosa, Salmonella enterica, and Streptococcus
pneumoniae revealed an overall lack of evolutionary conservation for the arginine switch.
Although the residues involved in PLP-binding (equivalent of B. subtilis GabR residues,
D279, R319, and K312) are conserved in the examined homologs, we found the residue
corresponding to B. subtilis GabR (R207) to be highly variable. In contrast to GabR, all
of the PLP-interacting residues and the two substrate-interacting arginines are identical
between B. subtilis GabT, a known GABA aminotransferase, and pig liver GABA-AT
(Figure 23). Such a contrast indicates the functional divergence of GabR from its
evolutionary relatives. Together, these critical differences in the active site architecture
of GabR strongly suggest that GabR may bind GABA in a different manner than a true
transaminase and may only catalyze the “full” transamination reaction with poor
efficiency, if at all. Without the ability to accommodate glutamate effectively,
GabR may not be able to complete the second half-reaction and enzymatically regenerate
the PLP form of GabR. Consistent with our crystal structure and with previous reports
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that GabR does not rescue GabT activity 24, we were unable to measure a GABA-AT
activity for GabR in coupled steady-state enzyme assays (described in Experiments
Procedures). Also, UV-visible scanning spectrophotometry experiments of GabR in the
presence of PLP and GABA did not reveal any of the spectral shifts typically produced by

Figure 23. BLAST protein sequence alignment. Sequence alignment between B. subtilis
GabT GABA aminotransferase (upper sequence; 1–436) and pig liver GABA-AT (lower
sequence; 1–472) are shown. The two proteins share 25% sequence identity and 43%
similarity between their AT domains. The conserved residues interacting with the
substrate carboxylate groups (R192 and R445), the pyridinium N and phenolic O of PLP
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(D298 and Q301, respectively), and the invariant Schiff base lysine (K329) are
highlighted. The residue numbers in parentheses denote residues from pig liver GABAAT.

the PLP or PMP intermediates in a PLPdependent transamination reaction. Together,
these experiments suggest that GabR may have very poor or no GABA aminotransferase
activity under physiological conditions. Although the trifunctional NAD-dependent S.
enterica repressor. NadR is an example of a cofactor-dependent protein containing an Nterminal DNA-binding domain and two catalytically active domains [a middle
adenylyltransferase domain and a C-terminal nicotinamide ribose kinase 4], there is also
precedence for adaptation of enzymes to regulatory roles in other proteins. For instance,
PyrR, a UMP-dependent transcription attenuator for pyrimidine biosynthesis in B. subtilis
contains a type I phosphoribosyltransferase (PRT) domain without measurable catalytic
activity 38. The B. subtilis purine repressor PurR has a two-domain architecture like
GabR: an N-terminal wingedhelix domain and a C-terminal PRT domain devoid of
catalytic activity 39. It is of course possible that GabR recognizes other substrates or
possesses a different PLP-dependent enzymatic activity that may or may not be related to
its function as a PLPand GABA-dependent transcriptional activator of gabT. However, so
far, no other enzymatic activity for GabR has been reported.
Model for GabR-Mediated Transcriptional Regulation at the gabR and gabT
Promoters
Based on the crystal structure of GabR, the sedimentation velocity data and the
model for the GabR−DNA complex, we propose three possible modes for GabR binding
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and regulation at the gabR and gabT promoters (Figure 24). Because we do not know the
precise GabR:DNA binding ratio, we consider different models with one or more GabR
dimers bound to DNA. In model 1, two copies of GabR dimers bind to the 47-bp DNA
with only one winged-helix domain from each dimer binding to each direct repeat. That
the Hill coefficient for the GabR−DNA complex is close to 2 (Figure 19) further suggests
that GabR may cooperatively bind DNA as a dimer of dimers in the same way that a
dimer of λcII dimers binds its DNA operator 40. In the λcII−DNA crystal structure, as in
model 1, only one monomer from each λcII dimer binds its DNA sequence comprising
two direct repeats. Even though the spacings between the direct repeats in the binding
sites of λcII and GabR are different (6 and 34 bp, respectively), the cooperative binding
of GabR to DNA as a dimer of dimers is still possible. In model 2, only one copy of the
GabR dimer binds to the 47-bp DNA and both winged-helix domains of the dimer are
involved in DNA binding. In this model, the two winged-helix domains of one GabR
dimer may be rearranged and some bending of DNA may occur. The small buried surface
area (422 Å2) between the winged-helix domain and AT-fold domains suggests that the
position of the wingedhelix domain may be dynamic in
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Figure 24. A model for transcriptional regulation at the gabR and gabT promoters.
Different models for GabR binding in the gabR–gabT regulatory region are depicted. The
GabR homodimer is represented as a cartoon with one monomer shown in white and the
other colored gray. The larger oval represents the AT-fold domain and the smaller oval
represents the winged-helix domain. Putative conformational changes in the presence of
GABA are indicated by symbols with dashed lines.

solution and that the proposed domain movements are possible using large-scale
movements facilitated by the long linker. We recognize that other viable models still
exist. For example, the second winged-helix domain of a GabR dimer may bind to
unidentified cis binding sites located at larger distances from the gabR−gabT locus to
form large DNA loops. Intriguingly, a large basic surface at the AT−AT interface begs the
question whether this surface is somehow also involved in DNA binding (Fig. S8). These
models suggest that GABA may bring about conformational changes in GabR or the
GabR−DNA complex, and that these changes may be necessary to activate gabT
transcription, for instance, by recruiting RNA polymerase to the gabT promoter (Figure
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24). Crystal structures of GabR−DNA complexes with and without GABA may help
unravel some of these unknowns.
Biological Implicaions
Our studies suggest that GabR may not possess “full” GABA aminotranferase
activity, although it requires PLP and GABA to activate transcription at the gabT
promoter. It is likely that the primary function of GabR in B. subtilis is to regulate
transcription at the gabR and gabT promoters and that the AT-fold domain of GabR has
adapted to primarily serve as an effector binding domain. How the AT-fold domain of
GabR assists the wingedhelix domain in transcriptional regulation and how GABA
mechanistically affects gabT activation by GabR still remain to be determined.
In summary, these studies were published in the in the Proceedings of the
National Academy of Sciences of the United States of America (PNAS): Raji
Edayathumangalam, Rui Wu, Yuguang Wang, Roman Garcia, Wei Wang, Cheryl
Kreinbring, Jingling Liao, Todd Stone, Quyen Q. Hoang, Boris Belitsky, Gregory A.
Petsko, Dagmar Ringe, and Dali Liu. (2013) 110 (44), 17820-17825.(Equal contribution
first author)
Materials and Methods
Protein Expression and Purification. The full-length coding region of the Bacillus
subtilis gabR gene (residues 1–479) was subcloned from a pBAD construct into pETite
C-His vector (Lucigen), which encodes an inducible T7 expression system. The Cterminally His6-tagged protein was expressed in Escherichia coli strain BL21 (DE3).
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Transformed cells were grown in LB media containing kanamycin at 37 °C to OD600 of
0.6 and induced with 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) at 37 °C for
4 h. Cells were harvested, resuspended in buffer containing twofold PBS buffer and 10
mM imidazole (pH 7.5), and sonicated. Insoluble material was removed by
centrifugation. The GabR-His6 protein (molecular weight, 56 kDa) was purified to
homogeneity by affinity chromatography Ni-NTA (GE Healthcare) and gel filtration
(HiLoad 16/60 Superdex 200 pg; GE Healthcare) in buffer containing twofold PBS (274
mM NaCl, 5.4 mM KCl, 16 mM Na2HPO4, 2.92 mMKH2PO4, pH 7.4), 475 mM
imidazole (pH 7.5), 1 mM pyridoxal 5′-phosphate (PLP), and 5% (vol/vol) glycerol. The
protein requires high salt and imidazole concentrations to stay soluble without
precipitation. Alternatively, the presence of 5% (vol/vol) glycerol and 0.5% Nonidet P-40
in the buffer helps to keep GabR soluble without the need for NaCl and imidazole.
Purified GabR-His6 protein was concentrated (Centricon Plus centrifugal filter units;
Millipore) and stored at 4 °C for short term ( 4 wk) or flash frozen in 50-μL aliquots in
liquid nitrogen after the addition of 15% (vol/vol) glycerol and stored at −80 °C for longterm use. The concentrated sample of purified GabR was pale yellow in color, indicating
that PLP was bound to the protein.
Analytical Ultracentrifugation Analysis. The oligomeric state of GabR−PLP in
solution was analyzed by sedimentation velocity using a Beckman-Coulter Optima XL-I
ultracentrifuge. The experiments were conducted at low protein concentrations (30, 50,
and 80 μg/mL) in the presence of 0.5 mM PLP and in the presence and absence of 20 mM

47
GABA. In each experiment, 450 μL of the protein solution was loaded into a sectorshaped centrifugation cell at concentrations corresponding to OD230 values of 0.3, 0.5,
and 0.8. The samples were spun at 48,000 rpm (Beckman AN60Ti Rotor) for 5 h with
radial scans capturing the boundary distribution every 2 min until the sample had almost
completely pelleted. Boundary profiles from sedimentation velocity scans were collected
and analyzed using the UltraScan II software suite. Initial model-independent van Holde–
Weischet analysis of the data clearly showed no evidence of mass action over the
concentration range investigated, thereby confirming an absence of dynamic equilibrium
between species. Therefore, all data were fit to a 50-iteration global genetic algorithm–
Monte Carlo (GA-MC50) model, which showed a narrow and randomly distributed
residual, indicative of good data quality and modelfitting.
Fluorescence Polarization DNA-Binding Assay. Fluorescence polarization data
for the GabR–DNA complex were obtained using an EnVison 2102 Multilabel Plate
Reader (Perkin-Elmer). Two 49-bp complementary single-stranded DNA
oligonucleotides containing the 47-bp GabR binding region (5′
TCTGATACCATCAAAAAGTTATAATTGGTACTTTTCATCATACCAAAGA3′) were purchased from Integrated DNA Technologies. The oligonucleotides were either
unlabeled or labeled at the 3′ end with the fluorophore, TAMRA. The double-stranded
oligonucleotides were prepared by annealing a mixture containing equimolar
concentrations of the two single-stranded oligonucleotides. For the fluorescence
polarization assay, varying concentrations of the GabR protein was titrated against a
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fixed concentration of TAMRA-labeled DNA (50 nM). GabR protein was serially diluted
in the DNA binding buffer [20 mM Tris·HCl, pH 8.0, 50 mM KCl, 2 mM MgCl2, 5%
(vol/vol) glycerol, 1 mM EDTA, 1 mM DTT, and 0.05% Nonidet P-40]. The TAMRADNA (50 nM) was mixed with the serially diluted GabR protein (final concentration,
0–1,000 nM) and 100 μL of each sample mixture was loaded into the individual wells of
a 384-well microplate. In the competitive binding assay, varying concentrations of
unlabeled DNA were titrated against a fixed concentration of preformed GabR-labeled
DNA complex (100 nM GabR and 100 nM TAMRA-DNA). The fluorescence
polarization (FP) signals of the GabR−DNA mixtures were measured with fixed
excitation (531 nm) and emission (595 nm) wavelength filters at room temperature.
Fluorescence intensity remained constant throughout the polarization measurements. The
fluorescence polarization signal for each sample was calculated and plotted against the
GabR protein concentrations in the fluorescence polarization assay and against the
concentrations of unlabeled DNA in the competitive binding assay. Each data point is the
average of three independent measurements. The titration plot for GabR versus TAMRADNA was fitted to a modified Hill equation (Eq. S1) in ORIGIN software to calculate the
dissociation constants and Hill coefficient. For the competitive binding assay, the IE50
value and Hill coefficient were obtained by fitting the data points to the
Hill equation. (Eq. S2).
(FPGTD – FPFTD) = [TAMRA-DNA]n / KnD+ [TAMRA-DNA]n;

[1]

where FPGTD represents FP signal when TAMRA-DNA is saturated with GabR; FPFTD
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represents FP when all TAMRADNA is free in solution without any GabR bound; KD is
the dissociation constant for the GabR–TAMRA-DNA complex; and n is the Hill
coefficient.
(FPGTD – FPFTD) = [Unlabeled DNA]n / (IEn50 +[Unlabeled DNA]n),

[2]

where FPGTD, FPFTD, and n are the same as in Eq. S1; IE50 represents the
concentration of unlabeled DNA needed to bind 50% of protein.
Crystallization. Crystals of GabR were obtained by the hangingdrop method using
protein at 5 or 10 mg/mL The initial sparse matrix screen was set up with the Gryphon
crystallization robot (Art Robbins Instruments) to obtain initial crystallization hits, which
were further optimized manually to obtain crystals with the best size and morphology.
The optimized crystallization solution contained 33% (vol/vol) PEG400, 200 mM
calcium acetate, and 200 mM imidazole, pH 7.5. The hanging drops were incubated at 20
°C or room temperature. Crystals appeared in 5 d and grew to maximum size in 1–2 wk.
Crystals with good morphology and size were picked directly from the hanging drops and
flash-cooled in liquid nitrogen. The heavy metal derivatives were prepared by soaking
crystals in 10 mM ethylmercury phosphate for 1 h before flash- cooling in liquid
nitrogen. The heavy metal soaking condition also included 1 mM PLP.
Data Collection and Processing. Single-wavelength anomalous dispersion
(SAD) data were collected at beamlines 19-ID and 19-BM at Advanced Photon Source,
Argonne National Laboratory. X-ray diffraction data for the mercury derivative of holoGabR (Table 1, Dataset 1) and for holo- and apo-GabR native crystals (Table 1, Datasets
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2 and 3) were collected at the wavelengths of 1.0039 and 0.9792 Å, respectively. The
datasets were indexed, integrated, and scaled with either the HKL package 41 or iMosflm
and Scala programs in the CCP4 program suite 42. The datasets were all scaled in the
space group P212121 to resolutions of 3.1, 2.7, and 2.55 Å, respectively. The data
statistics are reported in Table 1.

51
Table 1. Data collection and refinement statistics for full length GabR
(1) GabR-PLP,
mercury derivative

(2) GabR-PLP, native

(3) apo-GabR,
native

Wavelength (Å)

1.0039

0.9792

0.9792

Space Group

P212121

P212121

P212121

30-3.1 (3.15-3.1)

50-2.71 (2.76-2.71)

49.3-2.55

98.1 101.1 211.2

97.2 101.3 211.2

99.9 101.4 213.2

39106

57413

68270

6.7 (6.8)

4.8 (3.8)

5.8 (5.6)

Completeness (%)

100 (100)

99 (97.9)

95.8 (90.7)

Linear Rmergea (%)

10.7 (71.6)

0.102 (ND)

11.7 (68.7)

I/σ

21.9 (2.9)

18.7 (1.0)

9.4 (2.2)

Average Wilson Bfactor

67.7

59.9

38.7

Datasets

Resolution

range

(Å)
Unit cell (a b c)
(Å)
Total
reflections

unique

Multiplicity

Rcrystb

0.2124

0.1947

Rfreec

0.2556

0.2461

15247

15514

15108

15139

Ligands

99

73

Water

40

300

RMSDd bonds (Å)

0.005

0.010

RMSDd angles (°)

1.02

1.405

Ramachandran
favored (%)

94.0

89.8

Ramachandran
outliers (%)

1.5

3.5

Average B-factor
(Å2)

82.7

47.4

Macromolecules

82.6

63.0

Solvent

55.2

50.5

Number of atoms
Macromolecules
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The values for the highest resolution bin are in parentheses.
a

Linear Rmerge = Σ|Iobs-Iavg|/ ΣIav

b

Rcryst = Σ|Fobs-Fcalc|/ ΣFobs

c

Five percent of the reflection data were selected at random as a test set and only these data were used to
calculate Rfree.

d

RMSD, root mean square deviation.

ND, Not Determined/Calculated by the program

Sequence and Structure Analyses. GabR homologs were identified in the
sequence database using BLAST ; multiple sequence alignment using BLAST; conserved
domain searches using CDD (4) 34; buried surface area from PDBePISA server
(http://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver); and structural similarity using
DALI 43. Secondary structure superimpositions were done in Coot. Electrostatic surface
potentials were calculated with PyMOL (The PyMOL Molecular Graphics System,
version 1.5.0.4; Schrödinger). Figs. 3, 4, 6, and 9, and Figs. S2, S4, S5, S7, and S8 were
drawn with PyMOL.
Structure Solution, Model Building, and Refinement. Automated substructure
solution by AutoSol in PHENIX 44 found 15 heavy atom peaks in the mercury dataset
(Table 1, Dataset 1) and identified fourfold noncrystallographic symmetry (NCS) using
superposition of the mercury sites. AutoBuild in PHENIX automatically built 80% of
the residues. The initial phases were extended and refined to 2.7 Å using the native holoGabR dataset (Table 1, Dataset 2) to yield improved maps and further improved by
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fourfold NCS averaging and density modification. The remainder of the model was built
manually in Coot 45 guided by the structure of Thermococcus profundus multiple
substrate aminotransferase [Protein Data Bank (PDB) ID code 1WST], a homolog
obtained from the FFAS03 server (http://ffas.burnham.org/ffas-cgi/cgi/ffas.pl). Several
loops accounting for gaps in the model were placed and refined by a combination of
manual building and the fit_loops routine in PHENIX. Next, MR-SAD using the model
and the mercury dataset identified five more mercury sites and led to even better maps.
Several iterative rounds of manual model building and refinement using the maximumlikelihood amplitude targets in PHENIX and Rosetta using simulated annealing (in the
initial stages) and automatic NCS restraints were required to obtain the final model. The
initial model ( 80% complete) had Rcryst and Rfree values of 0.393 and 0.484,
respectively, for all data between 45.0 and 2.7 Å. The Rcryst and Rfree values of the final
model (98% complete) are 0.229 and 0.265, respectively. The final model of the
GabR−PLP complex consists of two homodimers of GabR in the asymmetric unit with
470 residues out of 479 accounted for in each monomer. The final model also contains 1
molecule of PLP per monomer, 16 molecules of ethylmercury, and 52 water molecules.
The quality of the final model is summarized in Table S1. This model has been deposited
in the PDB and is available with ID code 4N0B. The native dataset of apo-GabR (Table
1, Dataset 3), which was processed to a resolution of 2.55 Å, was phased by molecular
replacement using the final model of GabR as the input model.
The Rfactor and Rfree values of the final model from the native dataset are 0.195
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and 0.246, respectively. Other model statistics are summarized in Table S1. This model
has been deposited in the PDB with ID code 4MGR. The density for PLP is lacking in
this structure, as expected. We interpreted a difference density peak in the PLP-binding
pocket as imidazole (Figure 10) because imidazole is a major component in the protein
purification and crystallization buffer.
GabR Enzyme Assay. Activity was measured using varying concentrations
of GabR protein in an assay buffer containing 100mM Tris·HCl, 5 mM DTT, 100 mM
KCl, 100 μM PLP, 20 mM GABA, 20 mM α-ketoglutarate, 500 μM NADP+, and 3 units
of aldehyde dehydrogenase (ADH). In the coupled assay, ADH consumes the product of
the first half-reaction (succinic semialdehyde) to produce succinate. The coupled reaction
is measured spectrophotometrically (absorbance change at 340 nm) from the concomitant
reduction of the cofactor, NADP+ to NADPH.

CHAPTER THREE
PLP AND GABA TRIGGER GABR-MEDIATED TRANSCRIPTION REGULATION
IN BACILLUS SUBSILIS VIA EXTERNAL ALDIMINE FORMATION
Research Significance
The Bacillus subtilis protein GabR activates the biosynthesis of glutamate from γaminobutyric acid (GABA) at the transcription level upon binding to pyridoxal-5’phosphate (PLP) and GABA. We herein report that the external aldimine formed between
PLP and GABA is apparently responsible for triggering the GabR-mediated transcription
activation. A crystal structure of the GabR effector-binding/oligomerization (Eb/O)
domain (residues 88-479) in complex with both PLP and GABA revealed the formation
of a PLP-GABA Schiff base. Details of the GABA binding site in the Eb/O domain
structure suggest that binding monocarboxylic γ-amino acid such as GABA should be
preferred over dicarboxylic acid ligands. A reactive GABA analog, (S)-4-amino-5fluoropentanoic acid (AFPA), was used as a molecular probe to examine the reactivity of
PLP in both GabR and a homologous aspartate aminotransferase (Asp-AT) from E. coli
as control. The comparison between the complex structures of Eb/O-PLP-AFPA and
Asp-AT-PLP-AFPA revealed that GabR is incapable of facilitating further steps of the
transamination reaction after the formation of the external aldimine. Results of in vitro
and in vivo assays using full-length GabR support the conclusion that AFPA is a
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agonistic ligand capable of triggering GabR-mediated transcription activation via
formation of an external aldimine with PLP
Introduction
Bacterial transcription regulators are often directly responsive to the changes in
metabolite concentration 15, 16. GabR responds to the increase of GABA concentration in
bacterial cells 25 and upregulates glutamate regeneration from GABA. Belonging to the
MocR/GabR subfamily in the GntR family of bacterial transcription regulators 16, 25.
GabR-type regulators characteristically have a large C-terminal Eb/O domain, which is
homologous to the type I aminotransferases 31, and a small N-terminal “winged-helixturn-helix” (wHTH) DNA-binding domain 26. In B. subtilis, GabR represses its own
transcription 24, 25. With both PLP and GABA bound, GabR activates the transcription of
two genes, gabT and gabD, which encode the enzymes GABA aminotransferase (GABAAT) and succinic semialdehyde dehydrogenase (SSA-DH) respectively, forming a
pathway for glutamate regeneration from GABA 24, 25.
Previously, we have reported the crystal structures of full-length GabR as a
“head-to-tail” dimer 46, in which electron density supported the existence of PLP bound
to K312 of the Eb/O domain in the form of an internal aldimine. Although the PLPbinding site of GabR is largely conserved compared to that of type I aminotransferases,
no aminotransferase activity has been detected for GabR 46. To our knowledge, the
existence of PLP in MocR/GabR- type transcription regulators is the only case known in
nature where PLP functions as an effector in transcription regulation, including the other
reported case of a MocR regulator PdxR that controls the biosynthesis of PLP in bacteria
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47-49

. A previous report on GabR has shown that a “second metabolite pair” of

pyridoxamine-5’-phosphate (PMP) and succinic semialdehyde (SSA) could also cause
transcription activation upon binding to GabR 24. The first half of the “Ping-Pong”
transamination catalyzed by GABA-AT (Schemes 1 and 2) in fact converts PLP and
GABA to PMP and SSA, reversibly 50. It was hypothesized that certain step(s) of the
aminotransferase reaction might be required to trigger GabR-mediated transcription
activation 24. Such hypothesis has not been proven, and the chemical identity of the
GabR-PLP-GABA complex that results in transcription activation remained unknown.
Using X-ray crystallography, NMR spectroscopy and biological assays, an external
aldimine species formed between PLP and GABA when both bound to the effector
binding site of GabR has been identified and is apparently responsible for triggering
GabR-mediated transcription activation.
Crystallography of GabR Eb/O Domain and Asp-AT Complexed with Ligands
Three complex structures with PLP-ligand adducts bound were obtained through
co-crystllization. X-ray crystal structures were determined and refinment of all three
complex structures converged with good statistics (Table 2). The Schiff base adducts
were built into the electron density maps (fo-fc) in the final rounds of refinement. The
formed adduct was confirmed by the simulated annealing omit difference maps (fo-fc)
generated in Phenix
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. The final models for EB/O-PLP-GABA, EB/O-PLP-AFPA and

Asp-AT-PLP-AFPA have been deposited in the Protein Data Bank (PDB) with accession
codes XXXX, YYYY and ZZZZ, respectively. The full length GabR was truncated to its
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Eb/O domain (residues 88-479), expressed, purified and co-crystallized with PLP and
GABA. The complex structures Eb/O-PLP-GABA and Eb/O-PLP-AFPA were solved
with molecular replacement and refined at 2.23 Å resolution and 2.25 Å resolution,
respectively. The complex structure of Asp-AT-PLP-AFPA was solved and refined at
1.53 Å resolution. The overall structure of the Eb/O domain retains the same “head-to-

tail” homodimer architecture as those in the full-length GabR and type I
aminotransferases (Figure 25).
Figure 25. Head-to-tail-dimers of the full-length GabR (PDB code: 4N0B), Eb/O
domain of GabR and Asp-AT. Bound PLP’s are shown in spheres. a) In the full length
GabR, the Eb/O domains are in red, the flexible linker regions are in orange, and the
DNA-binding domains are in blue. b) An overlay of two dimeric structures of the GabR
Eb/O domain in complexes with GABA (magenta) and AFPA (green). c) The dimeric
structure of E. coli Asp-AT (PDB code 1SFF, cyan).
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Table 2. Data collection and refinement statistics for GabR Eb/O domain
Protein

GabR-EBO/GABA

GabR-EBO/AFPA

Asp-AT/AFPA

Data processing
Space group

C2221

C2221

C2221

α, β, γ (°)

90.0; 90.0; 90.0

90.0; 90.0; 90.0

90.0; 90.0; 90.0

a, b, c (Å)

92.4; 128.9; 65.1

96.6; 127.5; 67.6

84.9; 154.9; 79.3

49.2 - 2.23

50.8 - 2.25

29.0-1.53

(46.4)b

(64.4)b

6.8 (68.7)b

Cell dimension

Resolution (Å)
aR

merge

(%)

7.5

8.3

I/σ (I)

29.3(4.7)b

12.6(1.2)b

34.0(1.7)b

Completeness (%)

99.8(97.9)b

96.2(78.4)b

98.2(83.4)b

5.5 (4.9) b

3.1 (2.5) b

12.2 (5.6) b

No. Reflections

248492

132836

1914313

No. Unique Reflections

19166
Refinement

19311

147549

17.44/21.07

18.82/23.70

14.88/16.55

2921

2292

3465

Multiplicity

cR

d
work/ Rfree

(%)

No. of Atoms
Protein
Ligand

22

24

32

Water

136

182

510

40.41

42.24

23.72

28.60/41.18

24.80/43.97

13.05/27.80

Bond length (Å)

0.005

0.003

0.007

Bond angle (°)

0.862

0.604

1.128

Most Favored (%)

96.69

96.40

97.17

Allowed (%)

3.04

3.32

2.61

Outliers (%)

0.28

0.28

0.22

B-factors(Å2)
Protein
Ligand (Lowest/Highest)
eRMSD

(from ideal values)

Ramachandran plot

a

Rmerge = Σ|Iobs-Iavg|/ ΣIavg
The values for the highest resolution bins are in parentheses.
c
Rwork = Σ|Fobs-Fcalc|/ ΣFobs.

b
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d

Five percent of the reflection data was selected at random as a test set, and only these data were used to
calculate Rfree.
e
RMSD, root mean square deviation

Details of the Effector Binding Site in the GabR Eb/O Domain and Schiff Base
Formation between PLP and GABA
In the effector-binding pocket of the Eb/O domain, the omit map difference
electron density (fo-fc) revealed the existence of a Schiff base formed between PLP and
GABA Figure 26a). Three basic residues, R207, R430 and H114, from the same subunit
interact with the carboxylate of the GABA moiety. In a complex structure of GABA-ATPLP-aminooxyacetate (AOA) (Figure 26a), the PLP-AOA adduct mimicks the PLPGABA external aldimine, whose carboxylate interacts with one of the conserved arginine

Figure 26. PLP and GABA bound to the truncated Eb/O domain. a) The simulated
annealing omit map (fo-fc) is shown around the PLP-GABA Schiff base at 3σ. b) Eb/OPLP-GABA in comparison to GABA-AT with aminooxyacetate (AOA) bound to PLP
mimicking the PLP-GABA external aldimine (green, PDB code: 1SFF).
transamination reaction (Scheme 1).
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residues (R141) 52. Compared with the homologous type I aminotransferases such as
GABA-AT (Figure 26B), GabR is missing one (R141 in GABA-AT) of the two
conserved arginines, which are involved in binding to dicarboxylic acid substrates 37, 52,
such as L-glutamate or 2-ketoglutarate, in the second-half of a typical
This observed structural difference suggests that GabR has evolved to preferentially
recognize monocarboxylic acids, such as GABA, and orient the ligand in favor of
forming a Schiff base with PLP.

Scheme 1. The Mechanism of First Half of the GABA-AT Reaction.

Interestingly, the preserved basic residues in GabR are not aligned with GABAAT residue R141, which is proposed to interact with the GABA carboxylate 33, 52. While
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the aminooxyacetate (AOA)-PLP adduct, which mimics the GABA-PLP in the E. coli
GABA-AT structure, binds to the active site in an anti conformation, the PLP-GABA
Schiff base in GabR is in a gauche conformation (Figure 3b). The dihedral torsional
angle of C2-C1-O-N in the PLP-AOA “structural mimic” is measured to be 156.7° (13.3°
off from an ideal anti-conformation) in UCSF Chimera. In the complex structure of
Eb/O-PLP-GABA, the GABA moiety displays a gauche conformation (Figure 27).

Figure 27. GABA Moiety Displays a Gauche Conformation. (a) The GABA bound in the
Eb/O domain is in a gauche conformation. The PLP-GABA external aldimine is shown
in stick and ball form. The Cγ atom is placed (hidden) behind the Cβ atom, in the same
orientation as the Newman projection for the dihedral torsional angle Cα-Cβ-Cγ-N in the
PLP-GABA. A Newman projection of a PLP-GABA Schiff base is shown in a gauche
conformation. (b) The aminooxyacetate (AOA)-PLP imine bound in E. coli GABA-AT
(PDB code: 1SFF) mimicking the PLP-GABA Schiff base was shown in ball and stick
form. The O atom is placed (hidden) behind the C1 atom in the same orientation as the
Newman projection for the dihedral torsional angle C2-C1-O-N in the PLP-AOA. A
Newman projection of a PLP-GABA Schiff base is shown in an anti-conformation.
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The dihedral torsional angle of Cα-Cβ-Cγ-N in PLP-GABA Schiff base was measured to
be 77.3° (17.3° off from an ideal gauche conformation) in UCSF Chimera. Compared to
the anti conformation, the gauche conformation is of higher energy and a relatively minor
conformation for GABA molecule dissovled in an aqueous environment in the cell.
Herein, we speculate that GabR’s preference for a gauche conformation could be an
evolutionary outcome to sense the GABA’s concentration buildup instead of detecting
the basal GABA level inside the cell. Alternatively, we speculate that the chemical strain
could be released and provide extra energy for GabR’s action after or during transcription
activation.
In all PLP-dependent enzymes, a conserved lysine forms an internal aldimine with
PLP in a resting form and acts as a key catalytic residue during catalytic reactions, such
as in the first half of the “Ping-Pong” transamination 31 (Scheme 1). The conserved K312
46

(Figure 28) was previously proven to be essential for GabR’s function, although the

catalytic capacity to facilitate transamination was never detected for GabR 24. In the
Eb/O-PLP-GABA complex structure (Figure 2a), Y281 is observed to block K312 from
accessing the PLP-GABA Schiff base, preventing the reformation of the internal aldimine
as well as further transamination-like catalysis, in which the freed catalytic lysine would
deprotonate the carbon adjacent to the nitrogen atom of GABA (Scheme 1) 33, 37. As a
result, GabR is unlikely to catalyze the first half of the transamination reaction shown in
Scheme 1. As we previously reported 46, in the absence of GABA, Y281 is found in a
different orientation, allowing internal aldimine formation (Figure 28). The observed
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obstruction by Y281 supersedes the previous speculation that GabR’s inability to
stabilize the external aldimine might be the reason for no observed transaminase
activity46.

Figure 28. Comparison of the external aldimine vs. internal aldimine in GabR. Schiff
bases, K312, and Y281 are shown in stick form. Labels and carbon atoms for internal
aldimine (PDB code: 4N0B) are in black and grey, respectively. Labels and carbon
atoms for Eb/O-PLP-GABA are in magenta. Labels and carbon atoms for Eb/O-PLPAFPA are in cyan.

External Aldimine as the Final Adduct of GabR-Mediated Reaction
The Eb/O-PLP-GABA complex structure at 2.23 Å resolution could not allow us
to distinguish between external aldimine and ketimine (Scheme 1) for the chemical
identity of the PLP-GABA Schiff base observed. Therefore, we used a mechanism-based
inactivator, (S)-4-amino-5-fluoropentanoic acid (AFPA), which was designed to
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irreversibly inactivate PLP-dependent aminotransferases 53, as a molecular probe. A
previously proposed inactivation mechanism of an aminotransferase, mammalian GABAAT, by AFPA is shown in Scheme 2. Once a typical aminotransferase reaction
progresses beyond the external aldimine 1 stage, the AFPA moiety loses the fluorine
group, resulting in a reactive intermediate. Eventually, AFPA inactivates the PLPdependent aminotransferase via a ternary adduct, in which the AFPA moiety is covalently
linked to both PLP and the catalytic lysine, or alternatively forms external aldimine 3.
The catalytic lysine freed after the formation of the external aldimine 1 plays a critical
role in assisting the irreversible inactivation of the PLP enzyme. The formation of the
proposed ternary adduct should provide evidence that the reaction between AFPA and
PLP can progress beyond the external aldimine 1, reaching quinonoid or ketimine
intermediates (Schemes 2 and Figure 29 )
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Scheme 2. Proposed Reaction Mechanism of AFPA. The green dashed box (1) shows
the final adduct in the GabR Eb/O domain; the red dashed box (2) shows the expected
adduct for Asp-AT; the blue dashed box (3) indicates an alternative external aldimine
species
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Figure 29. Fluorine NMR Spectra. a) Fluorine NMR showing a triplet of doublets (J1 =
25.3 Hz, J2 = 21.4 Hz). b) Proton-decoupled fluorine NMR spectrometry that shows a
singlet.

In contrast, the intacted fluorine group of AFPA should indicate that the reaction
cannot proceed beyond the formation of the external aldimine 1. E coli Asp-AT, a
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homolog of the GabR Eb/O domain, has been used successfully as a model enzyme to
study mechanism-based inactivators of PLP-dependent enzymes 54-56. Due to the
desirable crystallographic behavior of Asp-AT in various co-crystallization conditions,
we chose it as a control for the co-crystallization experiment with AFPA.
Both the GabR Eb/O domain and Asp-AT were co-crystallized with PLP and
AFPA. The structure of the Eb/O-PLP-AFPA complex (refined at 2.25 Å resolution)
confirms the formation of external aldimine with the fluorine atom intact in the final
adduct (Figure 30) To validate the existence of the fluorine atom, extra rounds of
refinement were done after deletion of the fluorine atom; the omit map difference density
(fo-fc) strongly supports the presence of the fluorine atom in the complex. Residue Y281
is observed to be in the same position as that in Eb/O-PLP-GABA complex structure
(Figure 27), preventing the access of K312 to the PLP-AFPA Schiff base, which
otherwise could potentially push the reaction further along the proposed inactivation
pathway (Scheme 2).
Furthermore, the AFPA-treated protein sample was subjected to NMR studies to
eliminate the possibility of an alternative adduct (adduct 3 in Scheme 2, via pathway b in
Scheme 2). Pathway b and adduct 3 were never previously proven in the studies of the
AFPA inactivation. However, it is chemically plausible that a hydroxyl or water could
react with the reactive intermediate and replace the eliminated fluorine group; the
resulting adduct 3 would be structurally similar to the external aldimine proposed here
(adduct 1 in Scheme 2). At 2.25 Å resolution obtained for the complex structure Eb/O-
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PLP-AFPA, it is impossible to distinguish adduct 3 from adduct 1 even with the omit
map difference density (fo-fc) validation shown (as green mesh) in Figure 30a. Fluorine
NMR spectrometry was hence employed to eliminate this hypothetical possibility. The
results are shown in Figure 29. Figure S29a is the fluorine NMR spectrum that shows a
triplet of doublets (J1 = 25.3 Hz, J2 = 21.4 Hz), since the fluorine atom is split by its two
neighboring hydrogen atoms, then split again by another hydrogen atom on the adjacent
carbon in the external aldimine form.

Figure S1b represents the proton-decoupled

fluorine NMR spectrum that shows a singlet, because the fluorine atom and the protons
are decoupled. As concluded, the fluorine atom remains intact in the same environment
as intact AFPA, even after treatment with a saturated amount of GabR protein.
As a positive control, the structure of the Asp-AT-PLP-AFPA complex (refined at
1.53 Å resolution) showed that the proposed ternary adduct 3 (has formed via pathway a
in Scheme 2 (Figure 30b), indicating that the catalytic actions of the conserved lysine
have occurred in Asp-AT but not in the GabR Eb/O domain. On the basis of structural
information and NMR results, it was concluded that the external aldimine 1 is the final
chemical species when both PLP and AFPA are bound to the GabR Eb/O domain. This
suggests that the observed Schiff base in the Eb/O-PLP-GABA complex structure is also
an external aldimine.
For aminotransferases in general, the external aldimine intermediate can be
transiently observed spectroscopically 57. However, mutation of a catalytic residue 58 or
chemical modification of the ligands such as the amino acid 52 or PLP 59 was required to
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trap a stable external aldimine in an aminotransferase. GabR is, to our knowledge, the
first reported protein capable of forming a stable external aldimine between PLP and
GABA for its function in transcription regulation. Only mild global conformational
changes are introduced in the PLP-bound Eb/O domain upon binding to GABA and
formation of the external aldimine. A least squares structural comparison revealed that
the Eb/O domains of the GabR-PLP dimer (PDB: 4N0B) aligned well with those of the
Eb/O-PLP-GABA complex or the Eb/O-PLP-AFPA complex, with RMSD values for Cα
atoms around 1.12 Å and 1.13 Å, respectively. Conformational changes could be more
pronounced in the linker region between Eb/O and wHTH domains, and within the
wHTH domains in the full-length dimeric GabR; these conformational changes likely
contribute to the triggering of transcription activation.
Functional Significance of External Aldimine Formation
To extrapolate the functional interpretation from the GabR Eb/O domain to the
full length GabR, both in vivo and in vitro assays were conducted to compare the
biological effects of GABA and AFPA. When examining GabR-mediated activation in
vivo using a gabT-lacZ fusion 25(Figure 31a), both GABA and AFPA triggered GabRmediated transcription activation in B. subtilis cells In vitro, GabR, PLP, RNA
polymerase, and the gabT promoter-containing DNA fragments were mixed with
radioactively labeled nucleotides as described previously 24. The gabT transcript was
formed upon addition of either GABA or AFPA (Figure 31b). In contrast to in vivo
results, AFPA triggered the GabR-mediated transcription activation in vitro with a higher
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potency than did GABA. The GabR-PLP-AFPA complex may be a better transcriptional
activator than the GabR-PLP-GABA complex. However, the bacterial cellular uptake of
GABA may be more efficient than that of AFPA, resulting in a more pronounced
biological effect in vivo upon the addition of GABA.

Figure 30. Biological effects of GABA and AFPA. a) The gabT-lacZ expression is
monitored by absorbance at 420nM produced by the lacZ reaction using ONPG over
time. b) Self-developed film indicating the newly synthesized gabT mRNA. Lane 1:
Control without GABA or AFPA. Lanes 2-7: GABA added at concentration of 0.625,
1.25, 2.5, 5, 10 & 20 mM, respectively. Lanes 8-13: AFPA added with concentration of
0.625, 1.25, 2.5, 5, 10 & 20 mM, respectively.
Conclusions
We have shown that PLP bound to the GabR Eb/O domain reacts with the effector
GABA to form a stable external aldimine, which apparently triggers the transcription
from the gabT promoter in B. subtilis. This conclusion offers an explanation for the
previous results that the effector pair of PMP and SSA can also trigger GabR-mediated
transcription activation in vitro 24. Through a reverse transamination-like reaction
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(Scheme 1), SSA and PMP can potentially form a Schiff base, presenting a structure
similar to the PLP-GABA external aldimine 24. However, SSA and PMP may not work as
an actual effector pair in vivo. With an evolutionarily modified PLP/GABA binding site,
the GabR Eb/O domain is capable of preferentially binding to GABA and forming an
external aldimine. To perform the role of a transcription regulator, GabR employs Y281
to subdue the Eb/O domain’s catalytic potential by stabilizing the external aldimine
formed and preventing its further modification.
In summary, these studies were submitted to the Proceedings of the National
Academy of Sciences of the United States of America (PNAS) for publication: Rui Wu,
Ruslan Sanishvili, Boris R. Belitsky, Jose I. Juncosa, Hoang V. Le, Helaina J.S. Lehrer,
Michael Farley, Richard B. Silverman, Gregory A. Petsko, Dagmar Ringe, and Dali Liu.
(2015)
Materials and Methods
Materials. Chemicals for the assays were purchased from Fisher Scientific
(Pittsburgh, PA) and Sigma-Aldrich (St. Louis, MO); Cloning vectors were obtained
from Integrated DNA Technologies (Coralville, IA). Escherichia coli BL21 (DE3) cells
was purchased from New England BioLabs (Ipswich, MA). Bacterial growth media and
antibiotics were obtained from Fisher Scientific and Sigma-Aldrich. Crystallization
screen solutions and other crystallization supplies were purchased from Hampton
Research (Aliso Viejo, CA) and Emerald Bio (Bedford, MA). All chemicals were of the
highest quality available.
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Truncation & Cloning of GabR Eb/O Domain. The sequence coding for GabREb/O domain was amplified by PCR using previously cloned full-length GabR (in pETite
vector from Lucigen) as the template 46, the specific oligonucleotides as primers (forward
primer designed as GAAGGAGATATACATATGATCGACCAGAGCGATTGGATA
and the reverse primer designed as
GTGATGGTGGTGATGATGATCCCCTGTAACGGGGATTTT), and Phusion HF
DNA polymerase, following the manufacture’s instructions. The thermocycler program
used included an initial denaturation for 120 s at 95 °C; 35 cycles of 95 °C for 30 s, 50 °C
for 60 s, and 72 °C for 60 s; and a final extension of 72 °C for 5 min. The PCR product
was inserted into a pETite vector (Lucigen) for recombinant expression of GabR Eb/O
domain protein with a C-terminal His6-tag.
Protein Expression and Purification. Full-length GabR protein and L-aspartate
aminotransferase from E. coli were expressed and purified as described 24. The GabR
Eb/O domain was overexpressed in E. coli and purified using a similar method.
Transformed E. coli BL21 (DE3) cells were grown in 1L of LB supplemented with 50
µg/ml kanamycin at 37 °C and 250 rpm until OD600 nm reached ~ 0.6. Protein expression
was induced by the addition of 0.5 mM isopropyl-beta-D-1-thiogalactopyranoside
(IPTG). Cells were incubated at 25 °C and harvested after 16 h by centrifuging at 4800
rpm and 4 °C for 10 min. The cell paste was resuspended in the lysis buffer containing 1
x PBS and 10 mM imidazole, pH 8.0 followed by sonication. The resulting suspension
was centrifuged twice at 16,500 rpm and 4 °C for 20 min, and the soluble fraction was

74
loaded onto a 10 ml His-Trap column (GE Life Sciences, Piscataway, NJ) containing
Ni2+ and previously equilibrated with lysis buffer. Elution of the retained proteins was
achieved with a linear imidazole gradient (25 column volume, 10 mM-485 mM).
Fractions containing truncated EB/O domain were pooled, concentrated to 2 mL, and
loaded onto a 16/60 Superdex 200 size exclusion column (GE Life Sciences) that was
previously equilibrated with 84% elution buffer. Fractions containing enzyme were
pooled, concentrated, and used freshly after exchanging into suitable buffers for the
crystallization and biological assays. The wild type Asp-AT was overexpressed and
purified with the protocol used by Onuffer and Kirsch 60.
Crystallization of the GabR-Eb/O and X-ray Diffraction Data Collection. After
the initial crystallization screen and optimization, the GabR-Eb/O domain was
crystallized via hanging drop methods at 25 °C. The hanging drops were prepared with 1
µL of 12 mg/mL pre-incubated protein with inhibitor solution and 1 µL of the reservoir
solution that contained 0.1 M Tris (pH 8.5) buffer and 20 % ethanol. Crystals were
harvested in about 10 days. For cryo-cooling, crystals were transferred to the reservoir
solution with 20 % glycerol as cryo protectant, and were flash-cooled by plunging in
liquid nitrogen. The cocrystallization of Asp-AT and AFPA were conducted according to
previous studies 54, 55 The diffraction data were collected at GM/CA@APS beamlines
23ID-B and 23ID-D at Advance Photon Source (Argonne National Laboratory, Argonne,
IL). The wavelength used for data collection was 1.0332 Å, and diffraction images were
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recorded on 4x4 tiled CCD detectors (Rayonix, Evanston, IL) with 300×300 mm2
sensitive are. All data were indexed, integrated, scaled and merged using HKL2000 41.
Phasing, Model Building, and Refinement. Diffraction data were phased with
molecular replacement using the program Phaser 61in the CCP4 software suite 42.
Previously solved full-length GabR structure 46, truncated to contain residues 107-479,
was used as the search model. Rigid body refinement followed by restrained refinement
was carried out in Refmac5. Model building was conducted using the program COOT 45.
Iterative rounds of model building and refinement generated the final coordinates.
In Vivo and in Vitro Assays for GabR-Dependent Transcription Activation. The
in vivo assay was conducted as previously described 24, using GABA or AFPA as
effectors (0.625 – 20 mM). In vitro GabR-dependent RNA polymerase reactions were
performed as previously described 24. The PCR-fragment (50nM) contained the gabRgabT regulatory region. The total reaction was carried in transcription buffer containing:
40 mM Tris-HCl, 100 mM KCl, 10 mM MgCl2, 5% glycerol, 0.1 mM EDTA, 1 mM
DTT, 0,1 mg/mL of BSA with four units of RNasin, 150 µM ATP, CTP, and GTP, 20
µM UTP, 0.5 to 1 µl Ci of 32P-labeled UTP, and 0.02-0.04 unit of E. coli RNA
polymerase. The reaction was incubated at 37 oC for 15 min and terminated by additional
of 4 µL of the 20 mM EDTA, 95% formamide dye solution. The samples were
subsequently heated at 80 oC for 5 min. The samples were then analyzed without further
purification using 7 M urea / 5-6% polyacrylamide DNA sequencing gels. GABA was
purchased from Sigma. AFPA was synthesized according to previous publication 53.
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Nuclear Magnetic Resonance (NMR) Spectroscopy. The protein (100 mg) was
treated with AFPA. The molar ratio of the protein and AFPA was 2:1 to minimize free
AFPA in the solution. The sample was concentrated to a volume of 0.4 mL by
centrifugation. Deuterium oxide (0.15 mL) was added, and the solution was transferred to
a 5 mm standard NMR tube. Fluorine NMR and proton-decoupled fluorine NMR spectra
were taken at the Northwestern IMSERC facility on an Agilent DD2 500 MHz
spectrometer with an Agilent 5 mm HFX probe at 26 oC. 19F NMR δ 229.87 (td, J1=25.3
Hz, J2=21.4 Hz); proton-decoupled 19F NMR δ 229.87 (s).
Structural Analysis and Figure Making. All structural analyses were conducted in
COOT 45 and UCSF Chimera 53. Structure comparison of the PLP/amino acid binding
site was conducted in two steps (Figure 2b & Figure 6): First, the overall structural
comparison/overlap was conducted in UCSF Chimera using the Needleman-Wunsch
algorithm. Second, manual adjustments were done by overlapping the pyridine ring of
the PLP to achieve better pattern matching for the conserved key residues in the
PLP/amino acid binding site for comparison. All structural figures were made in UCSF
Chimera.

CHAPTER FOUR
CONCLUSIONS AND FUTURE INVESTIGATIONS
Full length GabR and Its Overall Structure
In conclusion, the studies presented herein have as provided useful information to
elucidate the transcription regulatorty mechanism of GabR, gain insight into the
functionality of a unique MocR subfamily member, gain insight into the regulation
pathway of the GABA shunt pathway, and provided some detailed molecular and
chemical information for future anti-vurilance drug discovery.
The obtained X-ray crystal structures of full length GabR provided information on
the domain arragements of MocR subfamily’s transcriotion. To our best knowledge, these
structures are the first X-ray crystal structures revealed in the GntR/MocR family. In
addition, we also bead model obtained from the small angle X-ray scattering (SAXS)
from protein solution sample (Figure 31), and structure impose indicated a high
agreement between the bead model and the X-ray crystal structure (Figure 32). These
suggested that the head-to-tail homodimer is probably physciology and in the functional
geometry before transcription initiation. More detailed structure analysis provides offer
more information:
(1) To allow us to propose a model for the DNA and protein complex, further to
spectulated how the interaction between DNA and GabR could position the regulatory
domain in the proper position and set the “perfect” geometry to initiate the transcription.
77
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Figure 31. Small Angle X-ray Scattering (SAXS) bead model of full length GabR.

Figure 32. Small Angle X-ray Scattering (SAXS) bead model of full length GabR
superimpose with X-ray crystal structure of full length GabR.
(2) The reveal of the effector/s (GABA and PLP) binding pocket in effector
binding and/or regulatory domain offer us a bold hypothesis that nature may recycled the
vitamin B6 and “borrow” a partial reaction from aminotransferase to regulate the
\
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transcription initation.
(3) The linker region between the DNA binding domain and the effectors binding
and /or regulatory domain shown to be the first case in GntR transcription regulator super
family. The long linker suggestes a rather dramatic confirmation changes could happen
upon binding to the effectos during the initiation of the transcription.
Effector Binding Domain and Related Biological Function
Although these structures have provided much needed answers in terms of static
image before GabR associate with the effector GABA. There are still more details that
need to be addressed to elucidate how effector triggers the transcription initiation.
Further studies reveavled several Eb/O domain structures in complex with
GABA, and molecular probe molecule AFPA. These two structures paved the way
toward understanding how GabR functions. Our results suggest that upon binding to
effector (GABA) or effectors analog (APFA), the internal aldimine would undergo a
reaction with coming effector to form external aldimine. Using multiple approaches, such
as: NMR, in vivo transcripton assay, in vitro transcription assay, we were able to
determine that the external aldimine is a critical chemical species that triggers the
transcription initation.
GabR and DNA Complex
One of the disadvantage of having only the Eb/O domain is no structural
information could support during the initiation of the transcription if there is a
conformational changes on the geometry between Eb/O and DNA binding domain, or if
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the DNA binding domain have re-located upon binding to effectors. This will hopefully
be addressed in the near future. Meanwhile a SAXS bead modeal of the GabR/DNA
complex (Figure 33 and Figure 34) shed some light on how the DNA and GabR would
interact. Noteably, the DNA fragment is at the bented confirmation from the
interpretation from the SAXS bead model. Looks apparent to us this bented geometry
somehow facilitate the transcription initiation, more specifically maybe facilitating RNA
polymerase, sigma factor and other important component to bind to initiate the
transcription.

Figure 33. Small Angle X-ray Scattering (SAXS) bead model of full length GabR and
DNA complex.
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Figure 34. The fittng model of Small Angle X-ray Scattering (SAXS) bead stcuture of
full length GabR and DNA complex and X-ray crystal structure of GabR.

CHAPTER FIVE
THE CRYSTAL STRUCTURE OF NITROSOMONAS EUROPAEA SUCROSE
SYNTHASE REVEALS CRITICAL CONFORMATIONAL CHANGES AND
INSIGHTS INTO THE SUCROSE METABOLISM IN PROKARYOTES
Research Significance
In this chapter we report the first crystal structure of a prokaryotic sucrose
synthase from the non-photosynthetic bacterium Nitrosomonas europaea. The obtained
structure was in an open form, whereas the only other available structure from the plant
Arabidopsis thaliana was in a closed conformation. Comparative structural analysis
revealed a “hinge-latch” combination, which is critical to transition between the open and
closed forms of the enzyme. The N. europaea sucrose synthase shares the same fold as
the GT-B family of the retaining glycosyltransferases. In addition, a triad of conserved
homologous catalytic residues in the family showed to be functionally critical in the N.
europaea sucrose synthase (Arg567, Lys572, Glu663). This implies that sucrose synthase
shares not only a common origin with the GT-B family, but also a similar catalytic
mechanism. The enzyme was proven to prefer transferring glucose from ADP-glucose
rather than UDP-glucose like the eukaryotic counterparts. This predicts that these
prokaryotic organisms have a different sucrose metabolic scenario from plants.
Nucleotide preference determines where the glucose moiety is targeted after sucrose is
degraded.
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Introduction
In plants, sucrose (Suc) is a major photosynthetic product and plays a key role not
only for carbon partition but also in sugar sensing, development, and regulation of gene
expression 62-64. It was first thought that Suc metabolism was a characteristic of plants but
it was later found in other oxygenic photosynthetic organisms 65, 66. In the last decade,
Salerno and coworkers demonstrated the importance of Suc for carbon and nitrogen
fixation in filamentous cyanobacteria 67, 68. More recently, genomic and phylogenetic
analyses revealed the existence of Suc-related genes in non-photosynthetic prokaryotes
such as proteobacteria, firmicutes, and planctomycetes 65, 66, 69. It has been suggested that
these organisms acquired the genes of Suc metabolism by horizontal gene transfer 65, 66,
69

. However, analysis of the enzymes encoded by such genes is currently lacking.
Nitrosomonas europaea is a chemo-litho-autotrophic bacterium that obtains

energy by oxidizing ammonia to hydroxylamine and nitrite in presence of oxygen 70. It is
a member of the β-proteobacteria group with a putative photosynthetic ancestor 71. N.
europaea has potential for many biotechnological applications, including bioremediation
of water contaminated with chlorinated aliphatic hydrocarbons 72 or ammonia, in
combination with Paracoccus denitrifi 70. N. europaea displays some metabolic
resemblance to photosynthetic organisms, but with marked differences. For instance, it
possesses all the coding genes for enzymes of the Calvin-Benson cycle, but with two
exceptions that could be replaced by other glycolytic enzymes 73. All the genes coding for
enzymes from the tricarboxylic acid cycle were found in N. europaea 73; however,
activity of α-ketoglutarate dehydrogenase is non-detectable 74.

83
The evidence from genomic studies suggests that N. europaea can synthesize Suc 73;
however, the biochemical properties of enzymes from Suc metabolism have not been
characterized. Generally, in plants, Suc is synthesized from UDP-glucose (UDP-Glc) and
fructose-6-phosphate (Fru-6P) in a reaction catalyzed by Suc-6-phosphate synthase (EC
2.4.1.14), followed by removal of the phosphate group by Suc-6-phosphatase (EC
3.1.3.24). The disaccharide can be degraded to Glc and Fru by invertases (EC 3.2.1.26) or
cleaved by UDP to form UDP-Glc and Fru by Suc synthase (SucSase, EC 2.4.1.13) 63, 64.
However, some plant SucSases have a certain degree of substrate promiscuity 75-82, and
Thermosynechococcus elongatus prefers ADP 77. For that reason, a general reversible
reaction could be written as:
NDP + Suc ⇌ NDP-Glc + Fru
Besides its physiological role, SucSase catalyzes a reversible reaction and its activity can
be measured in both directions in vitro. In filamentous cyanobacteria, the products
derived from Suc cleavage contribute to other biological processes, such as
polysaccharides synthesis 83. Therefore, understanding the catalysis and the regulation of
SucSase is of great significance. Recently, Zheng et al. 84 reported the crystal structure of
the Arabidopsis thaliana SucSase (AthSucSase) in complex with UDP and fructose in a
closed conformation. This enzyme is a homotetramer composed of four identical subunits
of ~90 kDa and belongs to group 4 of the GT-B retaining glycosyltransferase family
(http://www.cazy.org/GlycosylTransferases.html) 85. The reaction mechanism for this
enzyme family has not been elucidated. But, it has been suggested that it favors the SNilike reaction mechanism proposed by Lairson et al84-86.
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Although several cyanobacterial 69, 77, 80 and plant 75, 78, 87-90 SucSases have been
characterized, the enzyme from non-photosynthetic bacteria has never been studied and
no structural information of any SucSase from bacterial sources is available. In this work
we report the recombinant expression and biochemical characterization of N. europaea
SucSase (NeuSucSase) and its crystal structure. We also determined the catalytic
implications of highly conserved residues and the specificity for nucleotide substrates.
Sequence Analysis
To know how NeuSucSase relates to other SucSases from divergent organisms we
constructed a phylogenetic tree using 117 amino acid sequences retrieved from the NCBI
database (Figure 35, Table 3, and Figure 37). The tree comprised seven major branches,
containing the sequences from cyanobacteria (group I; 21 sequences), proteobacteria
(groups II and III; 17 sequences), the moss Physcomitrella patens subsp. patens (group
IV; 4 sequences), and vascular plants (groups V, VI, and VII; 75 sequences) (Figure 35).
The shape of the tree shown in Figure 35 is similar to the one published by Kolman et al.
69

. Group I is subdivided in two branches, containing the sequences encoded by the susA

(cyan) and susB (orange) genes (Figure 35) 69. Most sequences from proteobacteria are
included in group III (including β-, γ- and δ-)

85

V

I
Nos
Tel

100
89

98

100

100

II

100
100

100
100

VI
68

92

97

100
100 100

Neu

96

100
100

100

III
IV
VII

Ath

Figure 35. Phylogenetic tree of SucSases. Group I contains sequences from
cyanobacteria and is divided in two major branches, susA (cyan) and susB (orange)
proteins; groups II and III (pink) contain sequences from proteobacteria; group IV
contains the sequences from the moss P. patens (violet); and groups V, VI, and VII,
which contain the sequences from vascular plants are further divided in two branches,
dicots (green) and monocots (blue). Numbers for major branches are the bootstrap values
obtained during tree reconstruction, as described in the “Materials and Methods” section.
Neu, N. europaea; Ath, A. thaliana SucSase 1; Nos, Nostoc sp. PCC 7120 susA; Tel, T.
elongatus. proteobacteria); though, the sequences from δ-proteobacterium MLMS-1 and
Desulfurivibrio alkaliphilus AHT2 are in a diverging branch (group II)

Table 3. Sucrose synthase genes used for phylogenetic analysis. Different colors belong to different branches in Fig. 35.

Accession
(GI)

Organism

Phylum

Type

Annotation

158339122

Acaryochloris marina MBIC11017

cyanobacteria

sucrose synthase

75908500

Anabaena variabilis ATCC 29413

cyanobacteria

sucrose synthase

209523126

Arthrospira maxima CS-328

cyanobacteria

sucrose synthase

284053161

Arthrospira platensis str. Paraca

cyanobacteria

sucrose synthase

218440696

Cyanothece sp. PCC 7424

cyanobacteria

sucrose synthase

220907171

Cyanothece sp. PCC 7425

cyanobacteria

sucrose synthase

332712456

Lyngbya majuscula 3L

cyanobacteria

sucrose synthase

254416162

Microcoleus chthonoplastes PCC 7420

cyanobacteria

sucrose synthase

334117431

Microcoleus vaginatus FGP-2

cyanobacteria

sucrose synthase

159031025

Microcystis aeruginosa PCC 7806

cyanobacteria

unnamed protein product

119512682

Nodularia spumigena CCY9414

cyanobacteria

sucrose synthase

186682280

Nostoc punctiforme PCC 73102

cyanobacteria

sucrose synthase

17232477

Nostoc sp. PCC 7120

cyanobacteria

sucrose synthase

22298591

Thermosynechococcus elongatus BP-1

cyanobacteria

sucrose synthase

75909957

Anabaena variabilis ATCC 29413

cyanobacteria

sucrose synthase

220909283

Cyanothece sp. PCC 7425

cyanobacteria

sucrose synthase

332708740

Lyngbya majuscula 3L

cyanobacteria

sucrose synthase

119510624

Nodularia spumigena CCY9414

cyanobacteria

sucrose synthase

298489784

Nostoc azollae 0708

cyanobacteria

sucrose synthase

186685043

Nostoc punctiforme PCC 73102

cyanobacteria

sucrose synthase
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17228554

Nostoc sp. PCC 7120

cyanobacteria

sucrose synthase

168009716

Physcomitrella patens subsp. patens

streptophyta

moss

predicted protein

168029793

Physcomitrella patens subsp. patens

streptophyta

moss

predicted protein

168035060

Physcomitrella patens subsp. patens

streptophyta

moss

predicted protein

168058907

Physcomitrella patens subsp. patens

streptophyta

moss

predicted protein

297795665

Arabidopsis lyrata subsp. lyrata

streptophyta

eudicot

hypothetical protein

297805240

Arabidopsis lyrata subsp. lyrata

streptophyta

eudicot

hypothetical protein

297812265

Arabidopsis lyrata subsp. lyrata

streptophyta

eudicot

hypothetical protein

297814081

Arabidopsis lyrata subsp. lyrata

streptophyta

eudicot

hypothetical protein

297818772

Arabidopsis lyrata subsp. lyrata

streptophyta

eudicot

hypothetical protein

297842089

Arabidopsis lyrata subsp. lyrata

streptophyta

eudicot

hypothetical protein

15219457

Arabidopsis thaliana

streptophyta

eudicot

sucrose synthase 6

42568160

Arabidopsis thaliana

streptophyta

eudicot

sucrose synthase 5

22331535

Arabidopsis thaliana

streptophyta

eudicot

sucrose synthase 4

15235300

Arabidopsis thaliana

streptophyta

eudicot

sucrose synthase 3

15239816

Arabidopsis thaliana

streptophyta

eudicot

sucrose synthase 2

15242073

Arabidopsis thaliana

streptophyta

eudicot

sucrose synthase 1

151176306

Beta vulgaris

streptophyta

eudicot

sucrose synthase 1

14530225

Beta vulgaris

streptophyta

eudicot

sucrose synthase

38425095

Beta vulgaris

streptophyta

eudicot

sucrose synthase

6682841

Citrus unshiu

streptophyta

eudicot

sucrose synthase

6683114

Citrus unshiu

streptophyta

eudicot

sucrose synthase

115310620

Coffea arabica

streptophyta

eudicot

sucrose synthase

115310618

Coffea arabica

streptophyta

eudicot

sucrose synthase
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4468153

Craterostigma plantagineum

streptophyta

eudicot

sucrose synthase

4468151

Craterostigma plantagineum

streptophyta

eudicot

sucrose synthase

324984223

Gossypium barbadense

streptophyta

eudicot

sucrose synthase

324984221

Gossypium barbadense

streptophyta

eudicot

sucrose synthase

324984229

Gossypium hirsutum

streptophyta

eudicot

sucrose synthase

258489633

Gossypium hirsutum

streptophyta

eudicot

sucrose synthase 1

3915046

Medicago sativa

streptophyta

eudicot

sucrose synthase

4584690

Medicago truncatula

streptophyta

eudicot

sucrose synthase

345286419

Orobanche ramosa

streptophyta

eudicot

sucrose synthase 2

345286417

Orobanche ramosa

streptophyta

eudicot

sucrose synthase 1

3915037

Pisum sativum

streptophyta

eudicot

sucrose synthase 2

3766299

Pisum sativum

streptophyta

eudicot

sucrose synthase

3377764

Pisum sativum

streptophyta

eudicot

nodule-enhanced susy

313770771

Populus trichocarpa

streptophyta

eudicot

sucrose synthase 7

313770769

Populus trichocarpa

streptophyta

eudicot

sucrose synthase 6

313770767

Populus trichocarpa

streptophyta

eudicot

sucrose synthase 5

313770765

Populus trichocarpa

streptophyta

eudicot

sucrose synthase 4

313770763

Populus trichocarpa

streptophyta

eudicot

sucrose synthase 3

313770761

Populus trichocarpa

streptophyta

eudicot

sucrose synthase 2

313770759

Populus trichocarpa

streptophyta

eudicot

sucrose synthase 1

255550319

Ricinus communis

streptophyta

eudicot

sucrose synthase

255551835

Ricinus communis

streptophyta

eudicot

sucrose synthase

255564236

Ricinus communis

streptophyta

eudicot

sucrose synthase

255570671

Ricinus communis

streptophyta

eudicot

sucrose synthase

255584097

Ricinus communis

streptophyta

eudicot

sucrose synthase
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304651490

Solanum lycopersicum

streptophyta

eudicot

sucrose synthase isoform 4

304651488

Solanum lycopersicum

streptophyta

eudicot

sucrose synthase isoform 3

3660531

Solanum lycopersicum

streptophyta

eudicot

sucrose synthase

31455440

Solanum tuberosum

streptophyta

eudicot

sucrose synthase 4

28629438

Solanum tuberosum

streptophyta

eudicot

sucrose synthase 2

29289943

Solanum tuberosum

streptophyta

eudicot

sucrose synthase

225431790

Vitis vinifera

streptophyta

eudicot

hypothetical protein

225437428

Vitis vinifera

streptophyta

eudicot

hypothetical protein

225444613

Vitis vinifera

streptophyta

eudicot

hypothetical protein

225466221

Vitis vinifera

streptophyta

eudicot

hypothetical protein

62865493

Bambusa oldhamii

streptophyta

monocot

sucrose synthase

17980241

Bambusa oldhamii

streptophyta

monocot

sucrose synthase

17980243

Bambusa oldhamii

streptophyta

monocot

sucrose synthase

326531526

Hordeum vulgare subsp. vulgare

streptophyta

monocot

predicted protein

326504012

Hordeum vulgare subsp. vulgare

streptophyta

monocot

predicted protein

241896730

Hordeum vulgare subsp. vulgare

streptophyta

monocot

sucrose synthase

3980298

Hordeum vulgare subsp. vulgare

streptophyta

monocot

sucrose synthase 2

239984690

Hordeum vulgare subsp. vulgare

streptophyta

monocot

sucrose synthase

115450038

Oryza sativa Japonica Group

streptophyta

monocot

Os02g0831500

115452927

Oryza sativa Japonica Group

streptophyta

monocot

Os03g0340500

115453437

Oryza sativa Japonica Group

streptophyta

monocot

Os03g0401300

115457664

Oryza sativa Japonica Group

streptophyta

monocot

Os04g0309600

115466896

Oryza sativa Japonica Group

streptophyta

monocot

Os06g0194900

115473359

Oryza sativa Japonica Group

streptophyta

monocot

Os07g0616800

297602308

Oryza sativa Japonica Group

streptophyta

monocot

Os04g0249500

89

242063616

Sorghum bicolor

streptophyta

monocot

hypothetical protein

242035533

Sorghum bicolor

streptophyta

monocot

hypothetical protein

242035817

Sorghum bicolor

streptophyta

monocot

hypothetical protein

162458268

Zea mays

streptophyta

monocot

sucrose synthase 2

162460681

Zea mays

streptophyta

monocot

sucrose synthase 2

162460741

Zea mays

streptophyta

monocot

sucrose synthase 1

114331077

Nitrosomonas eutropha C91

β-proteobacteria

sucrose synthase

82703384

Nitrosospira multiformis ATCC 25196

β-proteobacteria

sucrose synthase

30249199

Nitrosomonas europaea ATCC 19718

β-proteobacteria

sucrose synthase

94264333

delta proteobacterium MLMS-1

δ-proteobacteria

sucrose synthase

94266940

delta proteobacterium MLMS-1

δ-proteobacteria

sucrose synthase

95929190

Desulfuromonas acetoxidans DSM 684

δ-proteobacteria

sucrose synthase

297569306

Desulfurivibrio alkaliphilus AHT2

δ-proteobacteria

sucrose synthase

298528445

Desulfonatronospira thiodismutans ASO3-1

δ-proteobacteria

sucrose synthase

77166514

Nitrosococcus oceani ATCC 19707

γ-proteobacteria

sucrose synthase

292493898

Nitrosococcus halophilus Nc4

γ-proteobacteria

sucrose synthase

300115586

Nitrosococcus watsonii C-113

γ-proteobacteria

sucrose synthase

350552412

Thiorhodospira sibirica ATCC 700588

γ-proteobacteria

sucrose synthase

350574485

Thiorhodovibrio sp. 970

γ-proteobacteria

sucrose synthase

220933364

Thioalkalivibrio sulfidophilus HL-EbGr7

γ-proteobacteria

sucrose synthase

255021595

Acidithiobacillus caldus ATCC 51756

γ-proteobacteria

sucrose synthase

198283392

Acidithiobacillus ferrooxidans ATCC 53993

γ-proteobacteria

sucrose synthase
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Figure 36. Alignment of sucrose synthases from Table 3.
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------------------------MLHKFEAWAADHRGDMYTLLRRWFELERPLLLHSDLGAVFNALSAEQAS--LLADSQVREIVNTLQEAVCRPPIVY
------------------------MPDNLRRCISQNPHCVAGLLRYLFNLQRPFLLYTDLQKAIGDFAADYGS--DADLVVLQEFFSRLQEAVLAEPWIY
------------------------MSDDLRRCINQNAHCVSGLLRHLFNLQRPFLLYTDLQKAISDFAADYGS--DADLVMLQEFFSRLQEAVLAEPWIY
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--------------------------MELVDFVGKHRDVVYLLLRRYLALQKPFLLRSDLIDEFDNFCDEKEVGSVLRNSPLAAMIQAVQEAAVDPEWIY
------------------------MLETLQAFISRHREPAYLLLRRYFSENRCFLLRNELQDGLQALMADKN-LPELAHTPLGEMIRDAQEAVLSAPWVY
------------------------MTQPTRDALELHREAAYLLLRRYLALGRPFLLRSELQDGFQALCLERD-EPGLAESPLADLVGQAQEAVLAAPWVC
--------MSEIFLEQRQEQSTGSLVPELIAFVREQRNLTHRVFHWLIGLQRPFLLHSDVADALAHLCRD---DPELGPTVLARALEQCQEVTLTPSWIY
------------------------MITELKTLFSEHRRTLYLLCQQFYTHEDSPFLLRSDLHQLFDLFIQTEQGQLLKDSAVEELFCSLQEASKNEPWIY
----------------------MIDVEELDGLDPELRKSLYLFLREMIRKEK-PFLLRSELQDMLADFFEDEEHGRHESALVFEVFRYTQVATIRNPWVY
-----------MASKLSFKRMDSIAETMPDALRQSRYQMKRCFQRYVSKGKRLLKNQQLMEELEKS-LDDKVENEKLVEGFLGYIICSTQEAVVLPPFVA
-----------MASKLSFKRMDSIAETMPDALRQSRYQMKRCFQRYVSKGKRLLKNQQLMEELEKS-LDDKVEKEKLVEGFLGYIICSTQEAVVLPPFVA
----------MASAKLSFKRMDSVAESMPDALRQSRYQMKRCFQRYVSRGRRLLKNQQLMEELDRS-LDDELEKEKLVEGFLGYIICSTQEAVVLPPFVA
-------------MAVGLRRSDSIADMMPEALRQSRYQMKRCFQRYVSQGKRLMKRQQLLDELDKS-VDDKADKDQLLQGFLGYVISSTQEAAVLPPFVA
---------MASSSSMPLRRSDSVADMMPEALRQRRYQMKRCFQSYVSKGRRLMKNQQLMEELETSEGDDKVEKARLAEGFLGYVICSTQEAVVLPPLVA
--------------------------MMPEALRQSRYHMKRCFQRFVSQGSRLMKQQHLLEELHGGGSADNN-KQLAADGFLGHVISCTHEAVVLPPYVA
----------------MEMTSGSLGNGIPEAMGQNRGNIKRCLEKYIENGRRVMKLNELMDEMEIV-INDVTQRRRVMEGDLGKILCFTQAVVIPPN-VA
------------------MPSGSLGNGIPEAIGQNRGNIKRCLEKYIENGRRVMKLNELMDEMEIV-INDVMQRRRVMEGDLGKILCFTQEAVVIPPNVA
--------------MATLKRSDSIADNMPEALKQSRYHMKKCFAKYIEKGRRTMKLQQLLDEMENV-IDDQVERTRVLEGLLGDIWFSIQEAVVNPPYVA
--------------MATLKRSDSIADNMPEALKQSRYHMKRCFAKYIEKGRRTMKLQQLLDEMENV-IDDQVERTRVLQGLLGDIWFSIQEAVVNPPYVA
----------MAASGATLKRSDSIADNMPEALKQSRYHMKKCFSKYVQKGRRIMKLQNLLDEMEDV-IDDKIERTKVLEGLLGDIWYSTQEAVVNPPYVA
-----------MASKPTLKRADSMAENMPDALRQSRYHMKRCFARYIGKGKRLMKLNHLMDEMEAV-IDDKNERTQVLEGVLGFILCSTQEAVAIPPHVI
-----------MASQTALQRSETITESMPEALRQSRYHMKKCFSRFVAPGKRLMKRQHLMDEVDES-IQDKNERQKVLEGLLGYILSCTQEAAVIPPFVA
-----------MASAPVLKRSETIAESMPDALRQSRYHMRICFSRFVAPGRRLMKRQHIMDEVDKS-IQDKNERQKVLEGLLGYILSSTQEAAVVPPFVA
-----------MASGPVIKRSETIAESMPDALRQSRYHMKRCFSSLAASGNRLLKHHNIMEEVEKS-IQDKGERKKVLEGLLGYILSSTQEAAVIPPYVA
---------MSSSSQAMLQKSDSIAEKMPDALKQSRYHMKRCFASFVGGGKKLMKREHLMNEIEKC-IEDSRERSKILEGLFGYILTCTQEAAVVPPFVA
---------MSSSSQAMLQRSDSIADKMPDALKQSRYHMKRCFASFVGGGKKLMKRKHLMNEIEKC-IEDSRERSKILEGLFGYILTCTQEAAVVPPFVA
-------------MAAKLARLHSLRERLGATFSSHPNELIALFSRYVNQGKGMLQRHQLLAEFD-ALIEA---DKEKYA-PFEDILRAAQEAIVLPPWVA
-------------MAAKLTRLHSLRERLSATFSSHPNELIALFSRYVHQGKGMLQRHQLLAEFD-ALIAA---DKEKYA-PFEDILRAAQEAIVLPPWVA
-------------MAAKLTRLHSLRERLGATFSSHPNELIALFSRYVHQGKGMLQRHQLLAEFD-ALFDS---DKEKYA-PFEDILRAAQEAIVLPPWVA
-------------MAAKLTRLHSLRERLGATFSSHPNELIALFSRYVHQGKGMLQRHQLLAEFD-ALFES---DKEKYA-PFEDILRAAQEAIVLPPWVA
--------MGEGAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLKNLGKGMLQPHQIIAEYN-NAIPEAEREKLKDG-AFEDVLRAAQEAIVIPPWVA
--------MGEAAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLKNLGKGMLQPHQIIAEYN-SAIPEAEREKLKDG-AFEDVLRAAQEAIVIPPWVA
--------MGEAAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLVNLGKGMLQPHQIIAEYN-NAIPEAEREKLKDG-AFEDVLRAAQEAIVIPPWVA
--------MGETAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLVNLGKGMLQPHQIIAEYN-NAIPEAERDKLKDG-AFEDVLRAAQEAIVIPPWVA
--------MGEAAGDRVLSRLHSVRERIGDSLSAHPNELVAVFTRLVNLGKGMLQAHQIIAEYN-NAISEADREKLKDG-AFEDVLRSAQEGIVISPWVA
--------MGETTGERALTRLHSMRERIGDSLSAHTNELVAVFSRLVNQGKGMLQPHQIIAEYN-AAIPEGEREKLKDS-ALEDVLRGAQEAIVIPPWIA
--------MGETAGERALSRVHSVRERIGHSLSAHTNELVAVFSRLVNQGKGMLQPHQITAEYN-AAIPEAEREKLKNT-PFEDLLRGAQEAIVIPPWVA
----------MANAERMITRVHSQRERLNETLVSERNEVLALLSRVEAKGKGILQQNQIIAEF--EALPEQTRKKLEGG-PFFDLLKSTQEAIVLPPWVA
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297812265
22331535
297818772
313770759
313770761
255550319
324984223
258489633
324984221
324984229
6683114
4584690
3915046
3766299
3377764
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3660531
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15235300
297814081
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3915037
225437428
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115452927
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304651490
29289943
115310620
4468153
345286419
4468151
151176306
14530225
15239816
297795665
225431790
255551835
168009716

----------MANAERMITRVHSQRERLNETLVSERNEVLALLSRVEAKGKGILQQNQIIAEF--EALPEETQKKLEGG-PFFDLLKSTQEAIVLPPWVA
----------MANAERVITRVHSQRERLDATLVAQKNEVFALLSRVEAKGKGILQHHQIIAEF--EAMPLETQKKLKGG-AFFEFLRSAQEAIVLPPFVA
----------MANAERVITRVHSQRERLDATLIAQKNEVLALLSRVEAKGKGILQYHQIIAEF--EAMPLETQKKLQGG-AFFEILRSAQEAIVLPPFVA
------------MAERALTRVHSIRERVDETLKAHRNEIVALLTRIEGKGKGILQHHQIVAEF--EAIPEDTRKTLAGG-AFAEVLRSTQEAIVVPPWIA
--------------MSVLTRVQSIRERLDETLKTHRNEIVALLTRIEGKGKGILQHHQIIAEF--EAIPEEIRKILAGG-AFSEVLRSTQEAIVLPPWVA
------------MAERVITRVHSIRERLDETLAANRNEIVALLTRIEGKGKGILQHHQIIAEF--EAIPEDIRKNLLDS-VFGEVLRSTQEAIVLPPWVA
------------MANPVITRVHSLRERLDETLLAHRNEILALLSRIEGKGKGILQHHQIILEF--EAIPEENRKKLADG-AFFEVLKASQEAIVLPPWVA
------------MANPVITRVHSLRERLDETLLAHRNEILALLSRIEGKGKGILQHHQIILEF--EAIPEENRKKLADG-AFFEVLKASQEAIVLPPWVA
------------MADRVITRVHSLRERLDETLLAHRNEILALLSRIEGKGKGILQHHQIILEF--EAIPEENRKKLANG-AFFEVLKASQEAIVLPPWVA
------------MADRVITRVHSLRERLDETLLAHRNEILALLSRIEGKGKGILQHHQIILEF--EAIPEENRKKLANG-AFFEVLKASQEAIVLPPWVA
------------MAERALTRVHSLRERLDETLSAHRNEILALLSRIEGKGKGILQNHQLIAEF--ESISEENRKHLTEG-AFGEVLRATQEAIVLPPWVA
------------MATERLTRVHSLKERLDETLTANRNEILALLSRLEAKGKGILQHHQVIAEF--EEIPEDSRQKLTDG-AFGEVLRSTQEAIVLPPWVA
------------MATERLTRVHSLKERLDETLTANRNEILALLSRLEAKGKGILQHHQVIAEF--EEIPEESRQKLTDG-AFGEVLRSTQEAIVLPPWVA
------------MATDRLTRVHSLRERLDETLTANRNEILALLSRIEAKGKGILQHHQVIAEF--EEIPEENRQKLTDG-AFGEVLRSTQEAIVLPPWVA
------------MATDRLTRVHSLRERLDETLTANRNEILALLSRIEAKGKGILQHHQVIAEF--EEIPEENRQKLTDG-AFGEVLRSTQEAIVLPPWVA
------------MADGVLTGVHSLRARVDETLTAHRNEILSFLSRIEGHGKGILQPHQLLAEF--EALPEVNRKKLSDG-PFGDILKSIQEAIVLPPWIA
------------MAERVLTRVHRLRERVDATLAAHRNEILLFLSRIESHGKGILKPHELLAEF--DAIRQDDKDKLNEH-AFEELLKSTQEAIVLPPWVA
------------MAERVLTRVHSLRERVDATLAAHRNEILLFLSRIESHGKGILKPHELLAEF--DAIRQDDKNKLNEH-AFEELLKSTQEAIVLPPWVA
------------MAQRVLTRVHSLRERLDATLDAHRNEILLFLSRIESHGKGILKPHQLLAEF--ESIQKEDKDKLNDH-AFEEVLKSTQEAIVLPPWVA
------------MAERVLTRVHSLRERLDATLAAHRNEILLFLSRIESHGKGILKPHQLLAEF--ESIHKEDKDKLNDH-AFEEVLKSTQEAIVLPPWVA
------------MAERVLTRVHSLRERLDATLAAHRNDVLLFMSRLETHGKGILKPHQLLAEF--EEINKDGKQKIHDH-AFEEVLKSTQEAIVLPPWVA
------------MAERVLTRVHSLRERLDATLAAHRNEILLFLSRVEAHGKGILKPHQLVAEF--EAICQADKAKLQDH-AFQEVLKSTQEAIVLPPWVA
-------------MASRLTRVPSLKERLDETLTAQRNEIISFLSKIASHGKGILQPHEVLSEF--EAVAD--KHKLADG-PFGEVLRHTQETIVLPPWIT
------------MANPKLTRVLSTRDRVQDTLSAHRNELVALLSRYVDQGKGILQPHNLIDELESVIGDDETKKSLSDG-PFGEILKSAMEAIVVPPFVA
------------MANPKLTRIISTRDRVQDTLSAHRNELVALLSRYVDQGKGILQPHNLIDELESVIGDDATKQSLSDG-PFGEILKSAMEAIVVPPFVA
------------MAAPKLSRIPSIRERVEDTLSVHRNELVSLLSRYVAQGKGILQPHVLIDELDNIFGDDEGRQNLRDG-PFSEVIKSAQEAIVLPPFVA
------------MAAPKFARIPSMRERVEDTLSAHRNELVSLLCRYVDQGKGILQPHTLIDEFDNVVGDGESRQMLRNG-PFGEVLKSAQEAIVLPPFVA
------------MANPKLERIPSMRERVQDTLSANRNVLVSLLSRYVEQGKGILHPNNLIDELDNIVCDDAARLSLKDG-PFSEVLKAAQEAIVLPPFVA
-----------MSTHPKFTRVPSIRDRVQDTLSAHRNELISLLSRYVAQGKGILQPHNLIDELDNILGEDHATLDLKNG-PFGQIINSAQEAIVLPPFVA
------------MVTPKLGRSPSIRDRVEDTLSAHRNELVALLSRYVAQGNGILQPHHLIDELDNIVGDDVGRQKLSDG-PFGQILKSTQEAIILPPFVA
------------MSAPKLDRNPSIRDRVEDTLHAHRNELVALLSKYVNKGKGILQPHHILDALDEVQGS--GGRALAEG-PFLDVLRSAQEAIVLPPFVA
------------MSAPKLDRNASIRDRVEDTLHAHRNELVALLSKYVNKGKGILQPHHILDALDEVQGS--GVRALAEG-PFLDVLRSAQEAIVLPPFVA
------------MSGPKLDRTPSIRDRVEDTLHAHRNELVALLSKYVSQGKGILQPHHILDALDEVQSS--GGRALVEG-PFLDVLRSAQEAIVLPPFVA
------------MAAPKLDRTPSIRERVEDTLHAHRNELVALLSKYVSKGKGILQPHRILDTLDEVQVS--GGSALAEG-PFLDVLRSSQEAIVLPPFVA
------------MSNPKLSRIPSMRERVEDTLSAHRNQLVALLSRYVAQGKGILQPHHLIDELNNAVCDDTACEKLKEG-PFCEILKSTQEAIVLPPFVA
------------MSNPKFTRVPSMRERVEDTLSAHRNQLVALLSRYVAQGKGILQPHHLIDEFNSAVCDDTACEKLKEG-PFCEILKSTQEAIVLPPFVA
------------MATIKLQKLPSIRERVEDTLSAHRNELVALLSRYVAQGKGMLQPHHLIDELDNIVVDETACKKLSEG-PFSEVLRSAQEAIVLPPFVA
------------MATPKLTKIPSMRERVEVTLAAHRNELVSLLSRYVAQGKGLLQSHHLIDELENIILDDDAKKKLSDG-PFSEVLRSAQEAIVLPPFVA
------------MSNPKLTKITSMREGVEDTLSAHRNQLVSLLSRYVAQGKGILQPHHLIDELDNIIDDDSCRAKLNDG-PFGEVLKTAQEAIVLPPFVA
-----------MTTHEKAPASPCMRERVEETLADHRDELISLLSRYTSRGKCLLQSHQLMDELEDAIAEDPANKKLSDG-CFNEVLSSAQEAIVLPPFVI
-------------MAPKLTRIPSMRERVEDTLSVHRNELVSLLSKYVAQGKCLLQPHHLIDGLESVIGEDKGKQILSDG-PFSEVLRSAQEAIVVPPFVA
-------------MAPKLTRIPSMRERVEDTLSVHRNELVSLLSKYVAQGKCLLQPHHLIDGLESVIGEDKGKQILSDG-PFSEVLRSAQEAIVVPPFVA
---------------MPTGRFETMREWVYDAISAQRNELLSLFSRYVAQGKGILQSHQLIDEFLKTVKVDGTLEDLNKS-PFMKVLQSAEEAIVLPPFVA
---------------MPTGRFETMREWVHDAISAQRNELLSLFSRYVAQGKGILQSHQLIDEFLKTVKVDGTTEDLNKS-PFMKVLQSAEEAIVLPPFVA
--------------MPHRYDGQSMRERFQETLSAHRNELVSLFTGYVAQGKGILQPHHMIDELDKVVGKDEGMQKLRDS-PFSKVLKSAQEAIVLPPFVA
------------------MPLSSFRDRVHDILSVYRVELVSLLTRHVAEGKGILQTHDLLCELDNVVVDDEAMEKLRRS-PFVEVLQSTQEAIVLPPFVA
-----------MATQPALRRLNSIQERVQKVVQSNRNLILDLLSRYVKQGRTILQPHHLLDELN-NLGDADQVAEIKDS-AFGNLLQNCQEAMVLPPWVG
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168035060
168058907
168029793
94266940
94264333
297569306
254416162
332712456
17232477
75908500
186682280
119512682
334117431
218440696
159031025
220907171
22298591
158339122
284053161
209523126
17228554
75909957
186685043
119510624
298489784
220909283
332708740
Clustal Consensus

114331077
30249199
82703384
198283392
344199811
255021595
77166514
300115586
292493898
350552412
220933364
350574485
95929190
298528445
297602308
115457664

-----MAANGVAPKKPVLQRLNSIQERVQSAVQEHRNVIIDLLSRYVKQGRTHLQPHHIVDELN-SLTEADRVTEIKDS-AFGLLLLNCQEAIVLPPWLG
----------MSQPRPTLRRLTSLKERVESSLQEHRNELLHLLQGYVAQGRSILQPHHLQDQLA-AVHDA---AHIQDT-AIGKLLQNCQEAMVSPPWVG
-------MDGIATQAGALPRMTSMNKKIQGSLDDHRNENLRILSKLTAKRKALMQPHEVIDELN-KAAEESGSLKIMDG-PLARVFSLCQEAIVLAPWVG
----------------------MYDDLGSFIDEAEIPLLREFLLSLPPSEPPLLLRNDVLQAFQQFCEAHSEVDEPLG---CWRFLRKVQEILQADDLLV
----------------------MYDDLGSFIDEAEIPLLREFLLSLPPSEPPLLLRNDVLQAFQQFCESHPEVDDPLG---CWRFLRKVQEILQADDLLV
----------------------MENDLGCFVDEQDVAPLREFLLSLQRPEPPLLLRNDILLAFQQFAGQRPAAEGDLAG--AWRFLRKVQEVLLADDLLI
----------------------MLNLIQNVLDCEERNDLRQFASQLKQSGPRYLLRNDILSDFSKYCADQEKPDYFYHSSNLGRLIYYTQEIILDQESLY
----------------------MLNLIQDVLESDEKSDLRHFTSQLKTAEPRYLLRNEILAAFNEYCTKHKKSEYFYHSSHLGKLIYYTQEIILEDESLC
----------------------MSELMQAILDSEEKHDLRGFISELRQQDKNYLLRNDILNVYAEYCSKCQKPETSYKFSNLSKLIYYTQEIIQEDSNFC
----------------------MSELMQAILDSEEKNDLRAFISELRLQDKNYLLRNDILNVYSEYCSKCQKSETSYKFSNLGKLIYYTQEIIQEDSNFC
----------------------MSELLQAVLDSEERSDLRSFLSELRQQEKKYLLRNDILNVYSEYCSKSQKPEAYYTTSELGKLIYYTQEIIQEDSNFC
MQGGGVSFVLPVKNANLMLGVPMSELIQAILDSEEKSDLRSFASQLRQEEKNYLLRNDILNVFIDYCSKSEKSETSAASSRLGKLIYYTQEIIQEDSSLC
----------------------MSELFQAVIASDEKTELRQFVSDLRALGNKYLLRNDIVNAFAAYCTKYEKPEQFHQSSLLSKLIYYVQEIILEDGSLC
----------------------MSGLIETVLNSEEKIVLWQFIGELRTSDKRYLLRNDIVCAFEDFCKRNGNSQ-KIDSSPLGQMIHYTQEIILEEESIC
----------------------MAELIEAIANSNEKKDLQQFLHQLRQLEKPYLLRNDLLTAFADYCQRLDKPASFRQSSLLAKLIYYTQETILESESFC
----------------------MSELITAVLASEERRELKEFLLQLQRQDNRYLLRNEILAAFSQYGEEAGKPKEFFHSSQLGKLINFTQEIILEDESFC
---------------------MTCVLLKAVVESDERADLRQFSRILQLGEKRYLLRNDILDAFADYCRDQERPVPPPSESRLSKLVFYTQEIIVDNESLC
----------------------MSQLIQAVLNSDEKTDLRQFASEVHNQPERYLLRNDILSVFDTFCEKYEKTPAFQLSSRLQKLIYYTQEILVEDENLY
----------------------MSELIQNVIESDEKQDLRQFYSELRISEKRYLLRNDILQAFADYCLKFQKAAHFVDSSHLSKLIYYTQEIILENESIC
----------------------MSELIQNVIDSDEKQDLRQFASELRISEKRYLLRNDILQAFADYCLKFQKSDHFVHSSNLSKLIYYTQEIILENESIC
---------------------MHELFHPIFANGEEKAALQQLIIALDASGKRYFLRNEILHTFSQYCQQAQKPTYFYYSSSVGKLIQYTHEIVLAEDGTW
---------------------MHELFHPIFANGEEKAALQQLIIALDSSGKRYFLRNEILHTFSQYCQQAQKPTYFYYSSSVGKLIQYTHEIVLAEDSTW
----------------------MYELVQAVFNGDEKTALHQLIYTLSASGKRYLLRNEILQAFADYCHESQKPAYFYHSSSIGKLIQYTHEIIIEEESTW
----------------------MHELFETVLNKDEKITLRQFISELSDTDKRYFLRNEILHNFAEFCHQYQKPTYFYYSSSIGRLIHNTHEMILDEQGTW
----------------------MYELFQAVLTSDEKTALRQFLLILHDFDKCYFLRNEILQAFTNYCHQSEKPTYFYHSSSLGTLIHYTHEIIIEDENTW
----------------------MRDLVESVLTSDEKIDLARFLDRLIQQGKQYFLRNEILQHFSSYCREAEKAAHFYYASYLGKLLHYTHELILEEGAVW
----------------------MSSLLRAVLQSNEKADLRQFISQLRSEQERYFLRNQILQAFDNYCTTHDKPAYFKRTSSIAELLNYTHEIILEEKNLW
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....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
FVLRPGIAELEFVRMHQEHLMPEKITINEFLGFKE-TVTKG-EA--IESILEVDFGPFNRAFPKLRESRSIGQGVIFLNRQLSSEMFT-RIE--AGSTRL
LALRPEIAKWEFMRIHQEHLIPEKLTISEFLKFKE-TVVKG-EA--TESVLEVDFGPFNRGFPRLKESRSIGQGVIFLNRKLSSEMFS-RIE--AGHTSL
MAAREEAGCWWYARLHLDRLIPEAVTVSEYLAFKE-LLVNPEGA--NEPVLEIDFAPFNRGSPKLKEIRSIGQGVIFLNKQLAGGLFG-QLG--LGSDKL
LAWRPSPGRWTYLRMHWEQLHLETLAPSDYLAFKE-RQVLPAND--QEPILTVDFEDFRAAPYHLQDEDTIGQGLIYMNRRLAGRLFG-NIK--TGRQSI
LAWRPSPGRWTYLRLHREQLNLETLTAGDYLAFKE-RQVLPAND--QEPVLTVDFEDFRAVSYRLHDEATIGQGLMYMNRRLAGQLFG-DIK--AGRQSI
FAWRPRPGRWIYVRIHREQLALEELSTDAYLQAKE-GIVGLGAE--GEAVLTVDFRDFRPVSRRLRDESTIGDGLTHLNRRLAGRIFS-DLA--AGRSQI
LSVRPRIANWEYYRIHTEVMQIETVPVSQFLEFKERLVLGPTQP--QSWPLKIDMGPFNREFPRLRETRSIGRGMDFLNRHLSNQLFN-ELE--TGGQYL
LSVRPRIANWEYYRIHTEVMHIETVTVSQFLEFKERLVLGTSQP--QSWPLKIDMGPFNREFPRLKETRSIGRGMDFLNRHLSNQLFN-ELE--TGGQYL
LSIRPGIASWEYYRIHAEVIQIETVTISQFLEFKARLVLGPQQD--EPWPLKVDMGPFNREFPRLSETRSIGRGMDFLNRHLSSQLFK-ELE--TGGQCL
FAVRPRVGRWWYLRLHVDDLYPDSVEASEFLGFKERLISAQAG---TERPLEFDIEPFDRGFPKLRESRSIGRGMEFLNRKLSSQLFD-GGD--QGLEKL
LALRPRIGRWQFLRIHADDLSVEDLGVSEFLAIKERLVCPAPR---HGRPLEFDIEPFNREFPRLRETRSIGRGVEFLNRKLSSQLFD-RAN--GGLDKL
LALRRRVARWEFVRLHIETMDAQPVSVAEYLAFKERTATGGPE---DPWGLEIDMSPFYRDQFKLREEGSIGRGVEFLNRRLSSRLFE-ELG--KGDRRL
LAARSTIGHWNYYRLHSEEIEIDEIDVSEYLEFKERLVGYEAPS--DEYLLELDMTPFNREFPKLQEARSIGRGVEFLNRHLSSKLFV-EKR--EGSRKI
LAVRPEIAKWQYFRFHVEDVLFDEIGASDYLKFDEMQVNNSTQV--DEFLLEIDLEPFNREFPKLNEYTYIGKGVDFLNRHLSGQFFQ-DKK--RGHEKL
FAVRMNPGIWEYVKVHSDDLSVEGITPSEYLKFKETLYDEKWAKDDNS--LEVDFGALDLSTPHLTLPSSIGNGLQFVSKFMSSKLG--GKP--ESMKPL
FAVRMNPGIWEYVKVHSDDLSVEGITPSEYLKFKETLYDEKWAKDDNS--LEVDFGALDLSTPHLTLPSSIGNGLQFVSKFMSSKLG--GKP--ESMKPL
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326504012
115450038
326531526
242063616
42568160
297805240
313770765
313770767
255584097
225466221
313770769
313770771
255570671
15219457
297842089
115466896
17980243
162460741
239984690
162460681
242035533
62865493
17980241
115453437
115473359
3980298
15242073
297812265
22331535
297818772
313770759
313770761
255550319
324984223
258489633
324984221
324984229
6683114
4584690
3915046
3766299
3377764
225444613
3660531
31455440
304651488
28629438

FAVRMNPGIWEYVKVHADDLSVEGITPSEYLKFKDTLYDEKWAKDDNS--LEVDFGALDLSTPRLTLPSSIGNGMQFVSKFMSSKLN--GKP--ESMKPL
FAVRMNPGIWEFVKVHSANLSVEQMTPSDYLKNKEALVDDKWGAYDDDSQLEVDFGALDLSTPHLTLPSSIGKGAHLVSRFMSSKLT--DNK-----KPL
FAVRTNPGVWEFIRVHSGDLSVEQITPADYLKCKETLYDEKWARDDNS--LEVDFGALDLSTPHLALPSSIGNGMQFISRFMSSKLS--GKP--ESMKPL
LAVRRNPGVWEYITVHSGDLTVQQITPSDYLKRK-----EILFLYDNSSQLEVNLGALDLSTPRLTLPCSIGNGMHLVSRFLSSRLGGGGGR--TKNKAL
FAVRGTPGNWQYVKVNSSNLSVEALSSTQYLKLKEFLFDENWANDENA--LEVDFGALDFTLPWLSLSSSIGNGLSFVSSKLGGRLN-------DNPQSL
FAVRGNPGIWQYTKVNSSNLSVEALSSTQYFKLKELLFDENWANDENA--LEVDFGALDFTLPWLSLPSSIGNGVSFVSSKLGSRLN-------DNPQSL
FSIRPSPGFWEYVKVNSANLSVEGITVTDYLKFKEMIYDENWAKDANA--LEVDFGAFDFSVPHLTLSSSIGNGLGFVSKFVTSKLSG--RL--ENAQPL
LSIRPSPGFWEFVKVNSADLSVEGITATDYLKFKEMIYDENWAKDANA--LEVDFGAFDFSVPHLTLSSSIGNGLGFVSKFATSKLSG--RL--ESAQPL
FAIRPSPGFWEFVRVNSADLAVDGINVSEYLKFKEMIFEESWAKDVNT--LEVDFGAFDFSMPKLTLSSSIGNGHNFVSKFITSKLNG--RP--ENAQPL
FSIRSNPGFWEYVKVSSDDLSVEAITAADYLKFKEMVFDENWAKDDNA--LELNFSAFDFPMPRLTLSSSIGNGVSLVSKFMTSKLNG--NS--QSAQPL
FAVRPNPGFWEYVKVNAEDLSVEGISVSEYLQLKEMVFDEKWANNENA--LELDFGAMDFSTPRLTLSSSIGNGVNYMSKFMSSKLSG--SS--EAAKPL
FAVRPNPGFWEYVKVNAEDLSVDGISVSEYLQFKEMIFDEKWASNENA--LEVDFGAMDFSTPRLTLSSSIGNGLNYMSKFMSSKLRG--NS--DAAKPL
FAVRPNPGFWEYVKVNADDLNVDGISPSEYLQFKEMVFDEKWAKDENA--LEIDFGAIDFSIPRLNLSSSIGNGMSFISKFMSSNLCG--SY--SSAKPL
LAARPNPGFWEYVKVNSGDLTVDEITATDYLKLKESVFDESWSKDENA--LEIDFGAIDFTSPRLSLSSSIGKGADYISKFISSKLGG--KS--DKLEPL
LAARPNPGFWEYVKVNSGDLTVDEITANDYLKLKESVFDESWSKDENA--LEIDFGAIDFTSPRLSLSSSIGKGADYISKFISSKLGG--KS--GRLEPL
LAIRPRPGVWDYIRVNVSELAVEELSVSEYLAFKEQLVDGHTN---SNFVLELDFEPFNASFPRPSMSKSIGNGVQFLNRHLSSKLFQ--DK--ESLYPL
LAIRPRPGVWDYIRVNVSELAVEELSVSEYLEFKEQLVDGHTN---SNFVLELDFEPFNASFPRPSMSKSIGNGVQFLNRHLSSKLFQ--DK--ESLYPL
LAIRPRPGVWDYIRVNVSELAVEELSVSEYLAFKEQLVDGQSN---SNFVLELDFEPFNASFPRPSMSKSIGNGVQFLNRHLSSKLFQ--DK--ESLYPL
LAIRPRTGVWDYIRVNVSELAVEELTVSEYLAFKEQLVDEHAS---SKFVLELDFEPFNASFPRPSMSKSIGNGVQFLNRHLSSKLFQ--DK--ESLYPL
LAIRPRPGVWEYVRVNVSELAVEELRVPEYLQFKEQLVEEGPN---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL
LAIRPRPGVWEYVRVNVSELAVEELRVPEYLQFKEQLVEEGPN---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL
LAIRPRPGVWEYVRVNVSELAVEELRVPEYLQFKEQLVEGSTN---NNFVLELDLEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL
LAIRPRPGVWEYVRVNVSELAVEELRVPEYLQFKEQLVEGSTN---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL
LAIRPRPGVWEYVRVNVSELAVELLTVPEYLQFKEQLVEEGTN---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL
LAIRPRPGVWEYLRINVSQLGVEELSVPEYLQFKEQLVDGSTQ---NNFVLELDFEPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL
LAIRPRPGVWEYVRVNVSELGVEELSVLRYLQFKEQLANGRTD---NNFVLELDFGPFNASFPRPSLSKSIGNGVQFLNRHLSSKLFH--DK--ESMYPL
LAVRPRPGVWEYLRVNLHALVVEELQPAEFLHFKEELVDGVKN---GNFTLELDFEPFNASIPRPTLHKYIGNGVDFLNRHLSAKLFH--DK--ESLLPL
LAVRPRPGVWEYIRVNLHALVVDELQPAEFLHFKEELVDGVKN---GDFTLELDFEPFNASFPRPTLNKYIGNGVEFLNRHLSAKLFH--DK--ESLLPL
LAVRPRPGVWEYVRVNLHDLVVEELQASEYLQFKEELVDGIKN---GNFTLELDFEPFNAAFPRPTLNKYIGDGVEFLNRHLSAKLFH--DK--ESLHPL
LAVRPRPGVWEYVRVNLHDLVVDELQASEYLQFKEELVDGIRN---GNFTLELDFEPFNAAFPRPTLNKYIGNGVEFLNRHLSAKLFH--DK--ESLHPL
LALRPRPGVWEYIRLNVQALVVEELRVAEYLHFKEELVDGGCN---GNFVLELDFEPFNASFPRPTLSKYIGNGVEFLNRHLSAKLFH--DK--ESLHPL
LAVRPRPGVWEYVRVNVQALVVEELRVAEYLHFKEELVDGGSN---GNFVLELDFEPFSASFPRPTLSKYIGNGVEFLNRHLSAKLFH--DK--ESLHPL
LAVRPRPGVWEYIRVNVHALVVEELRVAEYLHFKEELVDGSQN---GNFVLELDFEPFNASFPRPTLSKYIGNGVEFLNRHLSAKLFH--DK--ESLHPL
LAVRPRPGVWEYIRVNVHALVVEELTVAEYLHFKEELVDGSSN---GNFVLELDFEPFNSSFPRPTLSKSIGNGVEFLNRHLSAKLFH--DK--ESMHPL
LAVRPRPGVWEYIRVNVHALVVEELTVAEYLHFKEELVDGSSN---GNFVLELDFEPFNSSFPRPTLSKSVGNGVEFLNRHLSAKLFH--DK--ESMHPL
LAVRPRPGVWEYIRVNVHALVVEELTVAEYLHFKEELVDGSSN---GNFVLELDFEPFNSSFPRPTLSKSIGNGVEFLNRHLSAKLFH--DK--ESMHPL
LAVRPRPGVWEYIRVNVHALVVEELTVAEYLHFKEELVDGSSN---GNFVLELDFEPFNSSFPRPTLSKSIGNGVEFLNRHLSAKLFH--DK--ESMHPL
LAVRPRPGVWEYIRVNVHALVVEELLVAEYLHFKEELVDGGSN---GNFVLELDFEPFNASFPRPTLSKSIGNGVEFLNRHLSAKLFH--DK--ESMHPL
LAVRPRPGIWEYLRVNVHALVVENLQPAEFLKFKEELVDGSAN---GNFVLELDFEPFTASFPRPTLNKSIGNGVQFLNRHLSAKLFH--DK--ESLHPL
LAVRPRPGIWEYLRVNVHALVVENLQPAEFLKFKEELVDGSAN---GNFVLELDFEPFTASFPRPTLNKSIGNGVHFLNRHLSAKLFH--DK--ESLHPL
LAVRPRPGVWEYLRVNVHALVVENLQPAEFLKFKEELVDGSAN---GNFVLELDFEPFTASFPRPTLNKSIGNGVQFLNRHLSAKLFH--DK--ESLHPL
LAVRPRPGVWEYLRVNVHALVVENLQPAEFLKFKEELVDGSAN---GNFVLELDFEPFTASFPRPTLNKSIGNGVQFLNRHLSAKLFH--DK--ESLHPL
FAVRPRPGVWEYIRVNVSALVVEELLVPEYLHFKEELVDGSCN---GNFVLELDFEPFTASVPRPTLSKSIGNGVEFLNRHLSAKMFH--DK--DSMQPL
LAIRLRPGVWEYVRVNVNALVVEELSVPEYLQFKEELVDGASN---GNFVLELDFEPFTASFPKPTLTKSIGNGVEFLNRHLSAKMFH--DK--ESMAPL
LAIRLRPGVWEYIRVNVNALVVEELSVPEYLQFKEELVDGASN---GNFVLELDFEPFTASFPKPTLTKSIGNGVEFLNRHLSAKMFH--DK--ESMTPL
LAIRLRPGVWEYVRVNVNALSVEELTVPEFLQFKEELVNGTSS---DNFVLELDFEPFTASFPKPTLTKSIGNGVEFLNRHLSAKMFH--DK--ESMTPL
LAIRLRPGVWEYVRVNVNALIVEELTVPEFLQFKEELVNGTSN---DNFVLELDFEPFTASFPKPTLTKSIGNGVEFLNRHLSAKMFH--DK--ESMTPL
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115310618
345286417
38425095
15235300
297814081
6682841
255564236
313770763
3915037
225437428
162458268
242035817
115452927
241896730
304651490
29289943
115310620
4468153
345286419
4468151
151176306
14530225
15239816
297795665
225431790
255551835
168009716
168035060
168058907
168029793
94266940
94264333
297569306
254416162
332712456
17232477
75908500
186682280
119512682
334117431
218440696
159031025
220907171
22298591
158339122
284053161
209523126

LAIRLRPGVWEYVRVNVHALVVEELTVPEYLHFKEELVDGSKN---GNFVLELDFEPFTASFPKPTLTKYIGDGVEFLNRHLSAKMFH--DK--ESMAPL
LAIRLRPGVWEYVRVNVNALVVEELTVPQYLHFKEELVNGAAN---GNFVLELDFEPFTASFPKPTLTKSIGNGVEFLNRHLSAKMFH--DR--ESMTPL
LAVRPRPGIWEYIRVNVDALAVEELTPSQFLHVKEELVDGSTN---GNFVLELDFEPFTASFPRPTLSKSIGNGVEFLNRHLSAKMFH--DK--ESMRPL
LAVRPRPGVWEYVRVNVFELSVEQLTVSEYLRFKEELVDGPNS---DPFCLELDFEPFNANVPRPSRSSSIGNGVQFLNRHLSSVMFR--NK--DCLEPL
LAVRPRPGVWEYVRVNVFELSVEQLTVSEYLRFKEELVDGPNS---DPFPLELDFEPFNANVPRPSRSSSIGNGVQFLNRHLSSVMFR--NK--DCLEPL
IAVRPRPGVWEYVRVNVYELSVEQLSVSEYLHFKEELVDAAFN---ERFVLELDFEPFNATFPRPNRSSSIGNGVQFLNRHLSSSMFR--NK--DCLEPL
IAIRPRPGIWEYVRVNVHDLSVEQLDVSQYLRFKEELVDGSSN---DPYVLELDFEPFNADVPKPHRSSSIGNGVQFLNRHLSSIMFR--NK--DCLEPL
VSIRPRPGVWEYVRVDVSQLNVEELTVSQYLRFKEELVDGPSN---DPYVLELDFEPFNAAFPRPTRSSSIGNGVQYLNRHLSSNMFR--NK--DTLEPL
IAVRPRPGVWEYVRVNVFELSVEQLSVSEYLSFKEELVEGKSN---DNIILELDLEPFNASFPRPTRSSSIGNGVQFLNRHLSSNMFR--NK--DCLEPL
IAVRPRPGVWEYVRVNVHELSVDQLSVSEYLRFKEELVDGMFN---DYYVLELDFEPFNASFPRPNRSSSIGNGVQFLNRHLSSIMFR--NK--ESLEPL
IAVRPRPGVWEYVRVNVHELSVEQLTVSEYLRFKEELVDGQHN---DPYVLELDFEPFNVSVPRPNRSSSIGNGVQFLNRHLSSIMFR--NR--DCLEPL
IAVRPRPGVWEYVRVNVHELSVEQLTVSEYLRFKEDLVDGQHN---DPYILELDFEPFNASVPRPNRSSSIGNGVQFLNRHLSSIMFR--NR--DCLEPL
IAVRPRPGVWEYVRVNVHELSVEQLTVSEYLRFKEELVDGQYN---DPYILELDFEPFNASVPRPNRSSSIGNGVQFLNRHLSSIMFR--NK--DCLEPL
IAVRPRPGVWEYVRVNVHELNVEQLSVSEYLRFKEELVDGQHN---NPYVLELDFEPFTALIPRPSRSSSIGNGVQFLNRHLSSILFR--NR--DCLEPL
IAVRPRPGVWEYVRVNVYDLSVEQLTVPEYLRFKEELVDGEDHN--HLFVLELDFEPFNASVPRPSRSSSIGNGVQFLNRHLSSNMFR--SN--ESLDPL
IAVRPRPGVWEYVRVNVYDLSVEQLTIPEYLRFKEELVDGEDN---NLFVLELDFEPFNASVPRPSRSSSIGNGVQFLNRHLSSNMFR--SK--ESLDPL
IAVRPRPGVWEYVRVNVYELSVDQLSISEYLHLKEELVDGRSE---DHLVLELDFEPFNATFPRPTRSSYIGNGVQFLNRHLSSIMFR--NK--DSLEPL
LAVRPRPGVWEFVRVNVYQLSVDELTISEYLRFKEELVDGGID---DNFVLELDFEPFNASFPRPTRSSYIGNGVQFLNRHLSSIMFR--NK--DCLEPL
IAIRPRPGVWEFVRVNVYELSVDELTVSEYLRFKEALVDGQHD---DHYVLELDFEPFNATFPRPTRSSSIGNGVQFLNRHLSSIMFR--NK--ESLDPL
LAVRPRPGVWAYVRVNMQELSIDELTVSEYLCFKEELVDGRGF---DPYVLELDFEPFNATFPRPSRSSSIGNGVQFLNRHLSSIMFR--NK--DSLEPL
IAVRPRPGVWEYVRVNVSELNVEQLTVSEYLHFKEELVDGKAD---DHYVLELDFEPFNESVPRPTRSSSIGNGVQFLNRHLSSSMFR--NK--DCLEPL
IAVRPRPGVWEYVRVNVSELNVEQLTVSEYLHFKEELVDGKAD---DHYVLELDFEPFNESVPRPTRSSSIGNGVQFLNRHLSSSMFC--NK--DCLEPL
LAIRPRPGVREYVRVNVYELSVDHLTVSEYLRFKEELVNGHAN---GDYLLELDFEPFNATLPRPTRSSSIGNGVQFLNRHLSSIMFR--NK--ESMEPL
LAIRPRPGVREYVRVNVYELSVDHLTVSEYLRFKEELVNGHAN---GDYLLELDFEPFNATLPRPTRSSSIGNGVQFLNRHLSSIMFR--NK--ESMEPL
IAIRPRPGVWEYIRVNVYELNVDQLSVSEYLQFKEELVDGQIK---GNYVLELDFEPFNATFPRPTRSSSIGNGVQFLNRHLSSIMFR--NK--ESLEPL
MAIRPRPGVWEYVRVNVYELSVDHLNVSEFLRFKEDLADGECD---ESYVLELDFEPFNATFPRPTRSSSIGNGVQFLNRHLSSVMFR--QK--ESLEPL
FAVRPRPGIWEYVRINVEELTLEELSVSEYLSFKEQLAN-GTEY--DPFVLELDFAPFNANFPHMTRPSSIGHGVQFLNRHLSSKLFH--TP--DSMEPL
LAVRPRPGIWEYLRINVEELILEELSVSEYLGFKEQLANSTDVR--DPFLLELDMAPFNSNFPRMTRPSSIGHGVEFLNRHLSLKLFQ--TA--DGIEPL
FAVRPRPGIWEYVRINVEELIVEELSVSEYLGFKEQLSLGSDSI--DLYVLELDFEPFNAHFPRMTRPSSIGHGVQFLNRHLSSKLFQ--NP--ESMEPL
LALRPRPGLWEYMRINVEEMIVEELTTSEYLSFKECLADENRCN--DLYVLELDIEPFNVGFPRMTRPQSIGNGVQFLNRHLSSRLFR--DA--DSMEPL
IVYRHRRANCLIFAINGQSDKLLKLSVGDFLAIKERLLRPELPP--QQRTLNLNLAPFYDYGPTLKDPNTIGQGIKFLNRHMSGRLANHPEK---WNRFL
IVYRHRRANCLIFAINGQSDKLLKLSVGDFLAIKERLLRPELPP--QQRTLNLNLAPFYDYGPTLKDPNTIGQGIKFLNRHMSGRLANHPEK---WNRFL
ILYRHRRASCRIFALSEDDDRLIPVTLIDFLAIKERLIRPNLPP--QQRTLAINLAPFYDYGPTLKDPNTIGQGIKFLNRHMSGNLSNHPEK---WNRSL
LIIRPKIAEQEAF-QVLEDLTVEPITIQTLLDVRDRFVNHYRPN--EGDVLELDFKPFYDYSPIIRDSKNIGKGVQFLNRFLSSKLFQDPRQ---WQESL
LIIRPKIAAKRAF-RLFEDLRAQEVTPEELLDIGDRFVNRYNPK--VGEVLQLDFQPFYDYSPLIRDPKNIGKGVRFLNRYLSSKLFQDPEQ---WLESL
FIIRPKIAAQEVY-RLTADLDVEPMTVQELLDLRDRLVNKFHPY--EGDILELDFGPFYDYTPTIRDPKNIGKGVQYLNRYLSSKLFQDSQQ---WLESL
FIIRPNIAAQEVY-RLTADLDVEPMTVQELLDLRDRLVNKFHPH--EGDLLELDFGPFYDYTPTIRDPKNIGKGVQYLNRYLSSKLFQDSQQ---WLESL
FIIRSKIASQEVY-WLTSDLSIEPMTVQDLLDLRDRLVNKFHPN--DGDLLELDFGPFYDYTPIIRDPKNIGKGVQFLNRYLSSKIFQDSKQ---LLENL
FIIRPKIASQEVY-RLTEDLNVEPMSVQELLDLRDRFVNKYHPL--EGDLLELDFGPFYDYTPVIRDPKNIGKGVQFLNRYLSSKIFQDSKQ---LLDSL
VLLRPKIASMEIV-RVADDLTVEQMTVQELLDVRDRFVNHFHPQ--EGDILELDFGPFYDYSPTIRDPKNIGKGVQFLNRYLSSKLFQDARQ---WQETL
IVYRPKIARQEVY-RLREDTPIEHLSVQQLLDVRDHFVNQFHPD--EGDVFEIDFEPFYDYSPTIRDSKNIGKGVRFLNRYMSSKLFQDPRQ---WLETL
LVVRPQIALSQAF-RLTDDLTCEPISVQELLDLRDRLVHRSHPE--EGDLLELDFRPFYDYSPIIRDAKNIGKGVQFLNRFLSSRLFQAEQTGEQWLQSA
LVLRPNIASQSVF-RITSDLAVEEMRVKELLTVRDRLVQRHHPE--EGELLELDFQPFYDYSPTIRDAKNIGKGMQLLTRYLSSKLFQDPQE---WTQVL
WIVRPRIAQQEVCRLLVEDLTIVPMTIPELLDLRDRLVNHYHPN--EGDVFEIDVQPFYDYSPIIRDAKNIGKGVEFLNRYLSSKLFQDPRQ---WQQNL
LIIRPKIASEEAYRLDPRELVYEQIQIDELLDLRDRFVGHYHPQ--EGDILEIDFRPFYDYSPVIRDPKNIGRGVQYLNRYLSSKMFEGPQQ---WLFSL
LIVRPQIATQERF-RLRPDLSVDVMSVQELLDLRDHFVDHHHPH--DGNVFAIDFGPFYDYSPQLRDSKNIGKGVRYLNRYLSSKLFQDSNQ---WLESL
LIVRPQIATQERF-RLRPDLSVDVMSVQELLDLRDHFVDHHHPH--EGNIFAIDFGPFYDYSPQLRDSKNIGKGVRYLNRYLSSKLFQDSNQ---WLESL
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FVVRPRIASQEVWRLTSDLAKFDSMSIDAFLDVSDRLVNAYEP-----NILEIDLNSFYEASPSISDPRNIGQGLAFLNRYLCSQIATDPQY---WVELV
FVVRPRIANQEVWRLTSDLAKFDSMPIDAFLDVSDRLVNAYEP-----NILEIDLSSFYEASPSISDPRNIGQGLAFLNRYLCSQIATDPQY---WVELV
FVIRPKIANQEVWRLTANLDSFEQMTQQALLDVRDRLVNRYQP-----GILEIDLHPFYEDSPRIDDPRNIGQGLAYLNRYLCNQLLTDPEY---WVEML
FVVRPRIGSQQMWRLQADFSGFEPMTPQAWLDVSDRLVNRYQP-----HILEIDFQPFAEESTRITDPRNIGQGLAFLNRYLCDQLSNDTHY---WLEVI
FVVRPRIASQEVWRLTADFTHFDLMTPKAFLDVSDRLVNRYQP-----HILEIDLHPFYQTSPRISDPREIGQGLTFLNHYLCNQFVSDPQY---WLETF
LLVRSTINDQQIWQISTDLNRYGRMSPHDLLEVRDRLVNRSQS-----SILEINVHPFYNMAYAVEDPRNIGQGLAFLNHYLCNQVSIDRTR---WLDVL
LLLRTRVASQEIYRLAADLTSFEPMPVEELLSLRDRWVKRYFPE--KGGLLEIDVGPFYKNTPTIRDPRKIGNGLEFLNRYLSSQLFADSEQ---WLEEL
*
:
:
: .:. :
:* *
:.
.

114331077
30249199
82703384
198283392
344199811
255021595
77166514
300115586
292493898
350552412
220933364
350574485
95929190
298528445
297602308
115457664
326504012
115450038
326531526
242063616
42568160
297805240
313770765
313770767
255584097
225466221
313770769
313770771
255570671
15219457
297842089
115466896
17980243
162460741
239984690
162460681

210
220
230
240
250
260
270
280
290
300
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
LHFLGVHTID----------GQQLMFTSNSHNINMVRSQLRQALEMLEAVDGTTPWAELSSDMSKIGFAPGWGHNAARVAETMNMLMDILEAPSPSALEA
LHFLGVHAIE----------GQQLMFSNNSHDIHAVRNQLRQALEMLETLDGTTPWIELAPKMNQLGFAPGWGHNANRVAETMNMLMDILEAPSPSALEE
LHFLTVHSMD----------GKQLMLGGNFADVPALRSGLRRALSMLEKYPDDTEWKDVAEPLGGIGFAPGWGNCVGRVSETMSLLVDILEAPSPQILES
LDFLAVHKLN----------GQSLMVHDQPPDFEALR----QTVQYLATLPKTKPWTEFAAEMTYRGFAPGWGDTAGRVRETMRLLMDLLDAPSAEGLQA
LDFLAVHKLN----------GQSLMVHDQPPDFEALR----RTVQYLATLPKTQAWTEIAAEMTHRGFAPGWGDTVGRVRETMRLLMDLLDAPSAEGLQA
LEFLSLHRLD----------GQNLMLSNGNTDFDSLR----QTVQYLGTLPRETPWAEIREDMRRRGFAPGWGNTAGRVRETMRLLMDLLDSPSPAALES
LSFLSVHHCR----------GQPLMLNDRIQDVQGLRCALRLAMDFLGGFQEAAEWDAVGHKLQEFGFERGWGRTAARIQDSFSLLMDILEAPEPGNLEH
LSFLSVHHCR----------GQPLMLNDRIQDVRGLRRALRLAMDFLGSFQEAAEWDAVGHKLQELGFERGWGRTAVRMQDSFSLLMDILEAPEPGNLEH
LNFLSVHHCR----------GQPLMLNDRIQDLRGLRRALRRAVDFLGGFPKAAEWEAVGHKLQELGFERGWGGTVAQMEDSFSLLMDILEAPDPGNLER
FHFLHEHCCE----------GQILMINERVRNVNELRGVIRRCEKLLNGYARHTPWAEVAPLLRDVGLEPGWGSDVGRILETLRLLSDLLEAPSPETLER
FRFLREHRCD----------GRLLMINDRIRDVDALRVAIRDAEQRLARLKRDTPWADFAHPLQDLGFEPGWGRDAGRVQETLRLLSELLEAPSPESLER
LNFLRMHSHR----------GQVLMLNDTITDVAGLRNALRQALLPLRRRAASTPYEELAPDLRPLGFEPGWGCDAARVRNTMGLLLDILEAPSPQTIEE
LDFLRVHQHR----------STQLMLNGMIEDVPGLQAALRKGVKFLKNCDEDTCWDDVAPTMMSYGFQPGWGRTLEDILEMFHMLMDILEAPDPQNLEK
FEFLRLHQIE----------GKQLMLNGHIETVSGLRSALRKALTFLKKQDPSQKWSGISRHMQTLGFQPGWGKDVERVRENLELLREILEAPTPNILAS
LDYLLTLNYR----------GEKLMINDTIDTVSKLQTALLLAEVFVSGLPKYTPYLKFEQRFQEWGLEKGWGDTAERCKETLNCLSEVLQAPDPTNMEK
LDYLLTLNYR----------GEKLMINDTIDTVSKLQTALLLAEVFVSGLPKYTPYLKFEQRFQEWGLERGWGDTAERCKETLNCLSEVLQAPDPTNMEK
LDYLLALNYR----------GEKLMVNDTIDTVNKLQTALLLAEVFVSGLPKFTPYLKFEQRFQEWGLEKGWGENAERCKETLNFLSEVLQAPDPINMEK
LDYLLALSHR----------GDKLMINDILDTVDKLQTALLLAEVYVAGLHPDTNYSEFEQKFQEWGLEKGWGDTAETCKETLSSLSEVLQAPDPINMEK
LDYLLALNYR----------GEKLMISDSLDTADKLQTALLLAEVFVASLEKSTPYQQFEQKFQEWGLEKGWGDTAETCRETLNFLSEVLQAPDPINMEK
LDYLLALRYYRRRPGDQQQINNKLLISDTLDTVGKLQAALLLAQAFVSEQHPDTPYQQMAHRFQEWGLEKGWGDTAEACGHTLACLAEVLQAPDPASIHR
VDYLLSLEHQ----------GEKLMMNETLNTARKLEMSLILADVFLSELPKDTPFQAFELRFKECGFEKGWGESAGRVKETMRILSEILQAPDPQNIDR
VDYLLSLEHQ----------GEKLMMNETLNTARKLEMSLILADVFLSELPKDTPFQAFELRFKEWGFEKGWGESAGRVKETMRILSEILQAPDPHNIDR
VDYLLSLNRQ----------GEKLMINETLGTVGKLQMALIVAEVYLSGLAKDTPYQNFEISFKEWGFEKGWGDTAERVKETMRCLSEVLQAPDPMNMEK
VDYLLSLNHE----------GEKLMINETLSSVRKLRMALIVAEAYLSGLPKDTQYQNFETSFKAWGFEKGWGNTAERVKETMRCLSEVLQAPDPLNMEN
VDYLLSLTHH----------GEKLMINENLSTVAKLQMALIVAEVYLSGLAGDTPYQNFELSFKEWGFEKGWGDTAERAKETMRSLSEVLQAPDPVNMEK
VDYLLSLNHQ----------GEKLMITNTLNTPTKLQMALIVAEVFVSALPKDTPYPSFELRFKEWGFEKGWGNTAERVKETMRSLSEALEAPDPMNMEK
LDYLLALNHQ----------GENLMINQTLDTVAKLQEALIVAEVVVSAFPKDTPYQDFQQRLRELGFETGWGDTAERVKETMRLLSESLQAPYPMKLQL
LDYLLALDHQ----------GENLMINQALDSVSKLQAALIVAEVVVSAFPKDAPYQDFQQSLKRLGFEKGWGDTAERVKETMRMLSESLQAPEPVKLEL
LDYLLALNYQ----------GEELMINEKLDTVAKLQKALTGAEDVLSVFSKEAAYKNVQQSLKEMGFEKGWGNTAERVKETMRLLSESLQAPDPAKLEL
LNYLLRLNHH----------GENLMINDDLNTVAKLQKSLMLAVIVVSTYSKHTPYETFAQRLKEMGFEKGWGDTAERVKETMIILSEVLEAPDNGKLDL
LNYLLRLNHH----------GENLMINDDLNTVAKLQKSLMLAVIVVSTYPKHTPYETFALRLKEMGFEKGWGDTAERVKETMVMLSEVLEAPDNVKLDL
LNFLKAHNHK----------GTTMMLNDRIQSLRGLQSSLRKAEEYLMGIPQDTPYSEFNHRFQELGLEKGWGDCAKRVLDTIHLLLDLLEAPDPANLEK
LNFLKAHNHK----------GTTMMLNDRIQSLRGLQSALRKAEEYLMSFPQDTPYSEFNHRFQELGLEKGWGDTAKRVLDTIHLLLDLLEAPDPANLEK
LNFLKAHNYK----------GTTMMLNDRIQSLRGLQSSLRKAEEYLLSVPQDTPYSEFNHRFQELGLEKGWGDTAKRVLDTLHLLLDLLEAPDPANLEK
LNFLKAHNYK----------GTTMMLNDRIQSLRGLQSALRKAEEYLISIPEDTPSSEFNHRFQELGLEKGWGDTAKRVHDTIHLLLDLLEAPDPASLEK
LNFLRAHNYK----------GMTMMLNDRIRSLSALQGALRKAEEHLSTLQADTPYSEFHHRFQELGLEKGWGDCAKRAQETIHLLLDLLEAPDPSTLEK
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242035533
62865493
17980241
115453437
115473359
3980298
15242073
297812265
22331535
297818772
313770759
313770761
255550319
324984223
258489633
324984221
324984229
6683114
4584690
3915046
3766299
3377764
225444613
3660531
31455440
304651488
28629438
115310618
345286417
38425095
15235300
297814081
6682841
255564236
313770763
3915037
225437428
162458268
242035817
115452927
241896730
304651490
29289943
115310620
4468153
345286419
4468151

LNFLRAHNYK----------GMTMMLNDRIRSLSALQGALRKAEEHLSTLQADTPYSEFHHRFQELGLEKGWGDCAKRAQETIHLLLDLLEAPDPSTLEK
LNFLRAHNYK----------GMTMMLNDRIRSLSALQGALRKAEEHLSGLSADTSYSDFHHRFQELGLEKGWGDCAKRAQETIHLLLDLLEAPDPSTLEK
LNFLRAHNYK----------GMTMMLNDRIRSLSALQGALRKAEEHLSGLSADTPYSDFHHRFQELGLEKGWGDCAKRAQETIHLLLDLLEAPDPSTLEK
LNFLRAHNYK----------GMTMMLNDRIRSLSALQGALRKAEEHLSGLSADTPYSEFHHRFQELGLEKGWGDCAKRSQETIHLLLDLLEAPDPSTLEK
LNFLRAHNYK----------GMTMMLNDRIRSLDALQGALRKAEKHLAGITADTPYSEFHHRFQELGLEKGWGDCAQRVRETIHLLLDLLEAPEPSALEK
LNFLRAHNYK----------GMAMMLNDRIRSLGTLQGALRKAETHLSGLPADTPYSEFHHRFQELGLEKGWGDCAQRASETIHLLLDLLEAPDPSSLEK
LKFLRLHSHQ----------GKNLMLSEKIQNLNTLQHTLRKAEEYLAELKSETLYEEFEAKFEEIGLERGWGDNAERVLDMIRLLLDLLEAPDPCTLET
LKFLRRHSHQ----------GKNLMLSEKIQNLNTLQHTLRKAEEYLAELKPETPYEEFEAKFEEIGLERGWGDNAERVLDMIRLLLDLLEAPDPCTLET
LKFLRLHSHE----------GKTLMLNNRIQNLNTLQHNLRKAEEYLMELKPETLYSEFEHKFQEIGLERGWGDTAERVLNMIRLLLDLLEAPDPCTLEN
LKFLRLHSHE----------GKTLMLNDRIQNLNTLQHNLRKAEEYLMELKPETPYSEFDHKFQGIGLERGWGDTAVRVLDMIRLLLDLLEAPDPCTLGN
LAFLKVHCHK----------GKNMMLNDRIRNLDSLQYVLRKAEEFLSTLKPDTPYSQFEHKFQEIGLERGWGDTAERVLEMIRLLLDLLEAPDPCTLET
LAFLKVHCHK----------GKNMMLNDRIHNLDSLQYVLRKAEEYLSSLKPETPYSQFEHKFQEIGLERGWGNTAERVLQMIQLLLDLLEAPDPCTLET
LEFLKVHCHK----------GKNMMLNDRIQNLNSLQYVLRKAEEYLVTLPAKTPYSEFEHKFQEIGLERGWGDTAERVLEMIRLLLDLLEAPDPCTLET
LEFLRVHCHK----------GKNMMLNDRIQNLNALQHVLRKAEEYLGTLPPETPCAEFEHRFQEIGLERGWGDTAQRVLEMIQLLLDLLEAPDPCTLEK
LEFLRVHCHK----------GKNMMLNDRIQNLNALQHVLRKAEEYLGTLPPETPCAGFEHRFQEIGLERGWGDTAQRVLEMIQLLLDLLEAPDPCTLEK
LEFLRVHCHK----------GKNMMLNDRIQNLNALQHVLRKAEEYLGTLPPETPCAEFEHRFQEIGLERGWGDTAERVLEMIQLLLGLLEAPDPCTLEK
LEFLRVHCHK----------GKNMMLNDRIQNLNALQHVLRKAEEYLGTLPPETPCAEFEHRFQEIGLERGWGDTAERVLEMIQLLLDLLEAPDPCTLEK
LEFLRVHCHK----------GKNMMLNDRIQNLNSLQHVLRKAEEYLTTVAPETPFSELALRFQEIGLERGWGDTAERALEMIQLLLDLLEAPDPCTLET
LEFLRLHSYK----------GKTLMLNDRIQNPDSLQHVLRKAEEYLSTIDPETPYSEFEHRFQEIGLERGWGDTAERVLESIQLLLDLLEAPDPCTLET
LEFLRLHSYK----------GKTLMLNDRIQNPDSLQHVLRKAEEYLSTIDPETPYSEFEHRFQEIGLERGWGDTAERVLESIQLLLDLLEAPDPCTLES
LEFLRLHSYK----------GKTLMLNDRIQNPDSLQHVLRKAEEYLGTVAPDTPYSEFEHRFQEIGLERGWGDTAERVLESIQLLLDLLEAPDPCTLET
LEFLRLHSYK----------GKTLMLNDRIQNPDSLQHVLRKAEEYLGTVAPDTPYSEFEHRFQEIGLERGWGDTAERVLESIQLLLDLLEAPDPCTLET
LDFLRTHQYK----------GKTMMLNDRIQNLDTLQFVLRKAEEYLSSQAPETPYPEFEHKFQEIGLERGWGDTAERVLEMIHLLLDLLEAPDPCTLEQ
LEFLRAHHYK----------GKTMMLNDRIHNSNTLQNVLRKAEEYLIMLPPETPFFEFEHKFQEIGLEKGWGDTAERVLEMVCMLLDLLEAPDSCTLEK
LEFLRAHHYK----------GKTMMLNDRIQNSNTLQNVLRKAEEYLIMLSPDTPYFEFEHKFQEIGLEKGWGDTAERVLEMVCMLLDLLEAPDSCTLEK
LEFLRVHHYN----------GKSMMLNDRIQNLYTLQKVLRKAEEYLTTLSPETSYSSFEHKFQEIGLERGWGDTAERVLEMICMLLDLLEAPDSCTLEK
LEFLRVHHYK----------GKTMMLNDRIQNLYTLQKVLRKAEEYLTTLSPETSYSAFEHKFQEIGLERGWGDTAERVLEMICMLLDLLEAPDSCTLEK
LDFLRVHQYK----------GKTMMLNDRIKDLNTLQAVLRKAEEYLTTLSADTPYSEFEHKFQEIGLERGWGDTAERVLEMICMLLDLLGAPDSCTLEK
LDFPRMHSYK----------GKTMMLNDRIRNLNSLQAVLRKAEEYLSTLPPETPFEDFEHKFQEIGLERGWGDNAQRVSGMISMLLDLLEAPDSCTLER
LDFLRMHHYK----------GKTIMLNDRIQNLDSLQAVLRKAEEFLTTIPADTPYSEFDHKFQEIGLERGWGDNAERVMDMIQLLLDLLEAPDSCTLEK
LDFLRVHKYK----------GHPLMLNDRIQSISRLQIQLSKAEDHISKLSQETPFSEFEYALQGMGFEKGWGDTAGRVLEMMHLLSDILQAPDPSSLEK
LDFLRVHKYK----------GHPLMLNDRIQSISRLESQLNKAEDHISKLSQETPFSEFEYALQGMGFEKGWGDTAGRVLEMMHLLSDILQAPDPSTLEK
LDFLRAHKYK----------GHLLMLNDRIQSISRLQSSLSKAEDHLSKLPPDTPFSQFEYVLQGMGFEKGWGDTAEHVLEMMHLLLDILQAPDPSTLEK
NDFLRAHKYK----------GHALMLNDRIQNISKLQSALAKAEEYVSKLPPDVPFSEFEYTLQGLGFERGWGDTAARVSEMMHLLLDILQAPDPSTLEK
LDFLRVHKYK----------GHALMLNDRIKSVSRLQSALLKAEEYISKLPSETLYTEFEYTFQGMGFERGWGDTAARVLEMMHLLLDILQAPDPSTLET
LDFLRVHTYK----------GHALMLNDRIQSISKLQSALVKAEDHLSKLAPDTLYSEFEYELQGTGFERGWGDTAARVLEMMHLLLDILQAPDPSTLET
LDFLRVHKYK----------GQVIMLNDRIQSISRLQSALVKADDHLTKLPPETPFGEFEYEFQGMGFERGWGDTAQRVLEMIHLLLDILQAPDPSTLET
LDFLRGHRHK----------GHVMMLNDRIQSLGRLQSVLTKAEEHLSKLPADTPYSQFAYKFQEWGLEKGWGDTAGHVLEMIHLLLDIIQAPDPSTLEK
LDFLRGHRHK----------GHVMMLNDRVQSLGRLQSVLTKAEEYLSKLPAETPYAQFAYKFQEWGLEKGWGDTAEHVLEMVHLLLDIIQAPDPSTLEK
LDFLRGHRHK----------GHVMMLNDRIQSLGRLQSVLTKAEEHLSKLPADTPYSQFAYKFQEWGLEKGWGDTAGYVLEMIHLLLDVLQAPDPSTLET
LDFLREHRHK----------GHVMMLNDRIQSVGRLQSVLTKAEENLSKLPAETPYSQFANQFQEWGLEKGWGDTAEHVLEMIHLLLDILQAPDPSTLET
LDFLRGHNHK----------GNVLMLNERIQRISRLESSLNKADDYLSKLPPDTPYTDFEYALQEMGFEKGWGDTANRVLETMHLLSDILQAPDPSTLET
LDFLRGHNHK----------GNVLMLNERIQRISRLESSLNKADDYLSKLPPDTPYTEFEYALQEMGFEKGWGDTAKRVLETMHLLSDILQAPDPSTLET
LDFLRAHKHK----------GHVLMLNDRIQRISRLESALSKAEDYLAKLPQDTPYSDFEYALQELGFERGWGDTAARVLNMMHLLSDILQAPDPSTLET
LEFLRAHKHK----------GHIMMLNDRIQHIPRLESALARAEDHLSKLPPDTPYSEFEYTLQGLGFERGWGDTAERVLEMMHLLSDILQAPDASTLET
LDFLRVHRHK----------GHVLMLNDRVQRISRLESQLAKAEDYVSKLPLDTPYSEFEYALQGMGFERGWGDTAARVLEMMRLLSDVLHAPDPSTLET
LDFLRVHSHK----------GHVMMLNDKIQRVSQLEYSLAGAEEYISKVPPDTPYSELESKLQGMGFERGWGDTARRSLEMMHLLSDILQAPDPSSLES
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297795665
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168009716
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LDFLRVHKHK----------GVVMMLNDRIQTIQRLQSALSKAEDYLIKLPADTPYSEFEFVIQGMGFERGWGDTAERVLEMMHLLLDILQAPDPSTLET
LDFLRVHKHK----------GVVMMLNDRIQTIQRLQSALSKAEDYLIKLPADTPYSEFEFVIQGMGFERGWGDTAERVLEMMHLLLDILQAPDPSTLET
LEFLRTHKHD----------GRPMMLNDRIQNIPILQGALARAEEFLSKLPLATPYSEFEFELQGMGFERGWGDTAQKVSEMVHLLLDILQAPDPSVLET
LEFLRTHKHD----------GRSMMLNDRIQNIPILQGALARAEEFLSKLPLATPYSEFEFELQGMGFERGWGDTAQKVSEMVHLLLDILQAPDPSVLET
LDFLRAHKHD----------GHVMMLNDRIQNISRLQSALARAEEYLSKLPPLTPYSEFEFELQGMGFEKGWGDTAQRVSEMVHLLLEILQAPDPSTLET
LEFLRTHKHD----------GHALMLNDRIQNLSSLHYALARAEEHLSKFPPNTPFSEFEFDLQSMGFERGWGDRAERVSEMVHLLMDILQAPDPASLES
FEFLRMHTYR----------GQTLMLNDRIASLVRLRPQLVKAEEALSKLPEKTPFADFAHQLQGLGLEKGWGNSAGRALETIKMLQDLLQAPDPDTLEK
FQFLRMHTYR----------GQTLMLNDRITSLRRLRPQLVKADDILSKLPEDTPFTDFAHKLQELGLEKGWGNTAGRVVETIKLLEDLLQAPDPDTLEK
FQFLRLHTYR----------GETLMLNERIATFSRFRPQLVRAEEALSKLPEDTPFSSFAHRLQELGLEKGWGNTAGRVLQTLKLLLDLLQAPDPDTLEK
VEFMRVHKYK----------DQTLLLNESITNVVRLRPALIKAEEYLIKLPNDQPLKDFYSKLQELGLERGWGDTAGRVLEMIHLLLDLLQAPDPDILEK
YEFLKLHQLH---------GIQLLLDGERVRNPVQLEDALAAALDFLERCHWPDDLERIRQRLRRLGFLDGWGDSLPRILETMHMLQDILEQPDEANLEE
YEFLKLHQLH---------GIQLLLDGERVRNPVQLEDALAAALDFLERCHWPDDLERLRQRLRRLGFLDGWGDSLPRILETMHMLQDILEQPDEANLEE
YEFLKLHQLH---------GTQLLLDGSLVRSPEELEEALSSAMDFLERCRYPDDLARISQRLGRLGFLAGWGNSLPRMLETMHMLQDILEQPDEANLEE
FNFLSLHEVQ---------GTQLLIN-GRIKSQQQLSDQVKLALGFVSDRAEDEPYESFRFKLQDMGFEAGWGNTASRVRETLEILDELIDSPDHQGLEE
YGFLKVRHFH---------GNQLLIN-ERIHNHQQLSEQVKLALEFVSDRPDSESYDKFRFKLQEMGFEPGWGNTASRVRETLAMLDELIDEPDDRALEQ
FNFLRLHNYN---------GIQLLIN-HQIQSQQQLSQQVKNALNFVSDRPNDEPYEQFRLQLQTMGFEPGWGNTASRVRDTLNILDELIDSPDPQTLEA
FNFLRLHNYN---------GIQLLIN-YQIQSQQQLSQQVKKALNFVSDRPHDEPYEQFRLQLQAMGFEPGWGNTASRVRDTLNILDELIDSPDPLTLEA
LNFLRLHHYN---------GVQLLVN-DRIQSQQQLSEQVKKAIGFVNNRPDDEPYEQFRFQLQSMGFEPGWGNTAARVRETLNILDELIDSADPQTLEA
LNFLRLHQYN---------GVQLLIN-DRITTQQQLSTQIKKAITFVSDRPKDEPYEKFRFELQMIGFEPGWGNTAKRVGDTLDILDELIDSPDPQTIEA
FNFLRLHRYN---------GVQLLIN-DRIKSQEQLSEQVKKALTFVSDLSEEEGYERFRLVLQMMGFEAGWGNTAARVHETLGILDELIDSPDPQTLEA
FNFLSLHCYN---------GITLLIN-GRIKNQHQLSEQVKDAIFFLNQFSDEIPFEDFRYEFQSMGFEPGWGNTAGRVKETLSILDELIDSPDDQVLEA
FQFLRMHQYN---------GITLLIN-DRIGNQRQLSQQVKAALDFLESYPSEEPYSNLRFELQSLGFEPGWGNTASRMRESLELLDGLIDAPDHQSLEA
FQFLSLHRYD---------GNQLLIS-ERIKNQHQLSMQVKQALHLVNSQPPQALFSDFRFELQNLGFEPGWGNTAARVKETLELLDSLIDSPDPHSLET
FNFLRIHRYN---------GYQLLIN-ERIRSPQHLSEQVKQALVVLSDRPPTEAYSEFRFELQNLGFEPGWGNTVARVRDTLEILDQLLDSPDHQVLEA
FSFLKLHSYN---------GTQLLIN-QRIQSPEHLSECVKQAISLVGGLPPEQPYPEFRFNFQELGFEPGWGNTAARVLETLEMLDELIDSPDDQVLEA
YQFLSLHSYN---------GLQLLIN-DRITNQNQLSYAIKKAISLLNKRSPKEPYEKFRFELQEIGFEPGWGNTARRALETLEILDELLDSPDHQVLEA
YQFLSLHSYN---------GLQLMIN-DRITNQNQLSHAIKKAISLLNKRSPKEPYENFRFELQEIGFEPGWGNTARRALETLEMLDELLDSPDHQVLEA
YLALRGLQYD---------GINLMIG-DAIPSGIHLAKQIHAAIKFLSALPPEEPYEKFYIELQKLGFEPGWGNTAQRILETITLLDKLIDSPQPAVLEA
YLALRGLQYD---------GINLMIG-DAIPSGIHLAKQIHAAIKFLSDLPPEEPYEKFYIELQALGFEPGWGNTAERILETITLLDRLIDSPQPAVLEA
FQALQGLQHD---------GIRLLLS-DRIPSGIHLAKQIKLALKLVNERSPHEPYEKFSLDLQELGFEPGWGNTAARVSETLELLDRLIYSPEPGILEA
FQALYQLTYD---------QKPLLIS-DRIPSGIHLVKQIKQALKFLNQQPPEEPYANFRPHLQELGFEPGWGNTSGRISETLELLEQLIDNPQPAILEA
FQALQGIQFN---------GMKVLIS-DRIHSGIQFAKLIKPAITLLSELPPDEPYAQFRSHLQELGLEAGWGNNAGRVRETLELLQRLIDTPQTYILEA
FRVLCGHEYD---------GLSLLIN-EQIGSGEDLYKQVQQALWFIRQRPGDEPWEQLHYYLEKLGFAPGWGDRASRVEETLELLQYLMDSPAPPILEA
LKNLQAHHYD---------HTPLLLN-NRIDSTTQLFEKLKEALTLVGELPAHTPYEKFRFELQVLGFEAGWGNTAGRVRETLELLERLMDAPDHAVLEA
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114331077
30249199
82703384
198283392
344199811
255021595
77166514
300115586
292493898

310
320
330
340
350
360
370
380
390
400
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
FLARIPMISRLLILSPHGYFGQDNVLGLPDTGGQVVYILDQVRALEQEMRDRLQLQGVQ---VEPKILIVTRLIPDAGDTTCNQRLEKVSGCTNTWILRV
FLACIPMISRLLILSPHGYFGQDNVLGLPDTGGQVVYILDQVRALEKEMHDRLQLQGVQ---VEPKILIVTRLIPDAGDTTCNQRLEKVSGCTNTWILRV
FLARIPMISKLLILSPHGYFGQDNVLGLPDTGGQVVYILDQVRALEREMSERLILQGID---AAPKILIGTRLIPDAGDTLCHQPLEKIHGTQNSWIVRV
FIDRIPMISKILIVSIHGWFAQDKVLGRPDTGGQVVYILDQARALEQEMRQRLARQGVD---IVPRILIATRLIPNADGTTCDQRLEPVHGADNVQILRV
FIDRIPMISKILIVSIHGWFAQDKVLGRPDTGGQVVYILDQARALEQEMRQRLARQGVD---IVPRILIATRLIPNADGTTCDQRLETVHGVDNVQILRV
FLDRIPMISRILIVSIHGWFAQDKVLGRPDTGGQVVYILDQARALEREMRNRLRQQGVD---VEPRILIATRLIPESDGTTCDQRLEPVVGAENVQILRV
FLARIPMIFNIVILSPHGYFGQGNILGLPDTGGQVVYILDQVRALEKEMHRQLKEQGLD---VAPQILVVTRLIPEAQGTRCDQRLESIVGTENAAILRV
FLARIPMIFNIAILSPHGYFGQGNILGLPDTGGQVVYILDQVRALEKEMRRQLKEQGLD---VTPQILVVTRLIPEARGTRCDQRLESIVGTENAAILRV
FLARIPMIFNIVILSPHGYFGQGNILGLPDTGGQVVYILDQVRALEKEMRRQLKEEGLD---IEPQILVVTRLIPEAQGTRCDQRLEAIVGTENAAILRV
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350552412
220933364
350574485
95929190
298528445
297602308
115457664
326504012
115450038
326531526
242063616
42568160
297805240
313770765
313770767
255584097
225466221
313770769
313770771
255570671
15219457
297842089
115466896
17980243
162460741
239984690
162460681
242035533
62865493
17980241
115453437
115473359
3980298
15242073
297812265
22331535
297818772
313770759
313770761
255550319
324984223
258489633
324984221
324984229
6683114
4584690
3915046

FLARIPMIFSLLILSPHGFFGQANVLGRPDTGGQVVYILDQVRALEREMRSRLQAQGLH---IEPRILVVTRLIPEAQGTSCDQPVERINGTRNAQILRV
FLARIPMIFSLLILSPHGFFGQAGVLGLPDTGGQVVYILDQVRALEREMRDRLAEQGLD---IEPRIRVVTRLIPEARGTSCDQPEEAVSGTENARILRV
FLGRIPMIFSIAILSPHGWFGQSNVLGRPDTGGQVVYILDQVRALEREMRARLAEQGID---IDPEVIVITRLIPESEGTTSDQRIEPIAGTQNARILRV
FLGRIPMIFSIVVVSPHGYFGQENVLGLPDTGGQVVYILDQVRALEKEMKEQIYRQGLD---IEPSIVVLTRLIPHCGDTSCNQPEEQIAGTSNATIVRV
FLSRIPMIFKLVIVSPHGYFGQSNVLGRPDTGGQIVYILDQVRALEKEMRRQIKEQGLE---IEPEIVVLTRQIPEAGDTTCNQRQEDIVGTSNARILRV
FFSRVPSIFNIVIFSIHGYFGQEKVLGLPDTGGQVVYILDQVRAMEEELLQRIKQQGLH---VTPKILVLTRLIPDAKGTKCNVELEPVENTKYSHILRV
FFSRVPSIFNIVIFSIHGYFGQEKVLGLPDTGGQVVYILDQVRAMEEELLQRIKQQGLH---VTPKILVLTRLIPDAKGTKCNVELEPVENTKYSHILRV
FFSRVPSIFNIVVFSIHGYFGQEKVLGLPDTGGQVVYILDQVRSMEEELLQRIKLQGLH---ITPKILVLTRLIPDSKGTKCNVELEPVENTKYSHILRV
FFSTVPCVFTVVIFSIHGYFGQEKVLGMPDTGGQVVYILDQVRALEDELLQRIKQQGLN---ATPKILVLTRLIPEAKGTKCNVELEPIENTKHSNILRV
FFSRVPSVFNIVIFSIHGYFGQEKVLGLPDTGGQVVYILDQVRALEEELLQRIKRQGLN---VTPKILVLTRLIPDAKGTKCNVELEPVEHTKHSSILRV
FFSRVPSVFDVVIFSVHGYFGQHKVLGMPDTGGQVVYILDQVRALEEELLQRIKGQGLT---FTPNILVLTRLIPEAKGTTCNVELEPIENTRHSSILRV
FFARVPRIFNVVIFSVHGYFGQTDVLGLPDTGGQVVYILDQVKALEDELLQRINSQGLN---FKPQILVVTRLIPDAKKTKCNQELEPIFGTKYSNILRI
FFARIPRIFNVVIFSVHGYFGQTDVLGLPDTGGQVVYILDQVKALEDELLHRINSQGLN---FKPQILVVTRLIPDAKNTKCNQELEPIFGTKHSNILRI
FLSRLPTVFNVVIFSPHGYFGQADVLGLPDTGGQVVYILDQVKALEEELLLRIKQQGLN---VKPQIVVATRLIPDARGTTCNLEFEAIDGTKYSNILRV
FFSRLPTVFNVVIFSPHGYFGQADVLGLPDTGGQVVYILDQVKALEDELLLRIEQQGLN---IKPQIVVVTRLIPEARGTKCNQELESINGTKHSNILRV
FLSRVPTIFNVVIFSPHGYFGQANVLGLPDTG-----------------------------------GQVTRLIPDARGTKCNQELEAINGTKHSNILRV
FLSRLPTIFNVVIFSPHGYFGQSDVLGLPDTGGQVVYILDQVRALEEELLLRIKLQGLN---VKPQILVVTRLIPDARGTKCNQEWEPIDNTKHSTILRI
LFSRIPNMFNIVIFSPHGYFGQSDVLGLPDTGGQVVYILDQVRALEEELLLKIKHQGLG---VKPRILVVTRLIPNAGGTKCNQEVEPIFGTQHSHIVRV
LFSRIPNVFNIVIFSPHGYFGQSDVLGLPDTGGQIVYILDQVRALEEELLLKIRQQGLS---VKPQILVITRLIPHAGGTKCNQEVEPIFGTKHSHIVRV
LFSRLPNMFNIVIFSPHGYFGQADVLGLPDTGGQVVYILDQVRALEEELLLRIKQQGLT---MKPQILVVTRLIPDAKGTKCNQEVEPIIGTKHSNILRI
LFSRLPTVFNVVIFSVHGYFGQQDVLGLPDTGGQVVYILDQVRALEEELLIRINQQGLG---FKPQILVVTRLIPEARGTKCDQELEAIEGTKHSHILRV
LFSRLPTLFNVVIFSVHGYFGQQDVLGLPDTGGQVVYILDQVRPLEEELLIRINQQGLG---FKPQILVVTRLIPEARGTKCDQELEAIEGTKHSHILRV
FLGTIPMMFNVVILSPHGYFAQSNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLD---ITPKILIVTRLLPDAVGTTCGQRVEKVIGTEHTDILRV
FLGTIPMTFNVVILSPHGYFAQSNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLD---ITPKILIVTRLLPDAVGTTCGQRLEKVIGTEHTDILRV
FLGTIPMMFNVVILSPHGYFAQSNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLD---ITPKILIVTRLLPDAAGTTCGQRLEKVIGTEHTDIIRV
FLGTIPMMFNVVILSPHGYFAQSNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLD---ITPKILITR-LLPDAVGTTCGQRLEKVIGTEHTDILRV
FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQCGLD---ITPKILIVTRLLPDATGTTCGQRLEKVLGTEHCHILRV
FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQCGLD---ITPKILIVTRLLPDATGTTCGQRLEKVLGTEHCHILRV
FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLN---ITPRILIVTRLLPDATGTTCGQRLEKVLGTEHTHILRV
FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLN---ITPRILIVTRLLPDATGTTCGQRLEKVLGTEHTHILRV
FLGTIPMVFNVVIMSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLN---ITPRILIVTRLLPDATGTTCGQRLEKVLGTEHTHILRV
FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLN---ITPRILIVTRLLPDAHGTTCGQRLEKVLGTEHTHILRV
FLGTIPMVFNVVILSPHGYFAQANVLGYPDTGGQVVYILDQVRAMENEMLLRIKQQGLD---ITPKILIVTRMLPDAHGTTCGQRLEKVLGTEHTHILRV
FLGRVPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRALEIEMLQRIKQQGLN---IKPRILILTRLLPDAVGTTCGERLERVYDSEYCDILRV
FLGRVPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRALETEMLQRIKQQGLD---IKPRILILTRLLPDAVGTTCGERLERVYDSEYCDILRV
FLGRIPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRALETEMLQRIKQQGLN---ITPRILIITRLLPDAAGTTCGQRLEKVYGSQYCDILRV
FLGRIPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRALETEMLQRTKQQGLT---ITPRILIITRLLPDAAGTTCGQRLEKVYGSQYCDILRV
FLGRIPMVFNVVIMSPHGYFAQDNVLGYPDTGGQVVYILDQVRALENEMLQRIKKQGLD---IIPRILIITRLLPDAVGTTCGQRLERVYGSEHCDILRV
FLGRIPMVFNVVIMSPHGYFAQDNVLGYPDTGGQVVYILDQVRALESEMLLRIKQQGLD---ITPRILIITRLLPDAVGTTCGQRLEKVYGSEHCDILRV
FLGRIPMVFNVVIMSPHGYFAQDNVLGYPDTG-----------------------------------GQITRLLPDAVGTTCGQRLEKVFGTEHSDILRI
FLGRIPMVFNVVILTPHGYFAQDNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLN---ITPRILIITRLLPDAVGTTCGQRLEKVYGTEYSDILRV
FLGRIPMVFNVVILTPHGYFAQDNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLN---ITPRILIITRLLPDAVGTTCGQRLEKVYGTEYSDILRV
FLGRIPMVFNVVILTPHGYFAQDNVLGYPDTGGQVVYILDQVRALENEMLLRIKQQGLN---ITPRILIITRLLPDAVGTTCGQRLEKVYGTEHSDILRV
FLGRIPMVFNVVILTPHGYFAQDNVLGYPDTGGQVVYILDQVRALENETLLRIKQQGLN---ITPRILIITRLLPDAVGTTCGQRLEKVYGTEHSDILRV
FLGRIPMVFNVVILTPHGYFAQDDVLGYPDTGGQVIYILDQVRALEDEMLLRIKQQGLD---ITPQILIITRLLPDAVGTTCGQRLEKVYGTKYSDILRV
FLDRIPMVFNVVILSPHGYFAQDDVLGYPDTGGQVVYILDQVRALESEMLSRIKKQGLD---IIPRILIITRLLPDAVGTTCGQRLEKVYGTEHCHILRV
FLDRIPMVFNVVILSPHGYFAQDDVLGYPDTGGQVVYILDQVRALESEMLSRIKKQGLD---IIPRILIITRLLPDAVGTTCGQRLEKVYGTEHCHILRV
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3766299
3377764
225444613
3660531
31455440
304651488
28629438
115310618
345286417
38425095
15235300
297814081
6682841
255564236
313770763
3915037
225437428
162458268
242035817
115452927
241896730
304651490
29289943
115310620
4468153
345286419
4468151
151176306
14530225
15239816
297795665
225431790
255551835
168009716
168035060
168058907
168029793
94266940
94264333
297569306
254416162
332712456
17232477
75908500
186682280
119512682
334117431

FLDRIPMVFNVVILSPHGYFAQDDVLGYPDTGGQVVYILDQVRALESEMLNRIKKQGLD---IVPRILIITRLLPDAVGTTCGQRLEKVYGTEHCHILRV
FLDRIPMVFNVVILSPHGYFAQDDVLGYPDTGGQVVYILDQVRALESEMLNRIKKQGLD---IVPRILIITRLLPDAVGTTCGQRLEKVYGTEHCHILRV
FLGRIPMVFNVVILSPHGYFAQDNVLGYPDTGGQVVYILDQVRAMETEMLLRIKQQGLD---ITPKIIIVTRLLPDAVGTTCNQRIEKVYGTEHSIILRV
FLGRIPMVFNVVILSPHGYLAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---IIPRILIVTRLLPDAVGTTCGQRLEKVYGTEHSHILRV
FLGRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---IIPRILIVTRLLPDAVGTTCGQRIEKVYGAEHSHILRV
FLSRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---IKPRILIVTRLLPDAVGTTCGQRLEKVFGTEHSHILRV
FLSRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---IKPRILIVTRLLPDAVGTTCGQRLEKVFGTEHSHILRV
FLGRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---VKPRILIITRLLPDAPGTTCGQRLEKVYGSEYSHILRV
FLGRIPMVFNVVILSPHGYFAQENVLGYPDTGGQVVYILDQVPALEREMLKRIKEQGLD---ITPRILIVTRLLPDAVGTTCGQRLEKVFGAEHSHILRV
FLGRIPMVFNVVILTPHGYFAQANVLGYPDTGGQVVYILDQVRALEHEMLLRIKQQGLD---IIPRILIVSRLLPDAVGTTCGQRLEKVFGTEHSHILRV
FLGMVPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALETEMLLRIKRQGLD---ISPSILIVTRLIPDAKGTTCNQRLERVSGTEHTHILRV
FLGMVPMVFDVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALESEMLLRIKRQGLD---ITPRILIVTRLIPDAKGTTCNQRLERVSGTEHTHILRV
FLGRLPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALENEMLLRIKRQGLD---ISPKILIVTRLIPDAKGTTCNQRLERVSGTEHTHILRV
FLGRIPMVFNVVILSPHGYFGQANVLGLPDTG-----------------------------------GQVTRLIPDAKGTTCNQRLERVSGTEYTHILRV
FLGRVPMVFNVVILSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMLLRIQQQGLD---FKPKILIVTRLIPDSKGTSCNQRLERVSGTEHTHILRV
FLGRVPMVFNVVILSPHGFFGQANVLGLPDTGGQVVYILDQVRALESEMLVRIKKQGLD---FTPRILIVTRLIPDAKGTTCNQRLERVSGTEYTHILRV
FLGRIPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALENEMLLRMQKQGLD---VTPRILIVTRLIPDAKGTTCNQRLERVSGTEHSHILRV
FLGRIPMIFNVVVVSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMVLRLKKQGLD---VSPKILIVTRLIPDAKGTSCNQRLERISGTQHTYILRV
FLGRIPMIFNVVVVSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMVLRLKKQGLD---FSPKILIVTRLIPDAKGTSCNQRLERISGTQHTYILRV
FLGRIPMIFNVVVVSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMVLRLKKQGLD---FTPKILIVTRLIPEAKGTSCNQRLERISGTQHTYILRV
FLGRIPMIFNVVIVSPHGYFGQANVLGMPDTGGQIVYILDQVRALENEMVLRLKKQGLD---VTPKILIVTRLIPDSKGTSCNQRLERISGTQHTYILRV
FLGRLPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALEAEMLLRIKQQGLN---FKPRILVVTRLIPDAKGTTCNQRLERISGTEYSHILRV
FLGRLPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALEAEMLLRIKQQGLN---FKPKILVVTRLIPDAKGTTCNQRLERISGTEYSHILRV
FLGRVPMVFNVAILSVHGYFGQANVLGLPDTGGQIVYILDQVRALENEMLLRIKQQGLN---VTPRILIVTRLIPDAKGTTCNQRLERVSGTEYTSILRV
FLGRIPMVFNVVILSIHGYFGQANVLGLPDTGGQIVYILDQVRALENEMIKRIKAQGLS---IIPQILIVTRLIPDAKGTSCNQRLEKISGCEHSHILRV
FLGRVPMVFNVVILSVHGYFGQANVLGLPDTGGQIVYILDQVRALESETLQRIKKQGLQ---ITPRILVVTRLIPDAADTSCNQRLERLSGCEYSHILRV
FLGQLPMVFNVVVLSIHGYFAQTDVLGLPDTGGQVVYVLDQVRAMENEMIKRIKNHGLN---ITPRILIVTRLIPEARGTKCDQRLEKIDGCEHSHILRV
FLGRLPMVFNVVILSVHGYFGQAHVLGLPDTGGQIVYILDQVRSLEHEMLQRIKKQGLD---VTPRILIVSRLIPDAKGTTCNQRMEKVSGTEHASILRV
FLGRLPMVFNVVILSVHGYFGQAHVLGLPDTGGQIVYILDQVRSLEHEMLQRIKKQGLD---VTPRILIVSRLIPDAKGTTCNQRMEKVSGTEHASILRV
FLGRIPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALENEMLLRIQKQGLE---VIPKILIVTRLLPEAKGTTCNQRLERVSGTEHAHILRI
FLGRIPMVFNVVILSPHGYFGQANVLGLPDTGGQVVYILDQVRALENEMLLRIQKQGLE---VIPKILIVTRLIPEAKGTTCNQRLEKVSGTEHAHILRI
FLGRIPMVFNVVIVSPHGYFGQANVLGLPDTGGQIVYILDQVRALENEMLLRIQKQGLD---VIPKILIVTRLIPDAKGTTCNQRLERISGTEHTHILRV
FLGMLPMVFNVVIVSPHGYFGQANVLGLPDTG-----------------------------------GQVTRLIPHAKGTTCNQRLERISGTENTYILRV
FLARIPMVFSVVIVSPHGYFGQEGVLGLPDTGGQVVYILDQVRALENEMLENLQLQGLD---IIPQIVILTRLIPNAIGTTCNQRIEKVTGSRFSHILRI
FLARIPMVFSVVIVTPHGYFGQDGVLGLPDTGGQVVYILDQVRALENEMLENLQLQGLD---IVPKIVILTRLIPNAFGTTCNQRIEKVHGSRFSHILRI
FLARIPMIFTVCIVSPHGYFGQAGVLGLPDTGGQVVYILDQVRALENQMLENLQLQGLD---FKP--QILTRLIPNANGTTVNQRIEKVSGTQHSRILRV
FLARIPIVFSVAIISPHGYFGQSNVLGMPDTGGQVVYILDQVRAMEKEMLKNIKLQGLD---IEPQIVVVTRLIPNANGTTCNQRIEQIEGTKHSRILRV
FLARIPMVSKVALISPHGWFGQDNVLGRPDTGGQVVYILDQARALEQFLAADLRSAG---LEIEPKILIITRLIPENEGTTADQRLEPVRDTANVAILRV
FLSRIPMVSKVALISPHGWFGQDNVLGRPDTGGQVVYILDQARALEQFLAADLRSAG---LEIEPKILIITRLIPENEGTTADQRLEPVRDTANVAILRV
FLSRIPMVSSVALISPHGWFGQENVLGRPDTGGQVVYVLDQAKALEDFLAQDLRDAG---LEIAPKILIVSRLIPENEGTSADQRLEKVYDTDDVWILRV
FLSRIPMIFRIVLVSIHGWFGQEGVLGRPDTGGQVVYVLDQARSLEKQLQEDIKLAGLELLKVKPKVIILSRLIPNNDGTRCNERLEKVHGTDNAWILRV
FLSRIPMIFRIVLVSVHGWFGQEGVLGRPDTGGQVVYVLDQAKSLEKQLQENLTLAG---LNIQPKVIILTRLIPNNDGTRCNERLEKIKGTENAWILRV
FISRIPMIFRIVLVSAHGWFGQEGVLGRPDTGGQVVYVLDQAKNLEKQLQEDAILAGLEVLNVQPKVIILTRLIPNSDGTLCNQRLEKVYGTENAWILRV
FISRIPMIFRIVLVSAHGWFGQEGVLGRPDTGGQVVYVLDQAKNLEKQLQEDAILAGLEVLNVQPKVIILTRLIPNSDGTLCNQRLEKVHGTENAWILRV
FISRVPMIFRIVLVSAHGWFGQEGVLGRPDTGGQVVYVLDQAKSLEKQLQEDVLLAGLEKLNVEPKVIILTRLIPNSDGTLCNQRLEKVHGTENAWILRV
FISRIPMIFRIVLVSAHGWFGQEGVLGRPDTGGQVVYVLDQAKNLEKQLQEDAQLAGLDGLNVEPKVIILTRLIPNSDGTLCNQRLEKVHGTENAWILRV
FISRIPMIFKIVLVSPHGWFGQEGVLGRPDTGGQVVYVLDQAKSLEKQLQEDIHLAGLDSLGVKPKVIILTRLIPNSDGTRCNERLEKVHATENAWILRV
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218440696
159031025
220907171
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17228554
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FLSRVPMIFRIVLVSVHGWFGQEGVLGRPDTGGQVVYVLDQARSLEQQLKEDIILAGLDGYGIEPKVIILSRLIHNSDGTRCNQRLEKVHGTDNAWILRV
FLSRIPMLFRIVLVSVHGWFGQEGVLGRPDTGGQVVYVLDQARSLEQQLREDIFLAGLEGLGIEPKIIILTRLLPNSEGTRCDQRLEKVYGTDNACILRV
FLSRIPMIFRIALISPHGWFGQEGVLGRPDTGGQVVYVLDQARSLEQQLREEITLAGLEGLNVHPKVIILTRLIPNSDGTRCNQPLEKVYGTENVWILRV
FVSRIPMLFRIALISPHGWFGQEGVLGRPDTGGQVVYILDQVKSLEKQMREDLELAGLGVLEAQPKIIVLTRLIPNAEGTLCNQRLEKIYGTNDAWILRV
FISRIPMIFKIVLVSIHGYFGQEGVLGRPDTGGQVVYVLDQAKSLEKQLQEDLQFAGLDTLEVQPKLIILSRLIPNSEGTLCNQRLEKVHATDNVWILRV
FLARIPMIFRIVLVSIHGWFAQEGVLGRPDTGGQIVYILDQARSLEMELEEELKLSGLSVLGVQPKVMILTRLIPHSDGTRCDQRLEKVYGTKNAWILRV
FLARIPMIFRIVLVSIHGWFGQEGVLGRPDTGGQVVYILDQARSLEMELEEELKLSGLSVLGVQPKVMILTRLIPHSDGTRCHQRLEKVYGTKNAWILRV
FVARVPAVFRVVLVSIHGWVAQEDVMGRDETLGQVIYVLEQARSLENKLQQEIKLAGLEVLGIQPHVIILTRLIPNCEGTYCNLRLEKLHNTENAWILRV
FVARVPAVFRVVLVSIHGWVAQEDVMGRDETLGQVIYVLEQARSLENKLQQEIKLAGLEVLGIQPHIIILTRLIPHCEGTYCNLRLEKLHNTENAWILRV
FVARVPAVFRVVLISIHGWVGQEDVVGRDETLSQVIYVLEQARSLENELREQIKLAGLDQLGIKPHVIILTRLIPNCEGTFCYLPLEKVQDTENAWILRV
FVARVPAIFRVVLVSIHGWVGQQDVLGRDETLGQVIYVLEQARSLENKLQAEIKLAGLDLIGIQPHVIILTRLIPNCEGTECNLRLEKIHDTENAWILRI
FVARIPAVFRVVLISIHGWVAQEDVLGRDETLGQVIYVLEQARSLENKLQQEIKLAGLDFLGIKPHVIILTRLIPNCESTFCDLRLEKVHNTENAWILRV
FLARIPIVFRAVLVSIHGWVGQSGVMGRSETMSQVSYVLEQARQLEHELQSDIKRSGLDRLGIRPQVVILTRLIPHCEETLCYLPLEKLAETMNGWILRV
FISRIPLIFRVVLVSVHGWVGQEGVLGLPDTAGQVAYVIDQARSLEQTIQNNIKLSGLDVLGVEPKVIVLTRLIPNCEGTQCNLRLEKIQGTSNGWILRV
:. :*
:.: **:..* ::* :*
: .
*
* :
*:*:

114331077
30249199
82703384
198283392
344199811
255021595
77166514
300115586
292493898
350552412
220933364
350574485
95929190
298528445
297602308
115457664
326504012
115450038
326531526
242063616
42568160
297805240
313770765
313770767
255584097
225466221
313770769
313770771
255570671
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480
490
500
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
PFRKKNGEIIPQWISRFEIWPHLETFALD--VEREALAELGRRPDLIIGNYSDGNLVATLLSRRLGVTQCNIAHALEKTKYLHSDIYWQENEDKYHFSCQ
PFRKHNGEIIPHWISRFEIWPHLEIFAGD--VEREALAELGGHPDLIIGNYSDGNLVATLLSRRLGVTQCNIAHALEKTKYLHSDIYWQENEDKYHFSCQ
PFRKGSGEIVRHWISRFEIWPYLENFAHD--IEREALAQLSGRPDLIIGNYSDGNLVASLISKRIGVTQCNIAHALEQSKYLHSALYWRENEAQYHFNCQ
PFRYANGEILPQWISRFNVWPWLERYADD--LERETLAEFGRRPDLIIGNYSDGNLVATILSARLNVTQCNIAHALEKSKYLYSDLYWRDHDASHHFACQ
PFRYPNGEILPQWISRFNVWPWLERYADD--LERETLAEFGRRPDLIIGNYSDGNLVASMLSERLNVTQCNIAHALEKSKYLYSDLYWRDHDASHHFACQ
PFRYPDGRIHPHWISRFKIWPWLERYAQD--LEREVLAELGSRPDLIIGNYSDGNLVATLLSERLGVTQCNIAHALEKSKYLYSDLHWRDHEQDHHFACQ
PFRNAGGEVLPYWLSRFEVWPYLERYAMD--AEREMLAELEGSPDLIIGNYSDGSLVATLLSQRLRVTQCNIAHALEKAKYLYSDLYWRENDAQYHFACQ
PFRNAAGEVLPYWLSRFEVWPYLERYAMD--VEREMLAELEGSPDLIIGNYSDGSLVATLLSQRLRVTQCNIAHALEKTKYLYSDLYWRENDAQYHFACQ
PFRSAAGEALPYWLSRFEVWPYLERYAMD--VEREILAELEGSPDLIIGNYSDGNLVATLLAHRLRVTQCNIAHALEKTKYLYSDLYWRENDAQYHFSCQ
PFRSKEGEIIPHWISRFEIWPYLERFADD--VEQTVRAELGTRPDLIIGNYSDGNLVATLLSARMQVTQCHIAHALEKTKYLYSDLYWKENEAQYHFSCQ
PFRREDGEVVPQWISRFEIWPYLERFADE--VERTILADLGGRPDLIIGNYSDGNLVASLLSARLHVTQCNIAHALEKTKYLYSDLYWKDNDAQYHFATQ
PFRNENGDILPHWISRFHIWPYLERFALD--AETELLAELGDRPDLIIGNYSDGNLVASLMSRRLGVSQCNIAHALEKTKYLFSDLYWRDNEDRYHFSCQ
PFRNDQGEVINDWISRFKIWPHLERFSRE--SERKLLETIGARPDLIIGNYSDGNLVSFLLSRRLRVTQCTIAHALEKAKYLFSGLYWKEN-PEYNFQTQ
PFRYPSGEIVPHWISRFHVWPFLERFALD--STQEVHSELKGRPDLIIGNYSDGNLVASLMSKKMNITQCNIAHALEKSKYLFSSQYWKDNEAQYRFSSQ
PFKTEDGKDLRQWVSRFDIYPYLERYAQN--SCAKILDILEGKPDLIIGNYTDGNLVASLLSNKLCVTQGTIAHALEKTKYEDSDVKWREMDQKYHFSCQ
PFKTEDGKDLRQWVSRFDIYPYLERYAQD--SCAKILDILEGKPDLIIGNYTDGNLVASLLSNKLCVTQGTIAHALEKTKYEDSDVKWREMDQKYHFSCQ
PFKTEDGKDLRQWVSRFDIYPYLERYAQD--ASTKILDMLEGKPDLIIGNYTDGNLVASLMSSKLGVTQGTIAHALEKTKYEDSDVKWRELDQKYHFSCQ
PFKTEDGKVLPQWVSRFDIYPYLERYAQD--SSVKILEILEGKPDLVIGNYTDGNLVASLLTSKLGVTQGTIAHALEKTKYEDSDIKWRELDHKYHFSCQ
PFKTDDGKDLRQWVSRFDIYPYLERYAKD--SSVKILDILEGKPDMVIGNYTDGNLVASLLSSKLGVTQGTIAHALEKTKYEDSDVKWREMDHKYHFSCQ
PFKTQDGQDLPHWVSRFDIYPYLERYAQ-------ILDILGRKPDLVIGNYTDGNLVAYLVSRKLGVTQGTIAHALEKTKYEDSDVKWREMDHKYHFSCQ
PFVTENG-ILRRWVSRFDIYPYLERFTKD--ATTKILDILEGKPDLIIGNYTDGNLVASLMANKLGITQATIAHALEKTKYEDSDIKWKEFDPKYHFSSQ
PFVTESG-ILRRWVSRFDIYPYLERFTKD--ATTKILDILEGKPDLIIGNYTDGNLVASLMANTLGITQATIAHALEKTKYEDSDIKWKEFDPKYHFSSQ
PFRVENR-VLRQWVS----------RFDE--VTTKILDLMEGKPDLIIGNYTDGNFAATLMAGKLGITQATIAHALEKTKYENSDVKWKELESKYHFPCQ
PFSIENK-VLRQWVS----------RFDD--VITKLLDLMQRKPDLIIGNYTDGNLAATLMASKLGITQATIAHALEKTKYENSDVKWKELDPKYHFSCQ
PFTVENR-VLRQWVSRFDIYPYLEKFTQD--VADKILDLMDGKPDLIIGNYTDGNLAATLLANKLGITQATIAHALEKTKYEDSDIKWKELDPKYHFSCQ
PFRTEKG-ILNQWVSRFDIYPYLERFTQD--ATAKIIEHMEGKPDLIIGNYTDGNLVASLMATKLGITQGTIAHALEKTKYEDSDVKWKELEPKYHFSCQ
PFKTEKG-VLPQWVS----------RFDD--AADKVLEHMDSKPDLIIGNYSDGNLVASLMARKLSITLGTIAHALEKTKYEDSDVKWKELDAKYHFSCQ
PFKTEKG-VLPQWVSRFDVYPYLERFAQD--AADKVREHMDCKPDLLIGNYSDGNLVASLMAQKLGTTLGTIAHALEKTKYEDSDAKWKELDPKYHFSCQ
PFKTEKG-VLPQWVSRFDIYPYLEKFAQD--AADKVLEHMECKPDLIIGNYSDGNLVATLMANRLGITLGTIAHALEKTKYEDSDAKWKQLDPKYHFSCQ
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15219457
297842089
115466896
17980243
162460741
239984690
162460681
242035533
62865493
17980241
115453437
115473359
3980298
15242073
297812265
22331535
297818772
313770759
313770761
255550319
324984223
258489633
324984221
324984229
6683114
4584690
3915046
3766299
3377764
225444613
3660531
31455440
304651488
28629438
115310618
345286417
38425095
15235300
297814081
6682841
255564236
313770763
3915037
225437428
162458268
242035817
115452927

PFVTNKG-VLRQWVSRFDIYPYLERFTQD--ATSKILQRLDCKPDLIIGNYTDGNLVASLMATKLGVTQGTIAHALEKTKYEDSDAKWKELDPKYHFSCQ
PFVTDKG-ILRQWVSRFDIYPYLERFTQD--ATSKILQRLDCKPDLIIGNYTDGNLVASLMATKIGVTQGTIAHALEKTKYEDSDAKWKELDPKYHFSCQ
PFRSENG-ILRKWISRFDVWPFLETYTED--VANEIMREMQAKPDLIIGNYSDGNLVATLLAHKLGVTQCTIAHALEKTKYPNSDIYLDKFDSQYHFSCQ
PFRTENG-ILRKWISRFDVWPFLETYTED--VANEIMREMQAKPDLIIGNYSDGNLVATLLAHKLGVTQCTIAHALEKTKYPNSDIYLDKFDSQYHFSCQ
PFRNENG-ILRKWISRFDVWPYLETYTED--VSSEIMKEMQAKPDLIIGNYSDGNLVATLLAHKLGVTQCTIAHALEKTKYPNSDIYLDKFDSQYHFSCQ
PFRTENG-IR-KWISRFDVWPYLETYTEVNDVANELMREMQTKPDLIIGNYSDGNLVATLLAHKLGVTQCTIAHALEKTKYPNSDIYLDKFDSQYHFSCQ
PFRTENG-IVRKWISRFEVWPYLETYTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ
PFRTENG-IVRKWISRFEVWPYLETYTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ
PFRTENG-IVRKWISRFEVWPYLETFTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ
PFRTENG-IVRKWISRFEVWPYLETFTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ
PFRTENG-IVRKWISRFEVWPYLETFTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKMGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ
PFRTENG-TVRKWISRFEVWPYLETYTDD--VAHEISGELQATPDLIIGNYSDGNLVACLLAHKLGVTHCTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ
PFKTEDG-IVRKWISRFEVWPYLEAYTDD--VAHEIAGELQANPDLIIGNYSDGNLVACLLAHKLGVTHGTIAHALEKTKYPNSDLYWKKFEDHYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETYTED--AAVELSKELNGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLDDKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETYTED--AAVELSKELNGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLDEKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETFTED--VAAEISKELQGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLDEKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETFTED--VAAEISKELQGKPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLDEKYHFSCQ
PFRDGKG-MVRKWISRFEVWPYLETFTED--VAAEIAKELQGKPDLIIGNYSDGNIVASLLAHKLGVTECTIAHALEKTKYPDSDIYWKKFDEKYHFSCQ
PFRDEKG-MVRKWISRFEVWPYLETYTED--VAAEIAKELQGKPDLIIGNYSDGNVVASLLAHKLGVTECTIAHALEKTKYPDSDIYWKKFDEKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETYTED--VATEIGKEFQGKPDLIIGNYSDGNIVASLLAHKLGVTECTIAHALEKTKYPESDIYWKKLDDKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETYTED--VAHEISKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLEDKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETYTED--VAHEISKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLEDKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETYTED--VAHEISKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLEDKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETYTED--VAHEISKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKLEDKYHFSCQ
PFRTEKG-VVRKWISRFEVWPYLETYTED--VAVEIAKELQGKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKNLDDKYHFSCQ
PFRDTKG-IVRKWISRFEVWPYLETYTED--VAHELAKELQGKPDLIVGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKFEEKYHFSCQ
PFRDEKG-IVRKWISRFEVWPYLETYTED--VAHELAKELQSKPDLIVGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKFEEKYHFSCQ
PFRDQKG-IVRKWISRFEVWPYLETYTED--VAHELAKELQGKPDLIVGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKFEEKYHFSCQ
PFRDQKG-IVRKWISRFEVWPYLETYTED--VAHELAKELQGKPDLIVGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKFEEKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYLETYTED--VAKELATELQTKPDFIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPESDIYWKKLEDKYHFSCQ
PFRTEKG-IVRKWISRFEVWPYMETFIED--VAKEISAELQAKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKFDEKYHFSSQ
PFRTEKG-IVRKWISRFEVWPYMETFIED--VAKEISAELQAKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYWKKFDEKYHFSSQ
PFRTEKG-IVRKWISRFEVWPYMETFIED--VGKEITAELQAKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYLNKFDEKYHFSAQ
PFRTEKG-IVRKWISRFEVWPYMETFIED--VGKEITAELQAKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYLNKFDEKYHFSAQ
PFRTEKG-VVRKWISRFEVWPYMETFTED--VAKEVTAELQAKPDLVIGNYSEGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYLSKFDEKYHFSCQ
PFRTEKG-ILRKRISRFEVWPYMETFTED--VAKEITAELQSKPDLIIGNYSEGNLAASLLAHKLGVTQCTIAHALEKTKYPDSDIYLKNFDDKYHFSCQ
PFRTEKG-IVRRWISRFEVWPYLETYTED--VANEIAGELQAKPDLIIGNYSDGNIVASLLAHKLGVTQCTIAHALEKTKYPNSDIYWKSFEEKYHFSCQ
PFRSEKG-ILRKWISRFDVWPYLENYAQD--AASEIVGELQGVPDFIIGNYSDGNLVASLMAHRMGVTQCTIAHALEKTKYPDSDIYWKDFDNKYHFSCQ
PFRSDKG-ILHKWISRFDVWPYLENYAQD--AASEIVGELQGVPDFIIGNYSDGNLVASLMAHRMGVTQCTIAHALEKTKYPDSDIYWKDFDNKYHFSCQ
PFRSEKG-ILRQWISRFDVWPYLETFTED--VGSEITAELQGFPDFIIGNYSDGNLVASLLAYKMGITQCTIAHALEKTKYPDSDIYWKKFDEKYHFSCQ
PFRSEKG-ILRKWISRFDVWPYLETLLS------EIVAELQGIPDFIIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKFDDKYHFSCQ
PFRSEHG-ILRKWISRFDVWPYLETFAED--AASEIVAELQGIPDFIIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKFDDKYHFSCQ
PFRSEKG-ILRKWISRFDVWPFLETFAED--VASEIAAELQCYPDFIIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKFEDKYHFSCQ
PFRTDKG-ILRKWISRFDVWPYLETFAED--AASEIAAELQGVPELIIGNYSDGNLVASLLASKLGVTQCTIAHALEKTKYPDSDIYWKNFDDKYHFSCQ
PFRNENG-ILKKWISRFDVWPYLETFAED--AAGEIAAELQGTPDFIIGNYSDGNLVASLLSYKMGITQCNIAHALEKTKYPDSDIFWKNFDEKYHFSCQ
PFRNENG-ILKKWISRFDVWPYLETFAED--AAGEIAAELQGTPDFIIGNYSDGNLVASLLSYKMGITQCNIAHALEKTKYPDSDIYWKKFDEKYHFSCQ
PFRNENG-ILRKWISRFDVWPYLEKFAED--AAGEIAAELQGTPDFIIGNYSDGNLVASLLSYKMGITQCNIAHALEKTKYPDSDIYWTKYDEKYHFSCQ
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241896730
304651490
29289943
115310620
4468153
345286419
4468151
151176306
14530225
15239816
297795665
225431790
255551835
168009716
168035060
168058907
168029793
94266940
94264333
297569306
254416162
332712456
17232477
75908500
186682280
119512682
334117431
218440696
159031025
220907171
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284053161
209523126
17228554
75909957
186685043
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332708740
Clustal Consensus

PFRNENG-ILRKWISRFDMWPYLEKFAED--AAGEISAELQGTPDFIIGNYSDGNLVASLLSYKMGITQCNIAHALEKTKYPDSDIYWKKFDEKYHFSCQ
PFRTENG-ILHKWISRFDVWPYLEKFTED--VAGEMSAELQGVPDLIIGNYSDGNLVASLLAYKMGITQCTIAHALEKTKYPDSDIYWKKFEEKYHFSCQ
PFRTENG-ILHKWISRFDVWPYLEKFTED--VAGEMSAELQGVPDLIIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKFEEKYHFSCQ
PFRTEKG-ILRKWISRFDVWPYLETFTED--AANEISAELQGRPDLIIGNYSDGNLVASLLAHKLGVTQCTIAHALEKTKYPDSDIYWRKFEEKYHFSCQ
PFRTEHG-VLRQWISRFDVWPYLEKFAED--AASEISAELRGVPDLIIGNYSDGNLVASLMAHKMGVTQGTVAHALEKXKYPNSDIYWKXYEDKYHFSCQ
PFRTELG-VLHKWISRFDVWPYLEKFAED--AAGEIAAELQGVPDLIIGNYSDGNLVASSLSHKMGVTECTIAHALEKTKYPDSDLYWKKYEEKYHFSCQ
PFRTEQG-ILKQWISRFDVWPYLEKFAED--AGKEIRAEMKAVPDLLIGNYSDGNLVASLLAYKMGVTQCTIAHALEKTKYPDSDIYWKKHEEKYHFSCQ
PFRSEKG-ILRKWISRFDVWPYLENFTED--AAGEIIGELQGRPDLIIGNYSDGNIVASLLSHKMGVTQCNIAHALEKTKYPDSDIYWKRFEDKYHFSCQ
PFRSEKG-ILRKWISRFDVWPYLENFTED--AAGEIIGELQGRPDLIIGNYSDGNIVASLLSHKMGVTQCNIAHALEKTKYPDSDIYWKRFEDKYHFSCQ
PFRTEKG-ILRKWISRFDVWPYLETFAED--ASNEISAELQGVPNLIIGNYSDGNLVASLLASKLGVIQCNIAHALEKTKYPESDIYWRNHEDKYHFSSQ
PFRTEKG-ILRKWISRFDVWPYLETFAED--ASNEISAELQGVPNLIIGNYSDGNLVASLLASKLGVMQCNIAHALEKTKYPESDIYWRNHEDKYHFSSQ
PFRTENG-ILRKWISRFDVWPYLETFAED--ASNEIAAELQGVPDLIIGNYSDGNLVASLLSYKMGITQCNIAHALEKTKYPESDIYWRKFEDKYHFSSQ
PFRTQNG-ILRKWISRFDVWPYLETFADD--ASNEIAAELQGVPDLIIGNYSDGNLVASLLSYKLGITQCNIAHALEKIKYPDSDIYWRKYEDKYHFASQ
PFRHDGK-VLNNWISRFDVYPYLETYAQE--AAREISTDLAGPPDLIIGNYSDGNLVATLMCQQLGVTQCTIAHALEKTKYPDSDIYWKKFEEKYHFSCQ
PFRNDGQ-ILKNWISRFDVYPYLETYAQE--AASEICADLSGPPDLIIGNYTDGNLVATLLCQHLGVTQCTIAHALEKTKYPDSDIYWKNFEEKYHFSCQ
PFQHEGN-ILKNWISRFDVYPYLENYAQD--AAREVLGELQGRPDLIIGNYSDGNLVATLLSHYLDVTQCIIAHALEKTKYPDSDIYWKDFEEKYHFSCQ
PFRNENG-ILHNWISRFDVYPFLENFVYD--VAQELTVELPGKPDFIIGNYTDGNLVASLLCHQLGVTQCNIAHALEKTKYPDSDIYWKKFEEKYHFSCQ
PFRYPDLSVVPHWLSRFKLWPFLDQFAVD--VEEELRQEFAGRPDLLVGNYSDGNLVATRLSTSMGVIQCNIAHALEKSKYLFSDLYWHQFEADYHFSIQ
PFRYPDLSVVPHWLSRFKLWPFLDQFAVD--VEEELRQEFVGRPDLLVGNYSDGNLVATRLSTSMGVIQCNIAHALEKSKYLFSDLYWHQFEADYHFSIQ
PFRYPDNSVVPHWLSRFRIWPYLDQFAVD--AEEEIRRELGGRPDLLVGNYSDGNLVATRLSKNMGVIQCNIAHALEKSKYLFSDLYWDEFEPEYNFSIQ
PFREFNPNYTQNWISRFEIWPYLETYAID--AEKELRAEFQGVPDFIVGNYSDGNLVAFLLSRRMDVTQCIVAHALEKSKYLFSNLYWQELEDQYHFSIQ
PFREFNPKVTQDWISRFEIWPYLETYAID--AEKELLAEFQGRPDLIVGNYSDGNLVAFLLARRLKVTQCNIAHALEKSKYLFSNLYWQDSEQQYHFSLQ
PLREFNPKMTQNWISRFEFWPYLETFAID--SERELLAEFQGRPDLIVGNYTDGNLVAFLLTRRMKVTQCNIAHALEKSKYLFSNLYWQDLEEKYHFSLQ
PLREFNPKMTQNWISRFEFWPYLETFAID--SERELLAEFHGRPDLIVGNYTDGNLVAFLLARRMKVTQCNIAHALEKSKYLFSNLYWQDLEEKYHFSLQ
PLRDFNPNMTQNWISRFEFWPYLETFAID--SERELRAEFQGTPDLIVGNYTDGNLIAFLLARRLKVTQCNVAHALEKSKYLFSNLYWQELEEKYHFSLQ
PLRDFNPNMTQNWISRFEFWPYLETFAID--SEKELLAEFQGRPDLIVGNYSDGNLVAFLLARRMDVTQCNIAHALEKSKYLFSNLYWEELEDKYHFSLQ
PFRQFNPKLTQNWISRFEIWPYLETYALD--SEKELLAEFQGKPDLIVGNYSDGNLVAFLLSRKLKTTQCNIAHALEKSKYLFSNLYWQESEDKYHFSLQ
PFRDFNPNMTQNWISRFEIWPYLETYAID--AEKELYAQFHGRPDLIIGNYSDGNLVAFLLARRLDVTQFNIAHALEKSKYLFSNLYWQDLEHLYHFSIQ
PFREFNPKLTQNWISRFEIWPYLETFALD--AEREILAEFQGRPDLIIGNYSDGNLVAFLLARKLKVTQCNIAHALEKSKYLFSNLYWQDLEEQYHFSLQ
PFRSFNPKVTENWISRFEIWPYLETFAID--AEKALLAEFAGRPDLIVGNYSDGNLVAFLLSRRLGVTQGIIAHALEKSKYLFSNLYWQDLDDKYHFSLQ
PFREFNPKVTQNWISRFEIWPYLETFAID--AERELRAEFGHVPDLIIGNYSDGNLVAFLLARRLKVTQCNIAHALEKSKYLFSNLYWQDLEDKYHFSLQ
PFRELNPKYTQNWISRFEIWPYLETYAID--AERELLAEFRGLPDLIVGNYTDGNLVAFLLSRRLGVTQCNVAHALEKSKYLFSNLYWQDLEEQYHFSMQ
PFREFNPNVTQNWISRFEIWPYLETFAID--AETEILAEFQGRPDLIVGNYSDGNLVAFLLSKRLNVIQCNVAHALEKSKYVFSDLYWQDMDDKYHFSLQ
PFREFNPNVTQNWISRFEIWPYLETFSID--AETEILAEFQGRPDLIVGNYSDGNLVAFLLSKRLNVIQCNVAHALEKSKYVFSDLYWQNMEDKYHFSLQ
PFGEFNPEITNNWISKFEIWPYLETFALD--AEKQLLAQFQGKPNLIIGNYSDGNLVAFLLARRLKVTHCNIAHSLEKPKNLFSNLYWQDSEEKYHFSVQ
PFGEFNPAITNNWISKFEIWPYLETFALD--AEKQLLAQFQGKPNLIVGNYSDGNLVAFLLARRLKVTHCNIAHSLEKPKNLFSNLYWQNSEEKYHFSVQ
PFGEFNPEITNNWISKFEIWPYLEQFAID--AEKELLTQFKGKPNLLVGNYSDGNLVASLLSRRMKVTQCNIAHSLEKPKYLFSNLYWQDLENQYHFSAQ
PFGEFNSDITNNWISKYEIWPYLETFAQD--AEKELLTQFQGRPNLIVGNYSDGNLVASLISRSLKVTQCNIAHSLEKPKHLFSNLYWQDLEDNYHFSAQ
PFRDFNPEIINNWISKFEIWPYLEKFAQD--AERELLTEFSGKPDLIVGNYSDGNLVASLLSSSLKIPQCNIAHSLEKPKHLFSNLYWQDLDEKYHFSAQ
PFRECNPNVTDNWISKFEIWPYLENFAID--AEKVLLAQLGGRPQLIVGHYSDGNLVAYLLARRFKAIHCQVAHALEKPKYLFSDLYWQDWEAQYHFSAQ
PFQEFNPKVTQNWISKFEIWPYLESFALD--SEKALLEEFQGSPDLIIGNYSDGSLVAFLLARRLNAIHGSIAHTMEKPKYLFSDLYWKDFESQYNFSIQ
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YTADLLAMNAADFIVTSTYQEIAGTREAEGQYESYRAFSMPGLYRVINGIDLFDPKFNIVSPGADAEVYFPYTDQ-SRRLHSLIPEIESMLFDNTANFPA
YTADLLAMNSADFIVTSTYQEIAGTREAEGQYESYQAFSMPDLYRVIHGIDLFDPKFNIVSPGANADIYFPYSDP-NRRLHSLIPEIESLIFDDATNLPA
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82703384
198283392
344199811
255021595
77166514
300115586
292493898
350552412
220933364
350574485
95929190
298528445
297602308
115457664
326504012
115450038
326531526
242063616
42568160
297805240
313770765
313770767
255584097
225466221
313770769
313770771
255570671
15219457
297842089
115466896
17980243
162460741
239984690
162460681
242035533
62865493
17980241
115453437
115473359
3980298
15242073
297812265
22331535
297818772
313770759
313770761
255550319

YTADLIAMNSADFIITSTFQEIAGTEQTVGQYETYQNYTMPGLYRVVNGIDLFDPKFNIVSPGADAEVYFSYLDH-ERRLDALIPDIERLLYGDDPGVPC
FTADLIAMNSSDIIVTSTYQEIAGNDREVGQYEGYQNYSLPGLYRVENGIDVFDTKFNIVSPGADAHYYFPYSAS-EARLRYLHDDIDALLFGEEPAADR
FTADLIAMNSADIIVTSTYQEIAGNDHEVGQYEGHQNYSLPGLYRVENGIDVFDTKFNIVSPGADAHYYFPYSAS-EERLRYLHDDIDALLFGEEPAADR
FTADLIAMNAADIIVTSTYQEIAGNDREIGQYEGHQDYTLPGLYRVENGIDVFDSKFNIVSPGADPRFYFSYART-EERPSFLEPEIESLLFGREPGADR
FTGDLIAMNSADFIVTSTYQEIAGNKNSVGQYESYSAYTLPGLYQVIHGIDVFDPKFNIVSPGADGEVYFPYTDT-KRRLSGLRQEIEALIWGDERP-DA
FTGDLIAMNSADFIITSTYQEIAGNKNSVGQYESYSAYTLPGLYQVIHGIDVFDPKFNIVSPGADGEVYFPYTDT-KRRLSGLRQEIEALVWGDDRS-DT
FTADFIAMNSADFIITSTYQEIAGDRSSVGQYESYGAYILPGLYQVVQGIDVFDPKFNIVSPGADAEVYFPYRER-KRRLRGLRREIEELIWGNGRP-DA
FTADLIAMNAADFIITSTYQEIAGTDHSVGQYESYSAFSMPGLYRVVKGIDVFDPKFNIVSPGADAEVYFSYKDS-ERRLHGLHDELQTLIFGTPSE-DM
FTADLIAMNAADFIITSTYQEIAGTGEDIGQYESYMSFSLPDLYRVVRGIDVFDPKFNIVSPGADDRVYFPYTEE-ERRITGLHEEIEALLFGGHRD-DA
FTADLIAMNTADFIITSTYQEIAGTDESLGQYESYMNFTMPGLYRVVAGVDVYDPKFNIVSPGADEEIYFPFTET-ERRLAHLHGEIEQLIFGEPVPGQS
FTADLVSMNAADFIITSTYQEIAGTEESLGQYESYSSFTMPALYRVINGINIYDPKFNIVSPGADDRVYFPYYDE-ENRLTELHDELHELIYGDHME-GS
FTADLIAMNTADFIITSTYQEIAGTEESVGQYETYNAFTMPDLYRVVSGIDVFDPKFNVVSPGADENVYFPYYEK-DRRLTELHDELSDYIYGPPGD-WA
FTADMISMNTSDFIITSTYQEIAGSKEKPGQYEHHYAFTMPGLCRYATGINVFDPKFNIAAPGADQSIYFPFTQK-QKRLTDLHPQIDELLYSKDDTDEH
FTADMISMNTSDFIITSTYQEIAGSKEKPGQYEHHYAFTMPGLCRYATGINVFDPKFNIAAPGADQSIYFPFTQK-QKRLTDLHPQIDELLYSKDDTDEH
FTADMFAMNTTDFIITSTYQEIAGSKEKPGQYEHHYAFTMPGLCRFATGINVFDPKFNIAAPGADQSVYFPFTQK-QKRLTNLHPQIEELLYSKEDTDEH
FTADMIAMNTSDFIIASTYQEIAGSKEKPGQYESHYAFTMPGLCRYATGINVFDPKFNIAAPGADQSVYFPFTQK-QKRLTDLHPQIEELLYSKEDNNEH
FTADMIAMNTSDFIIASTYQEIAGSKDKPGQYESHYAFTMPGLCRYATGVNVFDPKFNIAAPGADQTVYFPFTQK-QARLTDLHPQIEELLYSKEDNDEH
FTADMIAMNTSDFIIASTYQEIAGSKDKPGQYESHYAFTMPGLCRFATGINVFDPKFNIAAPGADQSVYFPFTLK-HKRLTDLHPQIEALVYGKEENDEH
FTADLISMNSADFIIASTYQEIAGSKERAGQYESHMSFTVPGLYRVVSGINVFDPRFNIAAPGADDSIYFPFTAQ-DRRFTKFYTSIDELLYSQSENDEH
FTADLISMNSADFIIASTYQEIAGSKERVGQYESHMSFTLPGLYRVVSGINVFDPRFNIAAPGADDTIYFPFTAQ-DRRFTKFYPSIEELLFSQNENDEH
FMADIVAMNATDFIIASTYQEIAGSKDRTGQYESHAAFTLPGLCRVVSGVNVFDPKFNIAAPGADQSVYFPHTEK-QSRFTQFNPDIEELLYSKVVNDEH
FMADTIAMNATDFIIASTYQEIAGSKDRPGQYESHASFTLPGLCRVVSGIDVFDPKFNIAAPGADQSVYFPYTEK-QSRFTKFHPAIEELLYSKVVNDEH
FIADTISMNAADFIIASTYQEIAGSKERPGQYESHSAFTLPGLCRVVSGINVFDPKFNVAAPGADQSVYFPNTEK-QKRFSQFHSAIEELLYSKEENEEH
FTADTISMNAADFIITSTYQEIAGSKDRPGQYESHTSFTLPGLCRVVSGINLFDPKFNIAAPGADQSVYFPYMER-HKRLTSFQPAIEELLYSKQDNNEH
FTADMIAMNSADFIITSTYQEIAGSNVRPGQYESHTAFTMPGLCRVVSGINVFDPKFNIASPGADQSVYFPYTEK-QKRLTSFHPAIEELLYSNEDNHEH
FTADMIAMNTADFIITSTYQEIAGSKNRPGQYESHVAFTMPGLCRVVSGINVFDPKFNIASPGADQTVYFPYTEK-QKRLTSFHPAIEELLYNNEDNNEH
FTADMIAMNAADFIITSTYQEIAGSKDRPGQYESHKAFTMPGLCRVVSGVNVFDPKFNIAAPGADQSVYFPYTEK-RRRLTSFYPAIEELIYSKEGNDEH
FTADLIAMNVTDFIITSTYQEIAGSKDRPGQYESHTAFTMPGLCRVVSGIDVFDPKFNIAAPGADQSVYFPYTEK-DKRFTKFHPSIQELLYNEKDNAEH
FTGDLIAMNVTDFIITSTYQEIAGSKDRPGQYESHTAFTMPGLCRVVSGIDVFDPKFNIAAPGADQSVYFPYTEK-EKRFTKFHPSIQELLYNEKDNAEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHIAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSVYFPYTEA-DKRLTAFHPEIEELLYSEVENDEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHIAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSVYFPYTET-DKRLTAFHPEIEELIYSDVENSEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHIAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSVYYPYTET-DKRLTAFHPEIEELIYSDVENSEH
FTADLIAMNHTDFIITSTFQEIAGSKDSVGQYESHIAFTLPDLYRVVHGIDVFDPKFNIVSPGADMTVYFPYTET-DKRLTAFHSEIEELLYSDVENDEH
FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADLSIYFPYTES-HKRLTSLHPEIEELLYSQTENTEH
FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADLSIYFPYTES-HKRLTSLHPEIEELLYSQTENTEH
FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADLSIYFPYTES-HKRLTSLHPEIEELLYSDVDNHEH
FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYSES-HKRLTSLHPEIEELLYSDVDNNEH
FTTDLIAMNHADFIITSTFQEIAGNKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYSES-RKRLTSLHPEIEELLYSEVDNNEH
FTADLIAMNHADFIITSTFQEIAGNKETVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPFTES-QKRLTSLHLEIEELLFSDVENTEH
FTADLIAMNHADFIITSTFQEIAGKKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEQ-QKRLTSLHTEIEELLFSDVENAEH
FTADIFAMNHTDFIITSTFQEIAGSKETVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEE-KRRLTKFHSEIEELLYSDVENKEH
FTADIFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEE-KRRLTKFHSEIEELLYSDVENEEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHRSFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFAYTEE-KRRLTAFHLEIEELLYSDVENEEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMNIYFAYTEE-KRRLTAFHQEIEELLYSDVENEKH
FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADESIYFPYTDE-KRRLTSFHPEIDELLYSPVENEEH
FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADESIYFPYTEK-KLRLTSFHEEIEELLYSSVENDEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADESIYYPYTDT-KRRLTSFHPEIEELLYSPVENEEH

104

324984223
258489633
324984221
324984229
6683114
4584690
3915046
3766299
3377764
225444613
3660531
31455440
304651488
28629438
115310618
345286417
38425095
15235300
297814081
6682841
255564236
313770763
3915037
225437428
162458268
242035817
115452927
241896730
304651490
29289943
115310620
4468153
345286419
4468151
151176306
14530225
15239816
297795665
225431790
255551835
168009716
168035060
168058907
168029793
94266940
94264333
297569306

FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMEIYFPYTEE-KRRLKHFHTEIEDLLYSKVENEEH
FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMEIYFPYTEE-KRRLKHFHTEIEDLLYSKVENEEH
FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMEIYFPYTEE-KRRLKHFHPEIEDLLYSKVENEEH
FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMEIYFPYTEE-KRRLKHFHPEIEDLLYSKVENEEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYTEE-KRRLKSFHPEIEELLYSDVENKEH
FTADLFAMNHTDFIITSTFQEIAGSKDKVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADQTIYFPYTET-SRRLTSFYPEIEELLYSSVENEEH
FTADLFAMNHTDFIITSTFQEIAGSKDKVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADQTIYFPYTET-SRRLTSFYPEIEELLYSSVENEEH
FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADQTIYFPYTET-SRRLTSFYPEIEELLYSTVENEEH
FTADLFAMNHTDFIITSTFQEIAGSKDTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADQTIYFPYTET-SRRLTSFYPEIEKLLYSTGGNEEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHTGFTMPGLYRVVHGIDVFDPKFNIVSPGADMTIYFSYTEE-KMRLKALHPEIEELLFSPVENKEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGINVFDPKFNIVSPGADINLYFPYSES-EKRLTAFHPEIDELLYSDVENDDH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGINVFDPKFNIVSPGADINLYFSYSET-EKRLTAFHPEIDELLYSDVENDEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADVNLYFPYSEK-EKRLTTFHPEIEDLLFSDVENEEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADVNLYFPYSEK-EKRLTTFHPEIEDLLFSDVENEEH
FTADLIAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADTNLYFPHTEK-EKRLTSFHPEIEELLFSDVENEEH
FTADLYAMNHTDFIITSTFQEIAGSKDTVGQYESHMAFTMPGLYRVVHGIDVFDPKFNIVSPGADMNLYFPYTEK-EKRLTALHPEIEELLYSNVENDEH
FTADLIAMNHTDFIITSTFQEIAGNKDTVGQYESHMAFTLPGLYRVVHGIDVFDPKFNIVSPGADLSIYFNYTEE-KKRLTALHPEIEELLFSETQNEEH
FTADLIAMNNADFIITSTYQEIAGTKNTVGQYESHGAFTLPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSEE-TRRLTALHGSIEEMLYSPDQTDEH
FTADLIAMNNADFIITSTYQEIAGTKNTVGQYESHGAFTLPGLYRVVHGIDVFDPKFNIVSPGVDMAIYFPFSEE-TKRLTALHSSIEEMLYSPEQTDEH
FTADLIAMNNADFIITSTYQEIAGTKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMDIYFPYSEK-QKRLTALHGSIEQLLFDPEQNDEH
FTADILAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPYSEK-QKRLTALHGSIEKMLYDPEQTDEW
FTADVLAMNNADFIITSTYQEIAGTKTTVGQYESHTAFTLPGLYRVVHGINVFDTKFNIVSPGADMDIYFPYSDK-QKRLTTLHGSIEKMLYDSEQTDDW
FTADLIAMNNADFIITSTYQEIAGTKNTIGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSDK-EKRLTALHSSIEKLLYGTEQTDEY
FTADLIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMCIYFPYSDV-EKRLTALHGSIEKLLYDPEQNEEH
FTADIIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPHTEK-AKRLTSLHGSIENLIYDPEQNDEH
FTADIIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPHTEK-AKRLTSLHGSIENLLYDPEQNDQH
FTADIIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRIVHGIDVFDPKFNIVSPGADMSIYFPYTEK-AKRLTSLHGSLENLISDPEQNDEH
FTADIIAMNNADFIITSTYQEIAGSKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFPFTEK-AKRLTALHGSIESLIYDPEQNDEH
FTADLLSMNHSDFIITSTYQEIAGTKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYFDK-EKRLTSLHPSIEKLLFDPEQNEVH
FTADLLSMNHSDFIITSTYQEIAGTKNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSDK-EKRLTSLHPSIEKLLFDPEQNEVH
FTADLLAMNHSDFIITSTYQEIAGTNNTVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMAIYFPYSDT-EKRLTSFHGSIENLLFDPEQNDEH
FTADLLAMNNSDFIITSTYQEIAGTKNSVGQYESHAGFTLPGLYRVVHGIDVFDPKFNIVSPGADDGIYFSYSEK-ERRLTSYHDCLEKLLFDPQQTEEH
FTADLLAMNHSDFIITSTYQEIAGTKSTVGQYESHASFTLPGLYRVVHGIDVFDPKFNIVSPGADECIYFPYSEK-DKRLTALHESLEKLIFDPQQTDEH
FTADLLAMQHSDFIITSTYQEIAGTRNVVGQYESHVAFTMPGLYRVVHGIDVFDPKFNIVSPGADESIYFPYTDK-EKRLTNLQASIEKLLFDPEQNEEH
FSADLMAMNHADFIITSTYQEIAGTKNTVGQYESHKAFTFPGLYRVVHGIDVFDPKFNIVSPGADMAIYFPFSEK-EHRLTSLHSFIEQLLFKPEQNEEH
FSADLMAMNHADFIITSTYQEIAGTKNTVGQYESHKAFTFPGLYRVVHGIDVFDPKFNIVSPGADMAIYFPFSEKDVTCLTSLHRLIEQLLFKPEQNEEH
FTADLIAMNNADFIITSTYQEIAGSKNNVGQYESHTAFTMPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSDK-ERRLTALHESIEELLFSAEQNDEH
FTADLIAMNNADFIITSTYQEIAGSKNNVGQYESHTAFTMPGLYRVVHGIDVFDPKFNIVSPGADMTIYFPYSDK-ERRLTALHESIEELLFSAEQNDEH
FTADLIAMNNADFIITSTYQEIAGSKNHVGQYESHTAFTLPGLYRVVHGIDVFDPKFNIVSPGADMSIYFSYSEK-ERRLTALHDSIESLLYDSEQNDDH
FTADIIAMNNADFIITSTYQEIAGNKNNIGQYEGYTAFTLPGLYRVVHGINVFDPKFNIVSPGADSCIYFPYSDR-ERRLTALHGAIEELLYDPEQNEEH
FTADLIAMNHADFIITSTYQEIAGSAKTVGQYESHQAFTMPGLYRVVNGVNVFDPKFNIVSPGADMDVYFPYTDK-ERRLTKLHPTIEDLLFGTEQSDEH
FTADLIAMNHADFIITSTYQEIAGSAKTVGQYESHQAFTMPSLYRVVNGIDVFDPKFNIVSPGADMTVYYPFTDK-QHRLTKLHPAIEKLLFSSDQTDEH
FTADLIAMNSADFIITSTYQEIAGSADTVGQYESHQAFTMPGLYRVVNGIDVFDPKFNIVSPGADMNIYYPFADK-ERRLTSLQESIEELLYSPEQTDEH
FTADLIAMNQADFIITSTYQEIAGSEDTVGQYESHVAFSLPGLYRVVNGIDVFDPKFNIVSPGADTIVYFSFTEK-DRRLTDLHDKIEKLLYDPEQTAEH
FMVDLIAMNQANFIVTSTAQEITGTENSIGQYESYQFFTMPGLLNITSGIDLFHPRFNVIPPGVNQEVYFPWNRK-RSRPTKLRRRVSELLFSGEDD-DC
FMVDLIAMNQANFIVTSTAQEITGTENSIGQYESYQFFTMPGLLNITSGIDLFHPRFNVIPPGVNQEVYFPWNRK-RSRPTKLRRRVSELLFSGDDD-DC
FMADLLAMNQANFIITSTAQEITGTDNSIGQYESYQFFTMPGLVNVISGINLFHPRFNVIPPGVNQEVYFPYNRK-RGRKVKMRREVTRLLFEQEDA-DC
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254416162
332712456
17232477
75908500
186682280
119512682
334117431
218440696
159031025
220907171
22298591
158339122
284053161
209523126
17228554
75909957
186685043
119510624
298489784
220909283
332708740
Clustal Consensus

FTADLIAMNAANFIISSTYQEIVGKPDSVGQYESYQNFTMPDLYHVVNGIELFSPKFNVVPPGVNEQVYFPYTRS-EDRVPRDCERLEELLFTLDDPSQV
FTADLIAMNAANFIISSTYQEIVGTADSVGQYESYQNFTMPDLYHVINGIELFSPKFNVVPPGVNETVFFPYTRT-QGRVASDIKRLDEFLFTLDDEAQV
FTADLIAMNAANFVISSTYQEIVGTPDSIGQYESYKCFTMPELYHVVNGIELFSPKFNVVPPGVNENSYFPYTQT-QNRIESDRDRLEEMLFTLEDSSQI
FTADLIAMNAANFVISSTYQEIVGTSDSVGQYESYKCFTMPELYHVVNGIELFSPKFNVVPPGVNENSYFPYTHT-QDRIESDRDRLEEMLFTLEDSSQI
FTADLIAMNAANFVVSSTYQEIVGTPDSVGQYESYKCFTMPELYHVTNGIELFSPKFNVVPPGVNENNYFPYTRT-KDRVESDRQRLAETLFTLEDPTQI
FTADLIAMNAANFVVSSTYQEIVGTPDSVGQYESYKCFTMPELYHVVNGIELFSPKFNVVPPGVNESYYFPYTRK-EDRVEADSDRLADILFTLEDPHQI
FTADIIAMNAANCIVSSTYQEIVGQPDSVGQYESYHCFTMPDLYHVVNGIELFSPKFNVVPPGVNESVYFPYTRI-EDRVQGDRDRLNELLFTLEDPEQV
FTADLIAMNAANCIISSTYQEIVGRTDSVGQYESYESFTMPNLYHVVNGIELFSPKFNVVPPGVNENVYFPYTRT-DERVPNKREHLEDLLFTLEDPSQV
FTADLISMNAANFIISSTYQEIVGTSDSVGQYESYQCFTMPELYHVVSGIELFSPKFNVVPPGVNESYFFPYTNR-EERLLGEGERLEELLFTLEAPRRV
FTADLIVMNAAHFIISSTYQEIVGTPDSVGQYESYSSFTMPELYHVISGIELFSPKFNLVPPGVNENYFFPYTKV-EERLVTERHRLEELLFTLDDPAQV
FTADLIAMNAANFIISSTYQEIVGTPDSIGQYESYQSFTMPDLYHVVNGIELFSPKFNVVPPGVNEQVYFPYYHY-TERLEGDRQRLEELLFTLEDPQQI
FTADLIAMNAANFIVTSTYQEIAGRPDTIGQYESYRSFTMPDLYHVVYGAELFSPKFNVVPPGVNESVYFPFTRH-QERTPGDIDRLEELLFTLEDPEHV
FTADLIAMNAANFIISSTYQEIIGTTDSVGQYESYKSYTMPGLYHVVNGIELFSPKFNVVPPGVNETIFFPYTRT-EERISSDRQRLEELIFYLDDPNQV
FTADLIAMNAANFIISSTYQEIIGTTDSVGQYESYKSYTMPGLYHVVNGIELFSPKFNVVPPGVNETIFFPYTRT-EERISSDRQRLENLIFHLDDPSQV
FTADLITMNAADFIITSSYQEIFGTPESIGQYESYKFFTMPHLYHVVDGIDLFNPKFNMVPPGVNEQVFFPYSQT-ADRDPNVSKHVHDLLFHRQDS-QI
FTADLITMNAADFIITSSYQEIFGTPESVGQYESYKFFTMPHLYHVVDGVDLFSPKFNMVPPGVNEQVFFPYSQT-ADRDPNLSQSVHDLLFHRQDS-QI
FTADLISMNAADFIITSSYQEIVGTPDTIGQYESYKCFTMPQLYHVVDGIDLFSPKFNLVPPGVNESIFFPYSQK-ENRDSNLCTEIHNLLFSREDP-QI
FTADLISMNAADFIITSSYQEIVGTPDTIGQYESYKCFTMPELYHVINGIDLFSPKFNMVPPGVSENIFFPFSQK-DRRNPKLTSQVHDLLFEREHP-QI
FTADLISMNAADFIVASSYQEIVGTPDTMGQYESYKCFTMPQLYHVVDGIDLFNPKFNMIPPGVSETLFFPYSQT-EDRNPQESQKIKDLLFQQQDD-HI
FTADLITMNAANFIITSSYQEIVGTPESVGQYESYKCFTMPQLYHVVNGIELCSPKFNRVPPGVNENIFFPYTHK-DSRDPCLCQRIHHLLFHHTDD-HI
FTADLIAMNSADFILTSTYEELVGTPESVGYYESYKCFSMPELYHVVNGIELFSPKFNVVPPGVNENIFFPYTQT-SDRIAHDSERVKDLLLSKEDP-EI
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114331077
30249199
82703384
198283392
344199811
255021595
77166514
300115586
292493898
350552412
220933364
350574485
95929190
298528445
297602308
115457664
326504012
115450038
326531526
242063616
42568160
297805240
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RGILQDSDKPLIFTMARLDRIKNITGLVESYGASQRLRSLANLVIVGGKIDPQHSSDHEEQEQIHQMHHLMDEYKLDPQVRWLGMRLDKNLAGELYRYIA
RGYLQDPDKPLIFTMARLDRIKNITGLVELYAASPRLRSLANLVIVGGKIDPQHSSDHEEQEQIHRMHQLMDEHELDQQVRWLGMRLDKNLAGELYRYIA
RGYFADPAKPLIFTMARLDTVKNLTGLAAWFGQCEALSTAANLLVIGGHIDPAASCDGEERAEIEHMHALMNEYKLEGRMRWLGTRLEKNLAGELYRHVA
RGVLKERDKPIIFSMARMDHIKNLSGLAEIFGASERLRKLANLVIIGGHVDLQNSQDEEEGAQIQRMHDIMDAHQLDGQMRWIGTLLEKNVAGELYRVIG
RGVLKDRDKPIIFSMARMDHIKNLSGLAALFGASERLRTLANLVIIGGHVDPQDSQDEEERAQIHRMHGIMDAHQLDGQMRWIGTLLDKNVAGELYRVIG
RGVLEDRQKPLLLSMARMDRIKNLSGLAELYGRSSRLRGLANLVIIGGHVDVGNSRDAEEREEIRRMHEIMDHYQLDGQLRWVGALLDKTVAGELYRVVA
RGKLQDHTKPLLFTIARLDRIKNITGLVEWYGRCERLRKLANLVVVGGYIDKSQSADSEEQVQIARMHQLIEEYKLDSQVRWLGVMLQKNLAGELYRFIA
RGKLQDRSKPLLFTIARLDRIKNITGLVEWYGRCERLRQLVNLVVVGGYIDKSQSADSEEQAQIARMHQLMEEYGLDGQVRWLGVMLQKNLAGELYRFIA
RGRLQDKGKPLLFTMARLDRIKNITGLVEWYGRCERLRKQVNLVVVAGYVDEAQSADSEEQAQIARMHQLMEEYELDNQVRWLGTLLQKNLAGELYRFVA
RGTLKHPERPLIFTMARLDRIKNIAGLVQWYAENEALREQANLLIVAGYTDAGKSADREEQEQIGYLHHLFTTHGLDEQVRWLGVRLDKVFAGELYRFIA
RGVLAAPERPVIFTMARLDRIKNIAGLVSWYAQNAELRARANLVVVAGTVDPSRSDDQEEQAQIARMHQLFDAHDLNDCVRWLGVRLDKTLSGELYRCIA
RGQLQDRDKPLLFSMARLDRIKNIGGLVDWYARAPELRNRVNLVVVAGHVDGNASGDDEEREQIDYIHYLMNTHGLDGQVRWLGVHLDKFLAGEFYRCIA
RGLLDDKDKPLIFTMARLDKVKNITGLVECYAKSERLREQANLLVVAGSIHVDHSSDAEERYQIETMHRLFDEYQLDGQVRWLGKHLQKNKAGELYRYIA
KGELQDRTKPILFTMARLDRIKNLTSLVRWYGENPELRQEANLVLVAGSLDVRDSQDEEEKACIQEMHRLFEEFDLHEQVRWLGTRLDKNMSGELYRFIA
IGYLADRNKPIIFSMARLDKVKNITGLVEWYGQNKKLRDLVNLVVVAGLLDASQSKDREEIEEINKMHNLMDRYQLKGQIRWIKAQTDRVRNGELYRCIA
IGYLADRNKPIIFSMARLDKVK-----------NKKLRDLVNLVVVAGLLDASQSKDREEIEEINKMHNLMDRYQLKGQIRWIKAQTDRVRNGELYRCIA
IGYLADRSKPIIFSMARLDKVKNITGLVEWYGQNKKVRDLVNLVVVAGLLNAAQSKDREEIDEINKMHNLIDKYQLKGQIRWIKAQTDRVRNGELYRYIA
IGHLADRSKPIIFSMARLDKIKNITGLVEWYGQNKRLRDLVNLVIVGGLLDPSQSKDREEIEEINKMHSLINKYQLVGQIRWIKGQTDRVRNGELYRCIA
LGYLGDRSKPIIFSMARLDKVKNITGLVEWYGENKKLRDLVNLVIVGGLLEPSQSNDREEIEEINKMHSLMDKYQLKGQIRWIKAQTERVRNGELYRCIA
IGYLENRRKPVIFSMARLDKVKNITGLVEWYGQDKRLRVLVNLVVVGGLLDPTQSKDREEIEEINKMHSLINKYQLKGQIRWIKAQTDRVRNGELYRCIA
IGYLVDKKKPIIFSMARLDVVKNLTGLTEWYAKNKRLRDLVNLVIVGGFFDASKSKDREEISEIKKMHSLIEKYQLKGQFRWITAQTDRTRNGELYRSIA
IGYLVDKKKPIIFSMARLDVVKNLTGLTEWYAKNKRLRDLVNLVIVGGFFDPSKSKDREEISEIKKMHSLIEKYQLKGQFRWIAAQTDRTRNGELYRCIA
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313770765
313770767
255584097
225466221
313770769
313770771
255570671
15219457
297842089
115466896
17980243
162460741
239984690
162460681
242035533
62865493
17980241
115453437
115473359
3980298
15242073
297812265
22331535
297818772
313770759
313770761
255550319
324984223
258489633
324984221
324984229
6683114
4584690
3915046
3766299
3377764
225444613
3660531
31455440
304651488
28629438
115310618
345286417
38425095
15235300
297814081
6682841

IGYLEDKKKPIIFSMARLDTVKNLTGLTEWYGKNKRLRGLVNLVIVGGFFDPNKSKDREEMAEIKKMHELIEKYQLKGQIRWIAAQTDRKRNGELYRCIA
IGYLEDKKKPIIFSMARLDTVKNLTGLTEWYGKNKRLRGLVNLVIVGGFFDPNKSKDREEMAEITKMHGLIKKYRLNGQFRWIAAQTDRNRNGELYRCIA
IGYLADKKKPIIFSMARFDTVKNLTGLTEWYGKNKRLRNLVNLVIVGAFFDPSKSKDREEMAEIKKMHALIDKYQLKGQIRWIAAQTDRQRNGELYRCIA
IGFLADRKKPIIFSMARLDIVKNITGLTEWFGNNKRLRSLVNLVIVAGFFDPSKSKDREEMAEIKKMHTLIEKYQLKGQIRWIAAQNDRRRNGELYRCIA
IGYLADRKKPIIFSMARLDTVKNITGLTEWFGKNTKLRNLVNLVVVAGFFDPSKSNDREEIAEIKKMHALIEKYQLKGQFRWIAAQTDRYRNGELYRCIA
IGYLADKKKPIIFSMARLDTVKNITGLTEWYGKNAKLRNLVNLVVVAGFFDPSKSNDREEIAEIKKMHSLIEKYQLKGQFRWIAAQSDRYRNGELYRCIA
IGYLADRKKPIIFSMARLDTVKNITGLTEWYGKNKRLRNLVNLVVVAGFFDPSKSKDREEIAEINKMHALIEKYQLKGQIRWIAAQTDRYRNGELYRCIA
MGYLADREKPIIFSMARLDTVKNITGLVEWYGKDKRLREMANLVVVAGFFDMSKSNDREEKAEIKKMHDLIEKYKLKGKFRWIAAQTDRYRNSELYRCIA
MGYLAEREKPIIFSMARLDTVKNITGLVEWYGKDKRLREMANLVVVAGFFDMSKSNDREEKAEIKKMHDLIEKYKLKGKFRWIAAQTDRYRNSELYRCIA
KFVLKDKNKPIIFSMARLDRVKNMTGLVEMYGKNAHLRDLANLVIVCGDHG-NQSKDREEQAEFKKMYGLIDQYKLKGHIRWISAQMNRVRNGELYRYIC
KFVLKDKNKPIIFSMARLDRVKNMTGLVEMYGKNAHLRDLANLVIVAGDHG-KESKDREEQAEFKRMYSLIDEYKLKGHIRWISAQMNRVRNGELYRYIC
KFVLKDKKKPIIFSMARLDRVKNMTGLVEMYGKNARLRELANLVIVAGDHG-KESKDREEQAEFKKMYSLIDEYKLKGHIRWISAQMNRVRNGELYRYIC
KFVLKDRNKPIIFSMARLDRVKNMTGLVEMYGKNAHLKDLANLVIVAGDHG-KESKDREEQAEFKRMYSLIEEYKLKGHIRWISAQMNRVRNGELYRYIC
KFVLNDRNKPIIFSMARLDRVKNLTGLVELYGRNKRLQELVNLVVVCGDHG-NPSKDKEEQAEFKKMFDLIEQYNLNGHIRWISAQMNRVRNGELYRYIC
KFVLNDRNKPIIFSMARLDRVKNLTGLVELYGRNKRLQELVNLVVVCGDHG-NPSKDKEEQAEFKKMFDLIEQYNLNGHIRWISAQMNRVRNGELYRYIC
KFVLKDRNKPIIFSMARLDRVKNLTGLVELYGRNPRLQELVNLVVVCGDHG-NPSKDKEEQAEFQKMFDLIEQYNLNGHIRWISAQMNRVRNGELYRYIC
KFVLKDRNKPIIFSMARLDRVKNLIGLVELYGRNPRLQELVNLVVVCGDHG-NPSKDKEEQAEFKKMFDHIEQYNLNGHIRWISAQMNRVRNGELYRYIC
KFMLKDRNKPIIFSMARLDRVKNLTGLVELYGRNPRLQELVNLVVVCGDHG-NPSKDKEEQAEFKKMFDLIEQYNLNGHIRWISAQMNRVRNGELYRYIC
KFVLKDKKKPIIFSMARLDHVKNLTGLVELYGRNPRLQELVNLVVVCGDHG-KESKDKEEQAEFKKMFNLIEQYNLNGHIRWISAQMNRVRNGELYRYIC
KFVLKDKKKPIIFSMARLDRVKNMTGLVEMYGRNPRLQELVNLVVVCGDHG-KVSKDKEEQVEFKKMFDLIEKYNLSGHIRWISAQMNRVRNGELYRYIC
LCVLKDKKKPILFTMARLDRVKNLSGLVEWYGKNTRLRELANLVVVGGDRR-KESKDNEEKAEMKKMYDLIEEYKLNGQFRWISSQMDRVRNGELYRYIC
LCVLKDKKKPILFTMARLDRVKNLSGLVEWYGKNTRLRELANLVVVGGDRR-KESKDNEEKAEMKKMYDLIEEYKLNGQFRWISSQMNRVRNGELYRYIC
LCVLKDKKKPIIFTMARLDRVKNLSGLVEWYGKNTRLRELVNLVVVGGDRR-KESQDNEEKAEMKKMYELIEEYKLNGQFRWISSQMNRVRNGELYRYIC
LCVLKDKKKPILFTMARLDRVKNLSGLVEWYGKNTRLRELVNLVVVGGDRS-KESQDNEEKAEMKKMYDLIEEYKLNGQFRWISSQMNRVRNGELYRYIC
LCVLKDRNKPILFTMARLDRVKNLSGLVEWYGKNTKLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYSHIEKYNLNGQFRWISSQMNRVRNGELYRYIC
LCVLKDRNKPILFTMARLDRVKNLTGLVEWYGKNTKLRELANLVVVGGDRR-KESKDIEEQAEMKKMYSHIEKYKLNGQFRWISSQMNRVRNGELYRYIC
LCVLKDRSKPIIFTMARMDRVKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEQAEMKKMHGLIEKYNLNGQFRWISSQMNRVRNGELYRCIC
LCVLNDRNKPILFTMARLDRVKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEKAEMKKMFELIEKYNLNGQFRWISSQMNRIRNGELYRYIC
LCVLNDRNKPILFTMARLDRVKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEKAEMKKMFELIEKYNLNGQFRWISSQMNRIRNGELYRYIC
LCVLNDRNKPILFTMARLDRAKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEKAEMKKMFELIDKYNLNGQFRWISSQMNRIRNGELYRYIC
LCVLNDRNKPILFTMARLDRVKNLTGLVEWYGKNAKLRELANLVVVGGDRR-KESKDLEEKAEMKKMFELIDKYNLNGQFRWISSQMNRIRNGELYRYIC
LCVLKDRNKPILFTMARLDRVKNLTGLVEWYGKNAKLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYSLIDQYKLNGQFRWISSQMNRVRNGELYRYIC
ICVLKDRNKPIIFTMARLDRVKNITGLVEWYGKNAKLRELVNLVVVAGDRR-KESKDLEEIAEMKKMYGLIETYKLNGQFRWISSQMNRVRNGELYRVIC
ICVLKDRNKPIIFTMARLDRVKNITGLVEWYGKNAKLRELVNLVVVAGDRR-KESKDLEEIAEMKKMYGLIETYKLNGQFRWISSQMNRVRNGELYRVIC
ICVLKDRSKPIIFTMARLDRVKNITGLVEWYGKNAKLRELVNLVVVAGDRR-KESKDLEEKAEMKKMYEHIETYKLNGQFRWISSQMNRVRNGELYRVIC
ICVLKDRNKPIIFTMARLDRVKNITGLVEWYGKNAKLRELVNLVVVAGDRR-KESKDLEEKAEMKKMYEHIETYKLNGQFRWISSQMNRVRNGELYRVIC
LCVLKDRNKPIIFSMARLDRVKNLTGLVEWYGKNTRLRELVNLVVVGGDRR-KESKDLEEQSEMKKMHELIETYKLNGQFRWISSQMDRVRNGELYRYIA
LCVLKDRTKPILFTMARLDRVKNLTGLVEWYAKNPRLRGLVNLVVVGGDRR-KESKDLEEQAEMKKMYELIETHNLNGQFRWISSQMNRVRNGELYRYIA
LCVLKDRTKPILFTMARLDRVKNLTGLVEWYAKNPRLRGLVNLVVVGGDRR-KESKDLEEQAEMKKMYELIETHNLNGQFRWISSQMNRVRNGELYRYIA
LCVLKDRNKPIIFTMARLDRVKNLTGLVEWYAKNPRLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYELIKTHNLNGQFRWISSQMNRVRNGELYRYIA
LCVLKDRNKPIIFTMARLDRVKNLTGLVEWYAKNPRLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYELIKTHNLNGQFRWISSQMNRVRNGELYRYIA
LCVLKDKKKPILFTMARLDRVKNLTGLVELYAKNPKLRELVNLVVVGGDRR-KESKDLEEQAEMKKMYSLIETYNLNGQFRWISSQMNRVRNGELYRYIA
LCVLKDKNKPIIFTMARLDRVKNPTGLVELYAKSPKLRQLVNLVIVGGDRR-KESKDLEEQAEMKKMYNLIETYKLNGQFRWISSQMNRVRNGELYRCIA
ICVLKDRKKPIIFSMARLDRVKNMTGLVEWYGKNKKLRELVNLVVVAGDRR-KESKDTEEKEEMKKMYSLIEEYNLNGQFRWISAQMNRVRNGELYRYIA
VGTLSDRSKPILFSMARLDKVKNISGLVEMYSKNTKLRELVNLVVIAGNIDVNKSKDREEIVEIEKMHNLMKNYKLDGQFRWITAQTNRARNGELYRYIA
VGTLSDRSKPILFSMARLDKVKNISGLVEMYSKNTKLRELVNLVVISGNIDVNKSNDREEIAEIEKMDNLVKSYKLDGQFRWITAQTNRARNGELYRYIA
VGTLSDRSKPIVFSMARLDHVKNMTGLVECYGKNSRLRELVNLVVVAGYIDVNKSKDREEIAEIEKMHELMKTYKLDGQFRWIAAQTNRARNGELYRYIA
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255564236
313770763
3915037
225437428
162458268
242035817
115452927
241896730
304651490
29289943
115310620
4468153
345286419
4468151
151176306
14530225
15239816
297795665
225431790
255551835
168009716
168035060
168058907
168029793
94266940
94264333
297569306
254416162
332712456
17232477
75908500
186682280
119512682
334117431
218440696
159031025
220907171
22298591
158339122
284053161
209523126
17228554
75909957
186685043
119510624
298489784
220909283

IGTLKDKSKPLIFSMARLDRVKNITGLVEMYGKNAKLRELVNLVIVAGYIDVKKSKDREEIAEIEKMHDLMKKYNLEGQFRWITAQTNRARNGELYRYIA
IGTLTDKSKPIIFSMARLDRVKNISGLVECYGKNARLRELVNLVVVAGYIDVKKSNDREEILEIEKMHELMKKYKLDGQFRWLTAQTNRARNGELYRYIA
IGSLTDRSKPIIFSMARLDRVKNITGLVESYAKNSKLRELVNLVVVAGYIDVKKSSDREEIEEIEKMHDLMKQYNLNGEFRWITAQTNRARNGELYRYIA
IGMLNDRSKPIIFSMARLDQVKNITGLVECYAKNAKLREMANLVVVAGYNDVKKSNDREEIVEIEKMHDLMKEYNLHGQFRWMSSQTNRARNGELYRYIA
IGHLDDRSKPILFSMARLDRVKNITGLVEAFAKCAKLRELVNLVVVAGYNDVNKSKDREEIAEIEKMHELIKTHNLFGQFRWISAQTNRARNGELYRYIA
IGHLDDRSKPILFSMARLDRVKNITGLVEAFAKCTKLRELVNLVVVAGYNDVKKSKDREEIAEIEKMHELIKTYNLFGQFRWISAQTNRARNGELYRYIA
IGHLDDRSKPILFSMARLDRVKNITGLVEAYAKNARLRELVNLVVVAGYNDVKKSKDREEIAEIEKMHELIKTYNLFGQFRWISAQTNRARNGELYRYIA
IGHLDDPSKPILFSMARLDRVKNMTGLVKAYSKNAKLRSLVNLVVVAGYNDVKKSKDREEIAEIEKMHELIKTYNLFGQFRWISAQTNRVRNGELYRYIA
IGSLNDQSKPIIFSMARLDRVKNITGLVECYAKNATLRELANLVVVAGYNDVKKSNDREEIAEIEKMHALMKEHNLDGQFRWISAQMNRARNGELYRYIA
IGNLNDQSKPIIFSMARLDRVKNITGLVECYAKNATLRELANLVVVAGYNDVKKSNDREEIAEIEKMHALMKEHNLDGQFRWISAQMNRARNGELYRYIA
IGTLKDASKPIIFSMARLDRVKNITGLVECYAKNAELRELANLVVVAGYNDVKKSSDREEISEIEKMHMLMKEYNLDGEFRWIAAQTNRARNGELYRYIA
IGVLNDQSKPIIFSMARLDKVKNITGLVEMYAKNAKLRELANLVVVAGYNDVKKSSDREEIAEIEKMHSLIKEYKLDGQLRWISSQTNRVRNGELYRYVA
VGFLEDPSKPIIFSMARLDRVKNISGLVELYAKNARLRELANLVVVAGYIDVKKSSDREEISEIEKMHALIKQYDLDGQLRWISAQTNRARNGELYRYIA
IGVLKDRSKPIIFSMARLDRVKNITGLVEMYAKNKKLRELTNLVVVAGYNDVKKSSDREEKDEIEKMHNLIDQYDLNGSLRWISAQSNKARNGELYRYIA
IGVLDDTSKPIIFSMARLDRVKNITGLVECYGKNAKLRELANLVVVAGYNDVKKSNDREEIAEIEKMHRLIQEYNLRGQFRWIASQTNRVRNGELYRYIC
IGVLDDTSKPIIFSMARLDRVKNITGLVECYGKNAKLRELANLVVVAGYNDVKKSNDREEIAEIEKMHRLIQEYNLRGQFRWIASQTNRVRNGELYRYIC
VGLLSDQSKPIIFSMARLDRVKNLTGLVECYAKNSKLRELANLVIVGGYIDENQSRDREEMAEIQKMHSLIEQYDLHGEFRWIAAQMNRARNGELYRYIA
VGLLSDQSKPIIFSMARLDRVKNLTGLVECYAKNSKLRELANLVIVGGYIDVNQSRDREEMAEIQKMHSLIEQYDLHGQFRWIAAQMNRARNGELYRYIA
IGMLSDRSKPIIFSMARLDRVKNITGLVECFGKSSKLRELVNLVVVAGYIDVTKSRDREETKEIEKMHDLIKKYNLHGQFRWIPAQMNRARNGELYRYIA
IGYLTDQSKPIIFSMSRLDRVKNLTGLVEWYGKSSKLRELVNLVVVGGSMDVNKSRDREEMAEIKKMHGLITEYNLAGQFRWVAAQMNRARNGELYRYIA
IG-VIDKSKPILFTMARLDKVKNLTGLVELYGKNNKLKELTNLVIVGGEINPAKSKDREEVKEIAKMHDFIKEYNLHNSFRWIRSQTNRVQNGELYRYIA
VG-IIDKDKPILFTMARLDRVKNLTGLVELYGKNEKLREMTNLVIVGGEIDPAKSKDREEVKEIEKMHSFIKQYNLHNHFRWIRSQTNRVQNGELYRYIA
IG-LIDKEKPILFSMARLDRVKNLTGLVEMYGKNQKLKEFVHLVIVGGEINPSKSKDREEVREIEKMHNLIKRYKLENNFRWIRSQTNRIRNGELYRYIA
IGSLKDRNKPILFSMARLDKVKNISGLVEMFAKNPRLRELVNLVVVAGNIQKEKSKDREEMAEIDKMHNLMKEYELDGDFRWLCAQTDRVLNGELYRYIA
LGRLAEPDKPLLFTIARLDRIKNLTGLVEAYGRDSELRQRVNLVMVASVIDPQRSQDPEEAAEIRRMHEILEQYQLYGQVRWIGKFLGKVETGEAYRLVA
LGRLAEPDKPLLFTIARLDRIKNLTGLVEAYGRDSELRQRVNLVMVASVIDPQRSQDPEEAAEIRRMHEILEQYQLYGQVRWIGKFLGKVETGEAYRLVA
LGRLENLDLPPLFTIARLDRIKNLTGLVEAYGQDEELRRRVNLIMVASVTDPERSKDAEEAAEIRKMHGIIEQYGLRGQVRWVGKFLGKAETGEAYRIMA
YGKLDDPTKRPLFSIARLDRIKNLTGLTECFGKSKALQEQCNLIFVAGKLRTEDSTDNEEKDEIVKLYRLIDEYNLHGKIRWLGVRLPKLDSGEIYRVIA
FGKLDYPNKRPIFSMARLDRIKNLTGLAECFGKSRKLQERCNLILIAGNLRTEDSSDSEEKAEIIKLYQIIEEYNLYGKIRWLGVRLSKSDSGEVYRVIA
FGKLDDPNKRPIFSMARLDRIKNLTGLAECFGQSQELQERCNLILVAGKLRIEESEDNEEKDEIVKLYRIIDEYNLHGKIRWLGVRLSKNDSGEIYRVIC
FGKLDDPNKRPIFSMARLDRIKNLTGLAECFGKSKELQEHCNLILVAGKLRIEESEDNEERDEIVKLYRIIDEYNLHGKIRWLGVRLSKNDSGEIYRVIC
FGKLDDPNKRPLFSMARLDHIKNLTGLAECYGQSKELQEHCNLILVAGKLRVEESGDNEERDEIIKLYNIIDEYNLHGKIRWLGVRLSKTDSGEIYRVIA
FGKLDDPTKRPLFSVARLDRIKNLTGLAECYGKSPELQEHCNLILVAGKLRVEDSGDNEERDEIIKLYQIIEQYNLYGKIRWLGVRLTKSDSGEIYRVIA
FGKLDDPHKRPLFSMARLDRIKNMTGLAELFGKSPELQEKCNLILVAGKLRVEETEDYEEAEEIKKLYAIIDQYNLHGKIRWLGVRLSKSLSGEIYRVIA
FGKLDNPSKRPIFSMARLDRIKNLTGLAECFGRSPALQECCNLILVAGKLTVNESSDSEEREEIEKLYRIIDEHNLYGKIRWLGVRLPKADSGEIYRVIA
FGHLDNPDKRPLFSLARLDRIKNLTGLAECFGKSEALQEQCNLILVAGKLRAEDSTDREEISEIQKLYHLIDQYNLEGKIRWLGIMLPKADAGEIYRIIA
WGKLDHPDKRPLFSMARLDRIKNLTGLAEAFGQNPELQQHCNLILIAGKLRVEETIDHEEAMEIERLYEIIDRYQLTGKMRWLGVRLSKTDSGEVYRIIA
YGYLEAPEKRPLFSMARLDRIKNLTGLAEAFGRSKALQERCNLILVAGKLRTADSSDREEIAEIEKLYQIIHQYNLHGKIRWLGIRLPKADSGEIYRIIA
FGHLDNPGKPPLFSMARLDRIKNLTGLAECFGQHPQLQDHYNLILVAGKLRTSDSVDHEEINEIERLYRIIDQYNLHGKIRWLGVRFPKQDSGEIYRVVA
FGKLADPTKPPLFSVARLDRIKNITGLVECYGQHPELQEKANLIFIAGKLRVEDSSDYEEAEEIKKMYHLIEHYNLYDKVRWLGVRLSKTDTGEMYRVIA
FGKLADPTKPPLFSVARLDRIKNITGLVECYGQHPELQEKANLIFIAGKLRVEDSSDYEEAEEIQKMYHLIEHYNLYDKVRWLGVRLSKTDTGEMYRVIA
FGYLDQPQKPPIFAVAPITSIKNLTGLAECFGRSQELQAHSNLILLTSKLNIDESTNPEEAREIEKLHNIINQYQLHGHIRWLGLRLPNQEVGEAYRLVA
FGYLEQPQKPPIFAVAPITSIKNLTGLAECFGRSQELQAHSNLILLTSKLNIDETTNPEEAREIEKLHNIINQYQLQGHIRWLGLRLPNQEVGEAYRLVA
LGHLDRPNKRPIFSVSSISSIKNLAGLAECFGQSQRLQEHCNLILLSSKLHPDEATNPEEAEEIQKLHNIIDRYHLHSKIRWLGMRIPSSSLGEAYRVVA
IGKLDNPNKRPILTVAPITSVKNLTGLAECFAKNRGLQEHCNLIFITTKLYVNQATNPKEAEEIQRLHDIINQYELHGNIRCIGMRLPSPDLGEAYRVIA
LGNIDDIHKRPIFAVAPVTSIKNLTGLVECFGKSQELQTRCNLILLTSNLSVNEATYPEEAGEIDKLHNLIKEHHLQGKIRWLGMRLPSQKIGEAYRIIA
LGHLDQPEKKPLLTIAPISSIKNLTGLVECFGRSPELQNHCNLILITSKLHPSEASHAEEETEITQLHDLINQYQLHGRVRWLGLPLPHTDLGEIYRVVA
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VGYLNSPNQRPILSIAPLTSIKNLSGLVECFASSKELQQKCNLILITSHVRVEDATDPEEKGEIEKLNQLIKQYNLHGKIRWIGLRLTTPDIGESYRVIA
.
::::: .
*
:
:*:.:
:
:*
: :
. . *
.* :
.* ** :

114331077
30249199
82703384
198283392
344199811
255021595
77166514
300115586
292493898
350552412
220933364
350574485
95929190
298528445
297602308
115457664
326504012
115450038
326531526
242063616
42568160
297805240
313770765
313770767
255584097
225466221
313770769
313770771
255570671
15219457
297842089
115466896
17980243
162460741
239984690
162460681
242035533
62865493
17980241
115453437
115473359
3980298
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720
730
740
750
760
770
780
790
800
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
DKRGIFVQPALFEAFGLTIIEAMASG--------LPTFATRYGGPLEIIQHNRSGFHIDPNQGTATADLIADFLEKSHEKPLEWERLSQGALARVASRYT
DKRGIFVQPALFEAFGLTIIEAMASG--------LPTFATRYGGPLEIIQNNRSGFHIDPNQGAATADLIADFFEKNLENPQEWERISQGALDRVASRYT
DRRGIFVQPARFEAFGLTIIEAMASG--------LPVFATCYGGPREIIQHGVSGYHFDPNDGLAGASAMADFFERVAADPGFWDRISQKALQRVEARYT
DSRGCFVQPALFEAFGLTVIEAMSSG--------LPVFATRFGGPLEIIEDGISGFHIDPNNQQETAEKLADFLEAAAADIRVWETISDGALARVGAHYT
DTHGCFVQPALFEAFGLTVIEAMSSG--------LPVFATRFGGPLEIIEDGVSGFHIDPNNQQETAEKLADFLAAAAADIRVWETISDGALARVSTHYT
DGRGVFVQPALFEAFGLTVIEAMSSG--------LPVFATRFGGPLEIIEDGVSGFHIDPNDHEATAERLADFLEAARERPKYWLEISDAALARVAERYT
DSRGAFVQPALFEAFGLTVIEAMSSG--------LPTFATCYGGPLEIIQEGVSGFHIDPNHGEKAADRIADFFEHCQTEAGYWDKFSQGALRRIKNHYT
DSRGAFVQPALFEAFGLTVIEAMSSG--------LPTFATCYGGPLEIIQEGVSGFHIDPNHGEKVANRIADFFEHCQTEAGYWDRFSQGALHRIKNHYT
DSRGAFVQPALFEAFGLTVIEAMSSG--------LPTFATCYGGPLEIIQDEISGFHINPNHGEEAAGSIADFFERCQVEPEYWENLSQGALRRIRRRYT
DRRGVFVQPALFEAFGLTVIEAMVSG--------LPTFATHYGGPLEIIEHGQSGFHIDPMRGDQASAQLLAFLRECEQDPDYWVRISHGGMERVERHYT
DRRGVFVQPALFEAFGLTVIEAMASG--------LPTFATRYGGPLEIIEDGVSGYHIDPNHGEQAARILMEFLERCASDPDHWQQISRSAIRRVEQRYT
DHQGAFVQPALFEAFGLTVVEAMSCG--------LPTFATCYGGPSEIIEHGLSGFHIDPNHGDQAAALILEFFDACSQNPAHWQTFSTAAMARVQERYT
DQKGVFVQPALFEAFGLTVIEAMATG--------LPIFATQYGGPLEIIVDGKSGFHIDPNDNEEMAEKICTFFERAANHPQYWKVISDACITRVEENYT
DSRGAFVQPALFEAFGLTVVEAMNSG--------LPTFATIFGGPLEIIEDGKSGFHIDPTHGDEAAGLMANFFSRCRADASYWDTISNNSIKRVEEKYN
DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIIDGVSGFHVNPINGREAGIKIADFFQKCKEDPSYWNKVSTAGLQRIYEWQR
DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIIDGVSGFHVNPINDREAGIKIADFFQKCKEDPSYWNKVSTAGLQRICECYT
DSKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHINPMNGREAGTKIADFFQKCKEDPSYWNKMSTAGLQRIYECYT
DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDEVSGFHINPLNGKEASDKIADFFQKCKEDLIYWSKMSTAGLQRIYECYT
DTRGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVNEVSGFHINPLNGKESSDKIAAFFQKCKEDPTYWNKMSTAGLQRIYECYT
DTRGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDEVSGFHINPLDGKEASNKIANFFQKCNEDPMYWNRMSTAGLQRIYECYT
DTRGAFVQPAHYEAFGLTVIEAMSCG--------LVTFATNQGGPAEIIVDGVSGFHIDPSNGEESSDKIADFFEKSGMDPDYWNMFSNEGLQRINECYT
DTRGAFVQPAHYEAFGLTVIEAMSCG--------LVTFATNQGGPAEIIVDGVSGFHIDPSNGEESSDKIADFFEKSGTDLDYWNMFSTEGLQRINECYT
DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPSEIIVDGISGFHIDPKNGDESSNIIADFFEKCKVDPGHWNKYSLEGLKRINECYT
DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGISGFHIDPQNGDESSNIIADFFEKCKVDPGYWNKFAAEGLKRINECYT
DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIIDGVSGFLIDPNNGDESSNKIADFFEKCKIDAEYWNKFSEDGLKRINECYT
DTKGAFVQPAIYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHIDPNIGDESSNKIADFFEKCRDDSDHWNKISKAGLQRINECYT
DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEILVDGISGFHIDPNNGDESSNKIADFFEKCKTDAEYWNKMSAAGLQRIYECYT
DTKGAFIQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGISGFHIDPNNGDESSNKIADFVEKCKTDAEYWNKMSATGLQRIYECYT
DTKGAFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHIDPNNGNESSNKIADFFEKCKADPECWNKMSAAGLQRIHECYT
DTKGVFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHIDPNNGDESVTKIGDFFSKCRSDGLYWDNISKGGLKRIYECYT
DTKGVFVQPALYEAFGLTVIEAMNCG--------LPTFATNQGGPAEIIVDGVSGFHIDPNNGDESVTKIGDFFSKCSSDGLYWDNISKAGLKRIYESYT
DTKGVFVQPAFYEAFGLTVIEAMTCG--------LPTIATCHGGPAEIIVDGVSGLHIDPYHSDKAADILVNFFEKCKQDSTYWDNISQGGLQRIYEKYT
DTKGVFVQPAFYEAFGLTVIESMTCG--------LPTIATCHGGPAEIIVDGVSGLHIDPYHSNKAADILVNFFEKCKEDPTYWDKISQGGLKRIYEKYT
DTKGAFVQPAFYEAFGLTVIESMTCG--------LPTIATCHGGPAEIIVDGVSGLHIDPYHSDKAADILVNFFDKCKADPSYWDEISQGGLQRIYEKYT
DTKGAFVQPAFYEAFGLTVIEAMTCG--------LPTIATCHGGPAEIIVDGVSGLHIDPYHSDKAADILVNFFEKSTADPSYWDKISQGGLKRIYEKYT
DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATAYGGPAEIIVHGVSGYHIDPYQGDKASALLVDFFDKCQAEPSHWSKISQGGLQRIEEKYT
DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATAYGGPAEIIVHGVSGFHIDPYQGDKASALLVDFFEKCQTDSSHWNKISQGGLQRIEEKYT
DTKGAFVQPAFYEAFGLTVVESMTCG--------LPTFATAYGGPAEIIVHGVSGFHIDPYQGDKASALLVEFFEKCQQDHSHWTKISQGGLQRIEEKYT
DTRGAFVQPAFYEAFGLTVVESMSCG--------LPTFATAYGGPAEIIVHGVSGFHIDPYQGDKASALLVEFFEKCQQDPAHWTKISQGGLQRIEEKYT
DTKGAFVQPAFYEAFGLTVVESMTCG--------LPTFATAYGGPAEIIVNGVSGFHIDPYQGDKASALLVEFFEKCQEDPSHWTKISQGGLQRIEEKYT
DMRGAFVQPALYEAFGLTVIEAMTCG--------LPTFATAYGGPAEIIVHGVSGYHIDPYQNDKASALLVEFFEKCQEDPNHWIKISQGGLQRIEEKYT
DMKGAFVQAAFYEAFGLTVIEAMTCG--------LPTFATAYGGPAEIIVNGVSGYHIDPYQNDKASALLVDFFGKCQEDPSHWNKISQGGLQRIEEKYT
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15242073
297812265
22331535
297818772
313770759
313770761
255550319
324984223
258489633
324984221
324984229
6683114
4584690
3915046
3766299
3377764
225444613
3660531
31455440
304651488
28629438
115310618
345286417
38425095
15235300
297814081
6682841
255564236
313770763
3915037
225437428
162458268
242035817
115452927
241896730
304651490
29289943
115310620
4468153
345286419
4468151
151176306
14530225
15239816
297795665
225431790
255551835

DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCKGGPAEIIVHGKSGFHIDPYHGDQAADTLADFFTKCKEDPSHWDEISKGGLQRIEEKYT
DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCKGGPAEIIVHGKSGFHIDPYHGDQAANTLADFFTKCKEDPSHWDEISKGGLQRIEEKYT
DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFHIDPYHGDKAAESLADFFTKCKHDPSHWDQISLGGLERIQEKYT
DTKGAFVQPALYEAFGLTVVEAMTSG--------LPTFATCNGGPAEIIVHGKSGFHIDPYHGDQAAETLADFFTKCKHDPSHWDQISLGGLERIQEKYT
DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVNGKSGFHIDPYHGEKAAELLVDFFEKCKVDPAHWDKISHGGLQRIQEKYT
DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFHIDPYHGVQAAELLVDFFEKCKADPSYWDKISQGGLQRIQEKYT
DTKGVFVQPALYEAFGLTVVESMSCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAAELLVEFFEKCKADPCVWDEISKGGLQRIQEKYT
DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAADILVDFFEKCKKDPSHWDKISQGGLKRIEEKYT
DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAADILVDFFEKCKKDPSHWDKISQGGLKRIEEKYT
DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAADILVDFFEKCKKDPSHWDKISQGGLKRIEEKYT
DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFNIDPYHGDQAADILVDFFEKCKKDPSHWDKISQGGLKRIEEKYT
DTKGAFVQPALYEAFGLTVVEAMTCG--------LPTFATCKGGPAEIIVNGKSGYHIDPYHGEQAAEILVDFFEKCKADPSYWDKISLGGLKRIEEKYT
DTKGAFVQPAVYEAFGLTVVEAMATG--------LPTFATLNGGPAEIIVHGKSGFHIDPYHGDRAADLLVEFFEKVKVDPSHWDKISQGGLQRIEEKYT
DTKGAFVQPAVYEAFGLTVVEAMATG--------LPTFATLNGGPAEIIVHGKSGFHIDPYHGDRAADLLVEFFEKVKADPSHWDKISQGGLQRIEEKYT
DTKGAFVQPAVYEAFGLTVVEAMATG--------LPTFATLNGGPAEIIVHGKSGFHIDPYHGDRAADLLVEFFEKVKTDPSHWDKISQGGLQRIEEKYT
DTKGAFVQPAVYEAFGLTVVEAMATG--------LPTFATLNGGPAEIIVHGKSGFHIDPYHGDRAADLLVEFFEKVKTDPSHWDKISQGGLQRIEEKYT
DTKGVFVQPAFYEAFGLTVVEAMTCG--------LPTFATCNGGPAEIIVHGKSGFHIDPYHGDKAAELLANFFEKCKADPTHWEKISKAGLKRIEEKYT
DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATNHGGPAEIIVHGKSGFHIDPYHGEQAADLLADFFEKCKKEPSHWETISTGGLKRIQEKYT
DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATNHGGPAEIIVHGKSGFHIDPYHGEQAADLLADFFEKCKKEPSHWETISTGGLKRIQEKYT
DTRGAFVQPAFYEAFGLTVVEAMSCG--------LPTFATNQGGPAEIIVHGKSGFQIDPYHGEQAADLLAEFFEKCKVDPSHWEAISKGGLKRIQEKYT
DTRGAFVQPAFYEAFGLTVVEAMSCG--------LPTFATNQGGPAEIIVHGKSGFQIDPYHGEQAADLLADFFEKCKVDPSHWEAISEGGLKRIQEKYT
DTRGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATNHGGPAEIIIHGKSGFHIDPYHGEQVSELLANFFERCKKEPSYWDTISAGGLKRIQEKYT
DTKGAFVQPAFYEAFGLTVVEAMTRG--------LPTFATLHGGPAEIIVDGKSGFHIDPYNGEQVAETLVSFFEKCNKDPSHWEAISTGGLKRIQEKYT
DTRGAFVQPAYYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIVHGKSGFHIDPYHGDKAADLLVDFFEKSTADPSYWENISKGGLQRIEEKYT
DTRGAFAQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEHGLSGFHIDPYHPEQAGNIMADFFERCKEDPNHWKKVSDAGLQRIYERYT
DTRGAFAQSIRLLAMKTCILRGFWAYGSGSDDLRASDFRHLSGGPAEIIEHGLSGFHIDPYHPEQAGNIMADFFERGREDPNHWKKVSDAGLQRIYERYT
DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEHGASGFHIDPYHPDQAAELMADFFGKCKENPSHWKKISDGGLKRIYERYT
DTKGAFVQPAFYEAFGLTVVEAMTSG--------LPTFATCHGGPAEIIVDGVSGFHIDPYHPDQAAAIMADFFQQCKEDPSHWNKISDAGLQRIYERYT
DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEHGVSGFHMDPYYPDQAAEFMADFFEKCKDDPSYWKKISDAGLQRIYERYT
DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATNHGGPAEIIEHGVSGFHIDPYHPDQASELLVDFFQRCKEDPNHWNKVSDGGLQRIYERYT
DTRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIENGVSGFHIDPYHPDQVATTMVDFFEKCKEDSSHWNKISDAGLQRIYERYT
DTHGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATLHGGPAEIIEHGVSGFHIDPYHPEQAANLMADFFDRCKQDPDHWVNISGAGLQRIYEKYT
DTHGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATLHGGPAEIIEHGISGFHIDPYHPEQAANLMADFFERCKQDPNHWVKISEAGLKRIYEKYT
DTHGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATVHGGPAEIIEHGISGFHIDPYHPDQAANLIADFFEQCKQDPNHWVEVSNRGLQRIYEKYT
DTHGAFVQPALYEAFGLTVVEAMTCG--------LPTFATLHGGPAEIIEHGISGFHIDPYHPDQAATLMADFFGQCKQDPNHWVKISDKGLQRIYEKYT
DKRGIFVQPAYYEAFGLTVVEAMTCG--------LPTFATCHGGPMEIIQDGVSGYHIDPYHPNKAAELMVEFFQRCEQNPTHWENISASGLQRILDRYT
DKRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPMEIIQDGVSGYHIDPYHPNKAAELMVEFFQRCEQNPTHWENISASGLQRILDRYT
DKRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPKEIIEDGISGFHIDPYHPDKDSAAMVNFFQRCKEDPKYWEKISRGGLQRIYERYT
DTRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATSHGGPMEIIEDRISGFHIDPYHPEKAADLMADFFGKCNEDPSYWVKISEAALRRIQERYT
DKRGIFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPLEIIEDGISGFHIDPYHPDKSALLMADFFEKRNEDPSYWVKISEAALRRIQERYT
DKRGIFVQPAFYEAFGLTVVEAMTCG--------LPAFATLHGGPHEIIEDGVSGFHIDPYHAEKAATRMADFFAKCDDDPSYWVKISEQALQRIRECYT
DKGGIFAQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEDGVSGFHIDPYHADQAAEKMTEFFVKCREDPNYWTKISAGGLLRIKERYT
DKGGIFAQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEDGVSGFHIDPYHADQAEK-MTEFFVKCREDPNYWTKISAGGLLRIKERYT
DTKGVFVQPAFYEAFGLTVVESMTCA--------LPTFATCHGGPAEIIENGVSGFHIDPYHPDQVAATLVSFFETCNTNPNHWVKISEGGLKRIYERYT
DTKGVFVQPAFYEAFGLTVVESMTCG--------LPTFATCHGGPAEIIENGVSGFHIDPYHPDQVAATLVSFFETCNTNPNHWVKISEGGLKRIYERYT
DTKGAFVQPAFYEAFGLTVVEAMTCG--------LPTFATCHGGPAEIIEDGLSGFHIDPYHPDQVALRLADFFERCQKDPSYWDEISNGGLKRIYERYT
DAKGVFVQPAFYEAFGLTVIEAMTCG--------LPTFATCHGGPAEIIEHGTCGFHIDPHHPDQAASLLINFFERCKEDPSYWNTISDGGLKRIYERYT

110

168009716
168035060
168058907
168029793
94266940
94264333
297569306
254416162
332712456
17232477
75908500
186682280
119512682
334117431
218440696
159031025
220907171
22298591
158339122
284053161
209523126
17228554
75909957
186685043
119510624
298489784
220909283
332708740
Clustal Consensus

EAGGVFVQPALYEGFGLTVVEAMTCG--------LPTFATLHGGPAEIIEHGISGFHIDPYHPDEVADELVTFFEKVKSDSSFWTKISEAALQRIYSSFT
DAGGVFVQPALYEGFGLTVVEAMTCG--------LPTFATMHGGPAEIIVNGISGFHIDPYHPEGVAEVLVSFFEKVKTDPGVWTRISEAALQRIYSNFT
DSQGAFVQPALYEGFGLTVVEAMTSG--------LPTFATSHGGPAEIIEHGISGYHIDPYYPDEAAEQIVAFFEKCKNEPGLWNKVSEAGLQRIYSSYT
DSHGAFVQPALYEGFGLTVIEAMTCG--------LPTFATCHGGPKEIVVSDVSGFHIDPFHPESASKIIVDFFERCTKEKDYWTKLSDGGLERIRTKYT
DRGGVFVQPALFEAFGLTILEAMHSG--------LPVFATQFGGPLEIIEHEHSGFLINPTDPQAMTARLNEFFAACQADPRHWQGFSQRGLERARSRFT
DRGGVFVQPALFEAFGLTILEAMHSG--------LPVFATQFGGPLEIIEHEHSGFLINPTDPQAMTARLNEFFAACQADSRHWQGFSQRGLERARSRFT
DRRGVFVQPALFEAFGLTILEAMHSG--------LPVFATQFGGPLEIIEHEKSGFLINPTDQPAMTARLREFFHHCEENPRYWQGFSQRALERARERFT
DHRGIFVQPALFEAFGLTILEAMISG--------LPTFGTQFGGPLEIIQDKVNGFLINPTNLEETAQKILEFLSKCEQNPDYWLEISNRGMERVYSTYT
DRHGIFVQPALFEAFGLTILESMISG--------LPTFGTQFGGPLEIIQDKVNGILINPTNQEEMAQKILDFVTKCEENPQYWEEISNQGIERVYSTYT
DRQGIFVQPALFEAFGLTILESMISG--------LPTFATQFGGPLEIIQDKINGFYINPTHLEETATKILDFVTKCEQNPNYWNIISEKAIDRVYSTYT
DRQGIFVQPALFEAFGLTILESMISG--------LPTFATQFGGPLEIIQDQINGFYINPTHLEETATKILDFVTKCEHNPNYWKIISEKAIDRVYSTYT
DRQGIFVQPALFEAFGLTILESMVSG--------LPTFATQFGGPLEIIQDKVNGFLINPTNLDETATKIVDFITKCEQNPNYWNEISQRGIDRVYSTYT
DRKGIFVQPALFEAFGLTILESMVSG--------IPTFATQFGGPLEIIQDKVNGFYINPTNLEETAEKILEFVTKCEQSSHYWDAVSEEAIKRVLTTYT
DTQGIFVQPALFEAFGLTILEAMITG--------IPTFGTQFGGPLEIIQDGVNGFYINPTNHEDTAQKILDFLSKCEHNPNYWYEISTRGIDRVYSTYT
DRRGVFVQPALFEAFGLTILEAMISG--------LPTFATQFGGPLEIIQDKVNGFYINPTNLEETADKILEFVTKCDHNPDHWIQLSNKAMERVYSTYT
DRQGIFVQPALFEAFGLTVLEAMITG--------LPIFATEFGGPREIIQHGANGFLINPTHPEETATMILDFLAKCRQDPDYWREISEQAIQRVYSHYT
DHQGIFVQPALFEAFGLTILEAMITG--------LPTFATQFGGPLEIIQEGVNGFLINPTQPEATAAKILQYVRQCEDNPQTWQSISERAIERVYSTYT
DRQGIFVQPALFEAFGLTILEAMISG--------LPTFGTRFGGPLEIIQDGVNGFYINPTHLEEMAETIVRFLEACDRDPQEWQRISKAGIERVYSTYT
DHKGIFVQPALFEAFGLTVLEAMISG--------LPTFATRFGGPLEIIRDGIDGFYINPTHNEEIATKLLEFAKECATNPDYWQQISEQAIERVYTTYT
DHHGIFVQPALFEAFGLTILEAMISG--------LPTFATQFGGPLEIIKDKINGFYINPTNYDETAAKLDEFLVRCQYNIGFWNEISQRGMDRVYSSYT
DHHGVFVQPALFEAFGLTILEAMISG--------LPTFATQFGGPLEIIKDKINGFYINPTNYDETAAKLDEFLLRCQYNIGFWNEISQRGMDRVYSSYT
DYRGIYIHFARFEAFGRSILEAMISG--------LPTFATKFGGSLEIMEDQNNGFRINPTDLEGTAEKILAFFQECDTHPEHWQEVSQWMSQRIHQKYN
DYRGIYLHFARFEAFGRSILEAMISG--------LPTFATKFGGSLEILEDQNNGFRINPTDLEGTAEKILAFFQECDTHPEHWQEVSQWMSQRIHQKYN
DCQGISVHFARFESFGRSILEAMISG--------LPTFATQFGGSLEIIENQEEEFNVNPTDLVETAKKILDFFEKCNTHPEHWQEVSEWMSQRVHNRYN
DAQGIYVHFARFESFGRSILEAMVSG--------LPTFVTKFGGAVEIIQDQEETFHINPTDFKATAHQILNFIDQCETQPERWTEVSQMMSQRVINKYN
DYQGIYIHFALYEAFGRSILEAMISG--------LPTFATKFGGSSEILEDLQTGFHLNPTNLERTAKTILNFLDKCDANPEYWQETSQWMIQRIRHKYN
DQRGFFVHFARFEAFGQTILEAMISG--------LPAFATQFGGCLEIIQDGENGFHINPTDPEGTVKKILAFIHACAADPTYWQGISERAIERVQQQYN
DLGGFLVHPARFEAFGLTVLEAMISG--------LPTFATQFGGPSEIIQNGDNGFLINPTDLQDTAEKIQQFISKCEHTPDYWQKISQAGIKRVRDKYN
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114331077
30249199
82703384
198283392
344199811
255021595
77166514
300115586
292493898
350552412
220933364
350574485
95929190
298528445
297602308
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WKLYAERMMTLSRIYSFWKFVS-GLEREETDLYLNMFYHLQFRPLANRLAGDA----------------------------------------------WKLYAERMMTLSRIYGFWKFVS-GLEREETDRYLNMFYHLQFRPLANRLAHEI----------------------------------------------WRLYAERMMTLSRIYGFWKFVS-KLEHEETARYLNMFYHLQFRPMAQALPQ------------------------------------------------WGNYAAQMMTLARIFGFWRFML-KADRHAARRYLQMFQHLQWRPLAHAVPLGES---------------------------------------------WGNYATQMMTLARIFGFWRFML-KTDHHAARRYLQMFQHLQWRPLAHAVPLGES---------------------------------------------WERYAERLMTIARIFGFWRFVL-DRESQVMERYLQMFRHLQWRPLAHAVPME-----------------------------------------------WELYAERMMTLSRIYGFWKYVT-NLERAERRRYLEMFYNLQFRPLAQQIEH------------------------------------------------WELYAERMMTLSRIYGFWKYVT-NLEREERRRYLEMFYNLQFRPLAQQMEH------------------------------------------------WDLYAERMMTLSRIYGFWKYVT-NLEREESRRYLEMFYNLQFRPLAQQMEH------------------------------------------------WSLYAQRMMTLSRIYGFWKYVT-NLERAEARRYLEMFYALQYRPLARSLTGE-----------------------------------------------WKLYAERMMTLSRIYGFWKYVT-NLERAETRRYLEMFHALQYRPLALLK--------------------------------------------------WRRYAERMMTLSRVYGFWKYVT-DLERAETSRYLEMFYTLKLRPLAKAIQG------------------------------------------------WSLYARRLLTLSRVYGFWKYVS-NLEREETRRYLEMFHGLMFRNLASETQ-------------------------------------------------WRLYAQRLLSFSRIYGFWKYVS-NLERDETRRYLDMFYSLKMRSLSH----------------------------------------------------LWQEQGINRLGKPQQAWRLKAA-DSDAKDLNQVSRAEASSF-----------------------------------------------------------
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115457664
326504012
115450038
326531526
242063616
42568160
297805240
313770765
313770767
255584097
225466221
313770769
313770771
255570671
15219457
297842089
115466896
17980243
162460741
239984690
162460681
242035533
62865493
17980241
115453437
115473359
3980298
15242073
297812265
22331535
297818772
313770759
313770761
255550319
324984223
258489633
324984221
324984229
6683114
4584690
3915046
3766299
3377764
225444613
3660531
31455440
304651488

WKIYATRVLNMGSTYSFWKTLN-KEERQAKQRYLQIFYNVQYRNLAKAMARAGDQQARQTTTG---VAPSEIVVRPKERKPQTRMQRILTRLAGQKPPVS
WKIYATKVLNMGSMYGFWRTLN-KEERVAKQRYMQMFYNLQYRNLVKTVPRVGEQPPRPAASTGAVAERNQIVARPRERKPQGRVQRMMTSLLGPKPPTY
WQIYATKVLNMASIYGFWRTLD-KEERQAKQHYLHMFYNLQFRKLAKNVPTLGEQPAQ----PTESAEPNRIIPRPKERQVCPFLRNLLKKETGNN---WQIYATKVLNMGSMYGFWRTLN-KEERQAKQLYLQMFYNLLFRQLVKTVPKLGEQPAQ----PTTAP--ARIAPRPRERRPQTRIQRIATSLLGPVLPTS
WQIYATKVLNMGSMYGFWRTLD-KEEKQAKQQYLQMFYNLHFRKLANAVPKVGEQPEQ----ATAVPLPDRSAPRPKERQVCPLLRNLLKIKWGSN---WKIYANKVINMGSTYSYWRHLN-KDQKLAKQRYIHSFYNLQYRNLVKTIPILSDIPEPPPLPPKPLVKPSASKGSKRTQPRLSFRLFGA----------WKIYANKVINMGSTYSYWRYLN-KDQKLAKQRYIHSFYNLQYRNLVKNIQILSDIPQPPPPPPKPLVKPSASKGSRRTQSRLSFRLFGA----------WKIYANKLLNMGNVYSFWRQLN-KEQKLAKQRYIQLFFNLKFRELVQSVPIPTEEAQTPASEPTARTQSSAR---------------------------WKIYAKKLLNMGNMYSFWRQLN-KEQKLAKQRYIQMLYNLQFRRLVVWSLSCNQEAWIRTAIILCHLTLLNMFIHNVFYLLLSEFNFSVYDH-------WKIYANKVLNMGCIYTYWRQMN-KEQKQAKRRYIQLFYNLQLRKLVKNVPIPTEEAQQQPAPKPVNKASSRQVP-------------------------WKIYANKVLNMGCVFSFWRQLN-TEHKQAKQKYIHMFYTLQFRNLVKNIPIPASEVQPPVSRAITKHHHQALTVSTGKVKPKSQLTDYPASAFSQVKNDL
WKIYANKVLNMGSVYGFWRQTN-KEQKLAKQRYIEAFYNLQFNNLVGYCGQLVL---------------------------------------------WKIYANKVLNMGSVYGFWRQMN-KEQKLLKQRYIEAFYNLQFRNLVGYFRQLVT---------------------------------------------WKIYANKVLNMGSVYGFWRQLN-KEQKHAKQRYIETFYNLHFRNLVKNVPIASVGPQKQPSSSAGTSKTQEPSPPATTKSSQSQPTPKPKRKEESQKEKP
WKIYAEKLLKMGSLYGFWRQVN-EDQKKAKKRYIEMLYNLQFKQLTKKVTIPEDKPLPLRLASLRNLLPKKTTNLGAGSKQKEVTETEKTKQKSKDGQEQ
WKIYAEKLLKMGSIYGFWRQVN-EDQKKAKQRYIELLYNLQFKQLTKKVTIPEDKPLPLRLASLRNLLPKKTTPLGAGSKQKEVTEAEKTKQKSKDGQEQ
WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYIEMFYALKYRSLASAVPLAVDGESTSK---------------------------------------WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMFYALKYRSLASAVPLAVDGDSAAN---------------------------------------WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYIEMFYALKYRSLASQVPLSFD---------------------------------------------WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMFYALKYRSLAAAVPLAVDGESSGN---------------------------------------WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRTMASTVPLAVEGEPSSK---------------------------------------WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRTMASTVPLAVEGEPSSK---------------------------------------WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRTMASTVPLAVDGEPSSK---------------------------------------WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRKMASTVPLAVEGEPSNK---------------------------------------WKLYSERLMTLTGVYGFWKYVS-NLERRETRRYLEMLYALKYRTMASTVPLAVEGEPSNK---------------------------------------WKLYSERLMTLSGVYGFWKYVT-NLDRRETRRYLEMLYALKYRKMATTVPLAIEGEASTK---------------------------------------WKLYSERLMTLSGVYGFWKYVS-NLDRRETRRTLKCSMPSSTAKWLQLSHWLLRARPRANDLSLPEK--------------------------------WQIYSQRLLTLTGVYGFWKHVS-NLDRLEARRYLEMFYALKYRPLAQAVPLAQDD--------------------------------------------WQIYSQRLLTLTGVYGFWKHVS-NLDHLEARRYLEMFYALKYRPLAQAVPLAQDD--------------------------------------------WQIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRPLAQAVPLAHEE--------------------------------------------WQIYSERLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRPLAQAVPLAQEE--------------------------------------------WQIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYMEMFYALKYRKLAESVPLTKE---------------------------------------------WKIYSQRLLTLTGVYGFWKHVS-NLDHRESRRYLEMFYALKYRKLADSVPLTIE---------------------------------------------WQIYSQRLLTLTGVYGFWKHVS-KLDRRESRRYLEMFYALKYKKLADSVPLTVE---------------------------------------------WKIYSERLLTLTGVYGFWKHVS-NLERRESRRYLEMFYALKYRKLAESVPLAEE---------------------------------------------WKIYSERLLTLTGVYGFWKHVS-NLERRESRRYLEMFYALKYRKLAESVPLAEE---------------------------------------------WKIYSERLLTLTGVYGFWKHVS-NLERRESRRYLEMFYALKYRKLAESVPLAEE---------------------------------------------WKIYSERLLTLTGVYGFWKHVS-NLERRESRRYLEMFYALKYRKLAESVPLAEE---------------------------------------------WKIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVE---------------------------------------------WTIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVE---------------------------------------------WTIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVE---------------------------------------------WQIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVEE--------------------------------------------WQIYSQRLLTLTGVYGFWKHVS-NLDRLESRRYLEMFYALKYRKLAESVPLAVEE--------------------------------------------WKIYSERLLTLAGVYGFWKYVS-NLDRRETRRYLEMFYALKYRKLAQSVPLAVEE--------------------------------------------WQIYSERLLTLAAVYGFWKHVS-KLDRLEIRRYLEMFYALKYRKMAEAVPLAAE---------------------------------------------WQIYSERLLTLAAVYGFWKHVS-KLDRLEIRRYLEMFYALKYRKMAEAVPLAAE---------------------------------------------WQIYSDRLLTLAAVYGFWKHVS-KLDRLEIRRYLEMFYALKFRKLAELVPLAVE----------------------------------------------
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28629438
115310618
345286417
38425095
15235300
297814081
6682841
255564236
313770763
3915037
225437428
162458268
242035817
115452927
241896730
304651490
29289943
115310620
4468153
345286419
4468151
151176306
14530225
15239816
297795665
225431790
255551835
168009716
168035060
168058907
168029793
94266940
94264333
297569306
254416162
332712456
17232477
75908500
186682280
119512682
334117431
218440696
159031025
220907171
22298591
158339122
284053161

WQIYSDRLLTLAAVYGFWKHVS-KLDRLEIRRYLEMFYALKFRKLAQLVPLAVE---------------------------------------------WQIYSDRLLTLAGVYGFWKCVS-KLDRQEIRRYLEMFYALKYRKLAEAVPLAVDQ--------------------------------------------WQIYSDRLLTLAGVYGFWKYVS-KLDRLEIRRYLEMFYALKYRKLAEAVPLAVE---------------------------------------------WKIYSDRLLTLAGVYGFWKYVS-NLDRREARRYLEMFYALKYKKLAESVPLAIEDAN------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLVKTVPSTADD--------------------------------------------WNIYSERLMTLAGVYGFWKYAS-KLERRETRRYLEMFYILKFRDLVKTVPLTADD--------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLVKSVPLASENQH------------------------------------------WKIYSERLLTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLVQTVPLAIDDQH------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLVKTVPLSIEDWH------------------------------------------WKIYSERLMTLAGVYSFWKYVS-KLERRETRRYLEMFYILKFRDLANSVPIAKG---------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLSRRETRRYLEMFYTLKFRDLAKSVPLAIDDQH------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLERLETRRYLEMFYILKFRELAKTVPLAIDQPQ------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRELAKTVPLAIDQPQ------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRELAKTVPLAVDEAH------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKLRELVKSVPLALDETH------------------------------------------WKIYSERLMTLAGVYGFWKLVS-KLERRETRRYLEMFYILKFRELVKSVPLAVDEKQ------------------------------------------WKIYSERLMTLAGVYGFWKLVS-KLERRETRRYLEMFYILKFRELVKSVPLAIDDKH------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKLRELVKSVPLAVDDQH------------------------------------------WKKYSERLMTLAGVYGFWKHVS-KLERRETRRYLEMFYILKFRELVNSVPYAVDGSD------------------------------------------WKIYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRELVTSVPLAVDGSA------------------------------------------WNIYSERLMTLAGVYSFWKYVS-KLERRETRRYLEMFYILKFRNLAKSVPYATE---------------------------------------------WQKYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLANSVPLATDEEPSTTDAVATFRGP------------------------------WQKYSERLMTLAGVYGFWKYVS-KLERRETRRYLEMFYILKFRDLANSVPLATDEEPSTTDAVATFRGP------------------------------WKKYSERLLTLAGVYAFWKHVS-KLERRETRRYLEMFYSLKFRDLANSIPLATDEN-------------------------------------------WKKYSERLLTLAGVYAFWKHVS-KLERRETRRYLEMFYSLKFRDLANSIPLATDEN-------------------------------------------WKIYTERLLTLAGVYGFWKHVS-KLERRETRRYLEMFYILKLKDLATSIPLAVDEH-------------------------------------------WKIYSKRLLTLAGVYGFWKHVS-KLERREIRRYLEMFYILKFNNLVKSIPLAVDDQQ------------------------------------------WKLYAERLMTLTRVYGFWKYVS-NLHRREARRYLEMFYTLKFRELVRSLTLPHPILHLHLQLHNRQLLYSICIVNSTFQLSTICGNLCDQVKTVPLSKDD
WKLYAERLMTLTHVYGFWKYVS-NLQRRESKRYLEMFYTLKYRELVRKSPCPTYSFFIVSNFLMKNLMASYKFQ-------------------------WKIYAERLMTLSAVYGFWKYVS-KLHRQEARRYLEMFYILKFRELARTVPLSKDDEDVLEKVEKKAQLGPGVGAIVGEAATAVEARKAVTGHT------WEIYAERLLTLSRVYGFWKFVS-KLGRRETRRYLEMFYILKFRELVKTVPVASDDKSYLKEQEKKV---------------------------------WQLHCRSLTRLTKVYGFWRYSISQQAKTRLNQYSEVLYHLYFKEQAANLL-------------------------------------------------WQLHCRSLTRLTKVYGFWRYSISQQAKTRLNQYSEVLYHLYFKERAANLL-------------------------------------------------WQRHCRELTRLTKVYGFWRYSTSQQAKMRLNQYSEVLYHLFYKARAEQIR-------------------------------------------------WKIHTSRLLSLARIYGFWNYTS-KEKREDLLRYIESLFYLIYKPRAQQLLEEHLKR-------------------------------------------WKIHTTRLLSLARIYGFWNYTS-KANQEDMLRYLEALFHLIYKPRAKKLLEEHLTLPARA---------------------------------------WKIHTTKLLTLARIYGFWNFTS-KEKREDLLRYLESLFYLIYKPRAQQLLEQHKYR-------------------------------------------WKIHTTKLLTLARIYGFWNFAS-KEKREDLLRYLESLFYLIYKPRAQQLLEQHKYR-------------------------------------------WKIHTSKLLSLARIYGFWNFTS-KENREDLLRYLEALFYLIYKPRAQQLLEQHKYR-------------------------------------------WKIHTTKLLSLARIYGFWNFTS-KENREDLLRYLEALFYLIYKPKAQELLEQHQHR-------------------------------------------WKIHTTKLLTLARTYGFWNYSS-KENREDMLRYIESLFYLIYKPKAKALLAEHANR-------------------------------------------WKIHTSKLLSLSRIYGFWNFIS-KENREDILRYVESLFYLLFKPRAKELLEQHMHR-------------------------------------------WKIHTTRLLSLARIYGFWNHTS-QENREELLRYIETLFYLLFKPRAQHLLEIHGQR-------------------------------------------WKIHTTRLLSLARTYGFWNYSL-QENREDLLRYIESLFYLLFKPRAQQLLAEHLQR-------------------------------------------WKIHCTRLLSLAKIYGFWNFSS-QENREDMMRYMEALFHLLYKPRAQALLAEHLQR-------------------------------------------WKIHTSRLLSLAKIYGFWNYTS-REKREDMLRYIETIFYLLYKPMAKKLLAKHMDS-------------------------------------------WKIHTSRLLTLTRVYGFWKYVS-KEKRADMMRYLEALFYLIYKPRCQELLQQHLQR--------------------------------------------
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209523126
17228554
75909957
186685043
119510624
298489784
220909283
332708740
Clustal Consensus

WKIHTSRLLTLTRVYGFWKYIS-KEKRADMMRYLEALFYLIYKPRSQELLQQHLQR-------------------------------------------WQLHTSQLLALTKIYSFWNFIR-PESSEARVRYMESLFHLIYKPRAEQILAKHMSCH------------------------------------------WQLHTSQLLALTKIYSFWNFIR-PESSEARVRYMESLFHLIYKPRAEQILAKHMSCH------------------------------------------WHLYSNQLLLLAKMFTFWNFVA-PENNEARDRYMETLFHLIYKPRAEKILEKHMGANS-----------------------------------------WHLHTSQILLLAKIFSFWNFAL-PENNAAKHRYLETLFYLIFKPRAEKILEKHQQYSVIMNH-------------------------------------WESYTEQLLLIAKIFSFWNFIV-PEANDARDRYMEILFHLIYKPRAEQIIGQHQQRYAHIYK-------------------------------------WPSHIRQLLLLTKIYGFWNCMA-QQQREALLNYMDALYHLIYKPRAAEILAQHLYR-------------------------------------------WQLHTKQLLSLAKIYGFWSETS-KESREALLRYLEALFYLIYKPRATNLLAKHRSR-------------------------------------------:

114331077
30249199
82703384
198283392
344199811
255021595
77166514
300115586
292493898
350552412
220933364
350574485
95929190
298528445
297602308
115457664
326504012
115450038
326531526
242063616
42568160
297805240
313770765
313770767
255584097
225466221
313770769
313770771
255570671
15219457
297842089
115466896
17980243
162460741
239984690

910
920
930
940
950
960
970
980
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------E----------------------------------------------------------------------------------EQNGYR----------------------------------------------------------------------------------------------------------------------------------------------------------------NFSQDAA-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------KPETITTRHVI------------------------------------------------------------------------HDVKVGEREVREGLLAADASERVKKVLESSEEKQKLEKMKIAYGQQHSQGASPVRNLFWSVVVCLYICYILKQRFFGANSAQEY
NDGKVGERDVSETFLAAEASERTKKVLETSEEKQKLEKMKIAYGQQQNQGASPVRNLFWSVVVCLYICYILKQRFFGANSAQEY
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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162460681
242035533
62865493
17980241
115453437
115473359
3980298
15242073
297812265
22331535
297818772
313770759
313770761
255550319
324984223
258489633
324984221
324984229
6683114
4584690
3915046
3766299
3377764
225444613
3660531
31455440
304651488
28629438
115310618
345286417
38425095
15235300
297814081
6682841
255564236
313770763
3915037
225437428
162458268
242035817
115452927
241896730
304651490
29289943
115310620
4468153
345286419
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4468151
151176306
14530225
15239816
297795665
225431790
255551835
168009716
168035060
168058907
168029793
94266940
94264333
297569306
254416162
332712456
17232477
75908500
186682280
119512682
334117431
218440696
159031025
220907171
22298591
158339122
284053161
209523126
17228554
75909957
186685043
119510624
298489784
220909283
332708740
Clustal Consensus
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SucSase sequences from P. patens subsp. patens (group IV) are clearly separated from
those of vascular plants (Figure 35). Interestingly, groups V and VII are further divided in
two major branches, containing the sequences from dicots (green) and monocots (blue),
respectively. This separation is less clear in group VI (Figure 35). SucSase from N.
europaea is in a small branch with other β-proteobacteria in group III (proteobacteria).
Clearly, NeuSucSase is well separated from plant and cyanobacterial enzymes, though
they share a significant similarity among all of them. For instance the identity between
NeuSucSase and AthSucSase is 52.2% and between NeuSucSase and SucSase from T.
elongatus is 48.5%.
Protein Expression and Characterization
The gene of the putative SucSase in N. europaea (NCBI Protein ID NP_841269)
codes for 794 amino acids. To shed light on Suc metabolism of group III (Figure 35), we
amplified this sequence and expressed the recombinant protein in E. coli cells. The
enzyme was purified to homogeneity by HisTrap column and gel filtration
chromatography as mentioned in “Materials and Methods”. The recombinant protein
migrated in SDS-PAGE as a single band of ~95 kDa (data not shown), which is in good
agreement with the predicted molecular mass of 93 kDa (including the His-tag provided
by the pET28c vector). NeuSucSase eluted from the Superdex 200 (size exclusion)
column as a protein of ~360 kDa (data not shown), suggesting a tetrameric quaternary
structure, as it was reported for cyanobacterial and plant SucSases 77, 80, 84.

\

118
Substrate Specificity of NeuSucSase
SucSases from plants have shown a certain degree of promiscuity to transfer
glucoses from ADP-Glc and UDP-Glc, though UDP-Glc is generally preferred. We tested
the substrate specificity of SucSase from N. europaea in the Suc synthesis direction
(Table 4), and observed that ADP-Glc is a more efficient substrate than UDP-Glc. The
main difference is not given by Vmax, but by a higher apparent affinity towards ADP-Glc.
The S0.5 for ADP-Glc is 0.044 mM in presence of optimal concentrations of Fru (20 mM);
whereas the S0.5 for UDP-Glc is 0.98 mM in presence of optimal concentrations of Fru
(500 mM). On the other hand, the apparent affinity for Fru is higher in presence of ADPGlc rather than UDP-Glc. The S0.5 for Fru at saturated concentrations of ADP-Glc is 5.6
mM whereas the S0.5 for Fru in presence of UDP-Glc is significantly higher. Because of
the high concentrations of Fru needed to reach saturation, it is not possible to measure the
S0.5 for Fru with high precision; but it is at least ~20-fold higher (120 mM). The catalytic
efficiencies calculated for ADP-Glc and Fru(ADP-Glc) were 17- and 37-fold higher than
those obtained for UDP-Glc and Fru(UDP-Glc), respectively (Table 4). These results indicate
that NeuSucSase prefers ADP-Glc over UDP-Glc as substrate. Similar conclusions were
obtained for the enzyme from the cyanobacterium T. elongatus, which showed a 26-fold
higher catalytic efficiency for ADP-Glc than UDP-Glc 77.
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Table 4. Kinetic parameters for substrates of NeuSucSase in the direction of sucrose
synthesis. Assays were performed using the conditions described in the “Materials and
Methods” section. Analogous values to catalytic efficiency (Vmax/S0.5) were calculated
using the predicted molecular mass of 93 kDa.
Substrate

S0.5
(mM)

Vmax
(U mg-1)

nH

Vmax/S0.5
(mM-1 s-1)

UDP-Glc

0.89 ± 0.05

4.3 ± 0.1

1.1

7.5

ADP-Glc

0.044 ± 0.006

3.7 ± 0.1

1.3

130.3

Fru(UDP-Glc)

120 ± 10

2.8 ± 0.2

1.3

0.036

Fru(ADP-Glc)

5.6 ± 0.4

4.8 ± 0.2

1.6

1.33

X-ray Diffraction, Data Processing, Model Building, and Refinement
The best data set collected at synchrotron beamline was processed to 3.05 Å and
indexed as space group P65. It was integrated and scaled producing good statistics (Table
5). After the molecular replacement search, four copies of the starting model described in
“Materials and Methods” were found in one asymmetric unit. Iterative cycles of model
building and refinement were conducted yielding a well-defined structure for
NeuSucSase with Rwork and Rfree values of 17.37 % and 21.75 %, respectively (Table 5).
The truncated GT-B(D) domain was built according to the electron density map. The
final structural model contains all the residues except the first three at the N-terminus and
the last two at the C-terminus of the NeuSucSase amino acid sequence (Figure 36).
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Figure 37. The crystal structure of NeuSucSase. A. Tetrameric structure of NeuSucSase.
B. Monomeric structure and its four different domains: SSN-1, SSN-2, GT-B(A), and
GT-B(D).
Structural Analysis of NeuSucSase
Overall structure. Although the resolution of the data set was 3.05 Å, the backbone of the
protein and some of the key residues side chains were well defined by the electron
density (Figure 38 and Figure 39). This allowed us to conduct detailed structural analysis
on SucSase’s conformational changes involving backbone movement, which are relevant
to the catalytic cycle. The crystal structure of NeuSucSase displayed a similar fold to the
previously reported structural model of AthSucSase (PDB ID 3S29) 84. NeuSucSase is a
tetramer composed of four identical subunits (Figure 36A), where each monomer
contains four domains (Figure 36B). The first domain designated as “Sucrose Synthase
N-terminal-1” (SSN-1) domain included residues 1-119 (Figure 36B, red) and contained
five α-helixes and four β-strands. The second domain, which included residues 159-264,
is the “Sucrose Synthase N-terminal- (SSN-2) domain (Figure 36B, green) with five α-
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helixes. The third is the GT-B(D) domain (Figure 36B, cyan), which included residues
514-742 with eight α-helixes and three β-strands. This domain functions in the GT-B
family as the sugar donor (D) in catalysis 84, 86, 91. The fourth domain is the GT-B(A)
domain (Figure 36B, blue), which consists of residues from three separate regions: 120158, 265-513, and 743-794. These separate regions are encompassed by the SSN-1, SSN2 and GT-B(D) domains in the center of the monomer. The GT-B(A) domain included
nine α-helixes and eight β-strands and functions in the GT-B family as the sugar acceptor
(A) in catalysis 84, 86, 91. Both the GT-B(D) and GT-B(A) domains directly facilitate the
glycosyltransferase reaction 84.

Figure 38. The NeuSucSase monomer structure is shown in backbone trace. The electron
density (2Fo-Fc map at 1 sigma) is shown as mashes. The green portion of the electron
density covers the GT-B (D) domain in the “open” position, while the cyan portion of the
electron density covers the SSN-1, SSN-2, and GT-B (A) domains.
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Figure 39. The “hinge”. The picture displays the hydrogen bond between W73 and G514.
The electron density (2Fo-Fc map) is shown as blue mesh at 1.5 sigma level.
The obtained NeuSucSase structure with no substrates bound has a clearly
different overall conformation when compared to AthSucSase with UDP and Fru 84. This
implies that substrate binding induces significant conformational changes (Figure 40).
After superimposition of only the GT-B(A) domains of AthSucSase and NeuSucSase
(using the least squares function in COOT), the SSN-1, SSN-2, and GT-B(A) domains
from both structures overlapped well while the GT-B(D) domains were in a different
relative position. The angle between the GT-B(A) and GT-B(D) domains in NeuSucSase
was about 23.5 degrees wider than in the AthSucSase structure. Based on such
comparison, we suggest that the NeuSucSase structure in this work was in an “open”
conformation whereas the AthSucSase was “closed” 84. We have identified some distinct
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structural determinants (hinges and latches) related to the movements of the sugar (GTB(A)) and nucleotide (GT-B(D)) binding domains.
Sugar-binding GT-B(A) domain. Analysis of a difference distant matrix map of
the Fru-binding GT-B(A) domain as described in “Materials and Methods” (Figure 41)
highlights three main regions that move closer upon sugar binding. These are 325-375 to
280-290 (~5 Å), 425-435 to 280-290 (~4 Å), and 425-435 to 325-375 (~3 Å) (Figure 41).
Other pair of regions that move towards each other are 280-290 to 490-505 (~3 Å) and
280-290 to 450-460 (~2 Å) (Figure 41). From this analysis, the area 280-290 is the most
involved in an induced fit interaction with Fru. Further inspection of these areas reveals
that Fru induces local conformational changes via superimposition of the GT-B(A)
domains of the AthSucSase (closed) and the NeuSucSase (open) (Figure 42). These
include the side chain of K431 and the backbone of residues 288-290. The re-shaping of
the Fru binding site facilitates the closing via a set of inter-domain hydrogen bonds
(Figure 42 in green). These local conformational changes along with the presence of Fru
further promote the interactions between the GT-B(A) and GT-(D) domains. Thus, we
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propose that Fru binding contributes to the induced fit closing of the structure.

Figure 40. Comparison of the open and closed monomeric forms. The open form
structure is represented by the NeuSucSase structure reported in this paper; the closed
form is represented by the AthSucSase structure (PDB ID 3S29). The SNN-1, SNN-2 and
GT-B(A) domains are shown in blue for the open form structure and in cyan for the
closed form structure. The GT-B(D) domain is shown in magenta for the open form and
in green for the closed form. The “hinge-latch” features of the domain movement are
shown in blown-up views.
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Figure 41. Difference distance matrix map of the GT-B(A) domain. Distances were
calculated between all pair of Cα carbon of the open structure (NeuSucSase). A second
pairwise distance matrix was calculated for the close structure (homology model of
NeuSucSase using AthSucSase as template as described in “Materials and Methods”).
Afterwards, these two matrices were subtracted, and the Δdistance was color coded. The
negative and zero values are represented in white. Red colors (higher Δdistance values)
are pairs of Cα carbon that are getting closer upon closing of the enzyme. Only residues
from 260 to 510 are shown, which correspond to the GT-B(A) domain.
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Figure 42. Overlap comparison of the fructose binding sites of the open (NeuSucSase)
and closed (AthSucSase, PDB ID 3S29) structures. The carbon atoms in the closed form
structure are in pale yellow. The carbon atoms in the open form structure are in cyan
(GT-B(A) domain) and pink (GT-B(D) domain). Conserved residues between two
structures are labeled with respective residue numbers; the residue numbers of the open
form structure (NeuSucSase) are in parenthesis. The hydrogen bonds in the GT-B(D)
domain are shown in black. The hydrogen bonds in between GT-B(A) and GT-B(D)
domains and the ones in GT-B(A) domains are shown in green.
Nucleotide-binding GT-B(D) domain. The GT-B(D) domain binds to sugar
nucleotide (synthesis direction) or nucleotide (cleavage direction) substrates. When
overlapping GT-B(D) domains from both AthSucSase and NeuSucSase, residues
interacting with the phosphate and ribose moieties of the nucleotides are not only
conserved, but also at the same positions (Figure 43). On the other hand, two residues
interacting with the nucleotide base are not conserved. Residues Q648 and N654 from
AthSucSase are replaced by R636 and A642 in NeuSucSase, respectively. This difference
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creates a more spacious binding site in NeuSucSase, which may accommodate bulkier
adenosine nucleotide substrates. Similar sequence differences were observed in the
SucSase from T. elongatus 77. Based on sequence analysis and homology modeling it was
suggested that these two residues could be responsible for the preference towards
ADP/ADP-Glc over other nucleotides such as UDP/UDP-Glc in the cyanobacterial
enzyme. It is important to notice that the side chains in R636 and A642 in NeuSucSase
are not conserved in the E. coli Glycogen synthase, which is another glycosyltransferase
that binds ADP-Glc 92. E. coli Glycogen synthase has a different motif in that position
with a Tyr and Ser instead of Arg and Ala 86, 92, 93, implying a different structural
arrangement for accommodating ADP-Glc. Overall, the nucleotide binding to the GTB(D) domain does not seem to trigger significant local conformational changes (Figure
43). The direct interactions with the nucleotide do not make major contributions to the
induced fit mechanism.
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Figure 43. Overlap comparison of the nucleotide binding sites of the open (NeuSucSase)
and closed (AthSucSase, PDB ID 3S29) structures. The carbon atoms in the closed form
structure are in pale yellow. The carbon atoms in the open form structure are in cyan
(GT-B(A) domain) and pink (GT-B(D) domain). Conserved residues between two
structures are labeled with respective residue numbers; the residue numbers of the open
form structure (NeuSucSase) are in parenthesis. The asterisks indicate the non-conserved
binding residues with the closed form residues labeled in front of the ones in the open
form structure.
Hinge Analysis. We scanned the structures of the acceptor and donor domains for
hinges and subtle conformational changes that could be functionally important in
catalysis. We used the in-house program hingescan described in “Materials and
Methods”. Using several window sizes we detected several local conformational changes
(Figure 44). For a window size of 51, we detected two clear hinge elements near residues
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~515 and ~744 (Figure 45). These two elements actually form a single “hinge” that
comprises a hydrogen bond between two conserved residues (G514 and W743) in a
flexible area (Figure 40, Figure 39, and Figure 44). These two residues remain at the
same position in both the open and the closed conformations of the enzyme. For smaller
windows, we found other significant local secondary structure rearrangements (Figure 44,
Figure 46, and Figure 45). Upon closing, two α-helices in the GT-B(D) domain are
extended, and a β-strand replaces a previously coiled stretch. The outcome is a more
ordered peripheric structure of the GT-B(D) domain. We propose that this secondary
structure rearrangement, despite the local entropy decrease, would release extra energy to
close the conformation facilitating the binding of substrates.
Latches. A feature that contributes to the stabilization of the closed form is a
“latch”, E609, which comprises the highly conserved E609 residue located at the
periphery of the GT-B(D) domain (Figure 37). Going from an open to a closed
conformation, this glutamate residue moves ~11 Å towards the GT-B(A) domain and
ends up hydrogen-bonded to two tyrosine residues (Y432 and Y446) stabilizing the
closing (Figure 40 and Figure 47). Interestingly, there were small secondary structure
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Figure 44. Hinge analysis of NeuSucSase . Comparison between the open form and the
modeled closed form of the enzyme was performed with the program hingescan as
described in Materials and Methods. In the top panel, a color coded hinge score (0 to
4.5 .) is plot for different window sizes at each residue. Three points are highlighted, A
(control) and two hinge regions that are near in space (B and C). In all four panels (A, B,
C, and B+C), maroon structures belong to the closed form, and yellow ones to
the open form. Panel A shows optimal rigid body superposition of regions 307-357 of the
open and closed form. Panel B displays regions 489-539 of both the close and open form.
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The left, center and right overlaps are optimal rigid body superposition of the Cα of
residues 489-539, 514-539, and 489-514, respectively. The center and right overlaps were
performed to highlight the differences on the other half of the region. Spheres represent
center residue 514.Panel C displays regions 718-768 of both the close and open form.
The left, center and right overlaps are optimal rigid body superposition of the Cα of
residues 718-768, 718-743, and 743-768, respectively. The center and right overlaps were
performed to highlight the differences on the other half of the region. Spheres represent
center residue 743. Panel B+C shows both regions (489-539 and 718-768), in
which the optimal superposition was performed based on Cα of residues 514-539 and
718-743.

Figure 45. Hinge analysis by comparison of the open v. closed conformations. The blue
and red show the “hinge score” using 51 and 9 windows, respectively. The magmata dots
(also point with black arrows) shows the two distinct hinges: G514 and W743. The
purple arrows points at the region displaying the secondary structure rearrangements.
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A

B
Y432
Y446
E62

Figure 46. Secondary structure rearrangement during conformational changes between
open and closed structures of bacterial SucSases. A. Open conformation of the
NeuSucSase structure. B. Closed conformation of the AthSucSase structure (PDB ID
3S29). The GT-B(D) domain and a long bending helix is show in orange. The SNN-1,
SNN-2, and GT-B(A) domains are in grey. The side chains of the residues in the “latch”
and the “hinge” are shown as green sticks. The secondary structural rearrangement is
shown in magenta. T

Figure 47. The open “latch”. E609, Y446 and Y432 are shown in sticks. The electron
density (2Fo-Fc map) is shown as blue mesh at 1.0 sigma level around there key residues.
Local secondary structure fetures are shown in cartoon style.

rearrangements in the vicinity of this latch, which could facilitate the interaction between
E609 and the two tyrosines (Figure 46). On the other side of the active site, opposite to
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the latch described, there is a hydrophobic patch that contributes to seal the closing
(Figure 48). Two hydrophobic residues (M635, L637) in the GT-B(D) domain get in
contact with a hydrophobic cluster (V281, L282 and L284) in the GT-B(A) domain, upon
closing. The side chain of N280 also provides a methylene to build a non-polar pocket
that latches on to M635 and L637 (Figure 48). On the other hand, the amide polar group
is exposed to the solvent.

A

B

N 280
L

V
L

M
L

Figure 48. Hydrophobic residues contribute to the latch action. Panel A depicts the open
(NeuSucSase crystal structure) and B a homology model of a closed structure, which was
built as described in the “Materials and Methods” section. Upon closing, the hydrophobic
residues: M635, L637 in the GT-B (D) domain and N280, V281, L282 and L284 in GTB(A) domain generate a hydrophobic environment that stabilize the close action.
The closed structure seems to induce stronger interactions with the nucleotide and
vice versa. In NeuSucSase, the conserved E671 is in the same position as E369 in the E.
coli trehalose-6-phosphate synthase (OtsA) 92, 94. In OtsA, as well as in the close
conformation of AthSucSase (E683), the carboxylate of this side chain forms two
hydrogen bonds with the hydroxyl groups of the ribose of the nucleotide. In these
enzymes, the carboxylate is surrounded by hydrophobic residues (Y520, Y646, L667,
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T668 in NeuSucSase, Y533, Y658, L679 and T680 in AthSucSase), which makes the
hydrogen bonds stronger in the non-polar environment. In the open form of the
NeuSucSase structure, V291 (V306 in AthSucSase) moves away from the side chain of
the glutamate residue (Figure 49). This implies that the closing recruits a non-polar side
chain to completely surround the carboxylate. Consequently, nucleotide binding
stabilizes he carboxylate charge and facilitates the interaction with V291 upon closing.
Interestingly, in another glycosyltransferase such as bacterial glycogen synthase, E671
has been replaced by a Tyr, and V291 was replaced by Asp, thus, switching their roles 92.
Therefore, this ligand-dependent interaction may be a common feature in this family of
enzymes.
Site Directed Mutagenesis of Critical Residues
Previously, important residues for catalysis were identified in other retaining GTB glycosyltransferases. A triad of critical residues has been found in the active site of
maltodextrin phosphorylase 95, 96 and glycogen synthase from E. coli 97. Based on X-ray
structures, these residues were also predicted to be important for catalysis in OtsA 94 and
AthSucSase 84. The homologue residues in NeuSucSase are R567, K572, and E663
(Figure 50). When any of those residues were replaced by alanine the activity in the
direction of Suc synthesis severely decreased, either in presence of ADP-Glc or UDP-Glc
(Table 6). The most active of all these mutants was E663A in presence of ADP-Glc, but it
was still 200-fold less active than the wild type. These results indicate that this triad is
critical in NeuSucSase. Consequently, it also suggests that NeuSucSase together with all
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other retaining glycosyltransferases with a GT-B fold share the same reaction mechanism
(Figure 50).

Figure 49. Conserved hydrophobic residues are involved in substrate binding in both
open conformation of NeuSucSase (A and B), and closed conformation of AthSucSase
(PDB ID: 3S29) (C and D). In the open conformation, V291, E691 two conserved
hydrophobic residues are shown in sticks in figure A, and V291, Y520, Y646, L667,
T668 (rotate 90 degree from A) are shown in sticks in figure B. In the closed
conformation, V 306 and E 683 are conserved hydrophobic residues in figure C, and
V306, Y533, Y658, L679 and T680 (rotate 90 degree from C) are shown in sticks in
figure D.
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Figure 50. Three highly conserved catalytic residues in different members of the retaining
GT-B glycosyltransferase family. The structures analysed in this figure are maltodextrin
phosphorylase (PDB ID 1E4O), trehalose-6-phosphate synthase (PDB ID 1GZ5), and
glycogen synthase (PDB ID 2ZQS) from E. coli, AthSucSase (PDB ID 3S29), and
NeuSucSase (this work).
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Table 5. Data collection and refinement statistics for NeuSucSase
Data Processing
Space group

P65

Cell dimensions
a; b; c (Å)

236.90; 236.90; 231.44

α; β; γ (°)

90.00; 90.00; 120.00

Resolution (Å)

3.05

Mosaicity (°)

0.47

a

Rmerge

0.169 (0.963)

I/sigma

9.6 (2.1)

Completeness

97.9 (98.6)

Multiplicity

6.3 (6.3)

Refinement
Resolution (Å)

3.05

No. reflections

794715

No. unique reflections

126170

b

Rwork/cRfree

17.37/21.75

d

RMSD Bond length (Å)

0.009

RMSD Bond angle (°)

1.439

The values for the highest resolution bin are in parentheses.
a
Linear Rmerge = Σ|Iobs-Iavg|/ ΣIavg
b
R = Σ|Fobs-Fcalc|/ ΣFobs.
c
Five percent of the reflection data were selected at random as a test set and only these
data were used to calculate Rfree.
d
RMSD, root mean square deviation.
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Table 6. Activity of wild type and mutants of NeuSucSase. Assays were performed using
the conditions described in the “Materials and Methods” section.
Vmax
(U mg-1)

Substrate
WT

R567A

K572A

E663A

UDP-Glc

4.3 ± 0.1

< 0.0017

< 0.0019

< 0.01

ADP-Glc

3.7 ± 0.1

< 0.0014

< 0.0016

0.020 ± 0.02

Materials and Methods
Materials: Chemicals and coupled enzymes used for activity assays were from
Sigma-Aldrich (St. Louis, MO). Escherichia coli BL21 (DE3) cells were purchased from
New England BioLabs (Ipswich, MA). Bacterial growth media and antibiotics were from
Fisher Scientific (Pittsburgh, PA) and Sigma-Aldrich. Crystallization screen solutions
and other supplies were purchased from Hampton Research (Aliso Viejo, CA) and
Emerald Bio (Bedford, MA). All the other chemicals were of the highest quality
available.
Cloning: The sequence coding for NeuSucSase was amplified by PCR using
genomic DNA from N. europaea ATCC 19718 as template, the specific oligonucleotides
CATATGACCACGATTGACACACTCGCCACCTGTACCC (forward, NdeI site
underlined) and GTCGACTCATATCTCATGGGCCAGCCTGTTTGCCAGCGGCC
(reverse, SalI site underlined) as primers, and Phusion HF DNA polymerase (Thermo
Fisher Scientific, Rockford, IL) following the manufacturer’s instructions. The program
used included an initial denaturation of 30 s at 98 °C; 30 cycles of 98 °C for 5 s, 50 °C
for 20 s, and 72 °C for 2 min; and a final extension of 72 °C for 5 min. The PCR product
was purified after agarose gel electrophoresis and inserted into the pSC-B vector using
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the StrataClone Blunt PCR cloning kit (Agilent Technologies, Santa Clara, CA).
Sequence identity was checked by automated DNA sequencing at CRC (Comprehensive
Cancer Center at University of Chicago, IL). Afterwards, the sequence was subcloned
into the pET28c vector (Merck KGaA, Darmstadt, Germany) between NdeI and SalI sites
to obtain pNESS1, which is the plasmid that encodes the recombinant NeuSucSase with
an N-terminal His6-tag.
Site-directed mutagenesis: Site-directed mutagenesis was performed by PCR
overlap extension as previously described using Phusion DNA polymerase 98, 99. Plasmid
encoding the NeuSucSase (pNESS1) was used as a template for mutagenesis.
To introduce mutations in the sequence coding for NeuSucSase we used the following
primers: TTTACCATGGCGgcgCTGGATCGGATC (forward) and
GATCCGATCCAGcgcCGCCATGGTAAA (reverse) for mutant R567A;
CTGGATCGGATCgcgAACATTACCGGC (forward) and
GCCGGTAATGTTcgcGATCCGATCCAG (reverse) for mutant K572A; and
CCAGCCCTGTTCgcgGCATTCGGCCTG (forward) and
CAGGCCGAATGCcgcGAACAGGGCTGG (reverse) for mutant E663A. PCR
conditions were the same as those described above. Flanking primers for the PCR overlap
extension were the same used for cloning (described above). All mutations were
confirmed by DNA sequencing.
Protein expression and purification: Transformed E. coli BL21 (DE3) cells with
pNESS1 were grown in 4 x 1 L of LB supplemented with 100 µg/ml carbenicillin. This
was performed in a 2.8 L Fernbach flask at 37 °C and 250 rpm until OD600 nm reached
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~0.6. Protein expression was induced by the addition of 0.5 mM isopropyl-β-D-1thiogalactopyranoside. Cells were incubated at 25 °C and harvested after 16 h by
centrifuging at 5000 x g and 4 °C for 15 min. The cell paste was resuspended in Buffer C
[20 mM Tris-HCl pH 8.0, 200 mM NaCl, 5% (v/v) glycerol, 10 mM imidazole] and
disrupted by sonication. The resulting suspension was centrifuged twice at 30000 x g and
4 °C for 15 min and the soluble fraction (crude extract) was loaded onto a 5 ml HisTrap
column (GE Life Sciences, Piscataway, NJ) containing Ni2+ and previously equilibrated
with Buffer C. Elusion of the retained proteins was achieved with a linear imidazole
gradient (20 column volumes, 10-300 mM). Fractions containing SucSase activity were
pooled, concentrated to 2 ml, and loaded onto a 16/60 Superdex 200 column (GE Life
Sciences) previously equilibrated with 50 mM HEPES-NaOH pH 8.0 and 300 mM NaCl.
Fractions containing enzyme activity were pooled, concentrated, supplemented with 5%
(v/v) glycerol, and stored at -80 °C until use. Under these conditions the enzyme
remained stable and fully active for at least 3 months.
Protein assay and detection: Protein concentration was determined by measuring
the protein absorbance at 280 nm using a NanoDrop 1000 (Thermo Fisher Scientific) and
an extinction coefficient of 1.153 ml mg-1 cm-1, determined from the amino acid sequence
using the ProtParam server (http://web.expasy.org/protparam/). Denaturing protein
electrophoresis was performed as described by Laemmli 100.
Enzyme assays: Activity assays were performed as previously described 77, with
minor modifications. In the direction of Suc synthesis, the reaction medium contained 50
mM HEPPS pH 8.0, 10 mM MgCl2, 5 mM UDP-Glc, 500 mM Fru, 0.3 mM
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phosphoenolpyruvate, 0.3 mM NADH, 1 U pyruvate kinase, 1 U lactate dehydrogenase,
0.2 mg ml-1 BSA, and enzyme in an appropriate dilution in a final volume of 50 µl.
Alternatively, activity was measured with 1 mM ADP-Glc and 20 mM Fru. NADH
oxidation was followed by measuring the absorbance at 340 nm in a Multiskan Ascent
microplate reader (Thermo Fisher Scientific) at 37 °C. One unit of enzyme activity (U) is
defined as the amount of protein necessary to produce 1 µmol of product in 1 min under
the specified conditions.
Kinetic characterization: Data of initial velocity (v) versus substrate
concentration (S) were plotted and fitted to a modified Hill equation: v = Vmax SnH / (S0.5nH
+ SnH), where S0.5 is the concentration of substrate necessary to obtain 50% of the
maximal velocity (Vmax) and nH is the Hill coefficient. Fitting was performed by a nonlinear least-squares algorithm provided by the software Origin 7.0 (OriginLab
Corporation). Kinetic parameters were obtained using the averages of two independent
datasets that were reproducible within errors of ± 10%.
Phylogenetic analysis: We searched for protein sequences using the term “sucrose
synthase” and the RefSeq filter in the National Center for Biotechnology Information
(NCBI) database. Sequences were analyzed with the program BioEdit 7.0.5.3 101,
manually curated, and aligned using the ClustalW server
(http://www.genome.jp/tools/clustalw/). Tree reconstruction was performed using the
Neighbor-Joining algorithm with a bootstrap of 1000 in the program SeaView 4.4.0 102.
The tree figure was prepared using the FigTree 1.4.0 software
(http://tree.bio.ed.ac.uk/software/figtree/).
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Crystallization and data collection: After the initial crystallization screen and
optimization, the recombinant protein was crystallized via the hanging drop method. The
hanging drops were prepared with 1 µl of 15 mg ml-1 NeuSucSase protein solution and 1
µl of the reservoir solution, containing 5% Tacsimate pH 5.0, 5% (w/v) PEG 3350, and
0.1 M sodium citrate pH 5.6. The hanging drops were kept at 20 °C for crystallization.
Crystals appeared in 3 days and were allowed to continue growing at 20 °C for 4 more
days until they reached their maximum sizes. Crystals with good morphology and large
sizes were transferred to a cryo-condition, which contained 25% glycerol in addition to
the components of the reservoir solution, before being frozen in liquid nitrogen.
X-ray diffraction data sets were collected at the SBC19-ID beamline at the Advanced
Photon Source (Argonne National Laboratory, Chicago, IL). The wavelength used in the
monochromatic data collection was 1.008 Å. All the collected data sets were indexed and
integrated using iMosflm and scaled with Scala in the CCP4 program suite (Collaborative
Computational Project Number 4) 103. The resolution cut-off was decided by applying all
following criteria on the highest resolution bin: i) I/Sigma > 2, ii) completeness > 90%,
and iii) Rmerge < 1.0.
Phasing, model building, and refinement: Molecular replacement was carried out
using the program Phaser 61 from the CCP4 program suite. The starting search model in
molecular replacement was modified from the known A. thaliana SucSase structural
model (PDB ID: 3S29) 84. We truncated the GT-B(D) domain (cyan domain in Figure
36B) and used the rest of the molecule as the search model for molecular replacement in
Phaser. Once a solution was obtained, model building was conducted in COOT 45. The
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GT-B(D) domain was built according to the electron density maps. Rigid body
refinement and restrained refinement were conducted in refmac5 104. In order to remove
model bias and achieve the best refinement results possible, simulated annealing
refinement and ordered solvent identification were conducted using PHENIX.refine 44.
Final model and the structure factor have been deposited in the RCSB Protein Data Bank
with the accession code 4RBN.
Homology modeling: A model of the monomeric closed form of NeuSucSase
(residues 16 to 788) was constructed with the program Modeller 9.11
(http://salilab.org/modeller/) 105. As template we used the atomic coordinates of the A.
thaliana sucrose synthase (3S27) with the ligands UDP and fructose 84. Before the
modeling process, sequence alignment was performed manually to match functionally
conserved residues and secondary structures. An identity of 52.2% ensured a high
confidence alignment since we only had to introduce four one-residue indels. The
accuracy of the models was assessed with the Verify3D Structure Evaluation Server
(http://nihserver.mbi.ucla.edu/Verify_3D/) 106.
Difference distance matrix map: We used and ad hoc program written in C
applying previously developed concepts to detect domain motion and identify regions
that move closer upon conformational changes 107. Distances were calculated between all
pair of Cα of one reference structure (open), and a second pairwise distance matrix was
calculated for the target (closed) structure. Afterwards, the target matrix was subtracted
from the reference matrix to calculate the Δdistance plot
(https://github.com/ballicoragroup/didimama).
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Hinge analysis: In order to detect possible local conformations or hinges, we
performed an analysis with the ad hoc program “hingescan”
(https://github.com/ballicoragroup/hingescan). We compared the open crystal structure
of NeuSucSase with a NeuSucSase homology model based on the template provided by
the close structure of the AthSucSase. To detect if there is a significant local
conformational change around a given residue (“hinge”), we extracted the coordinates of
a given number (n) of Cα before the putative hinge and the same given number (n) of
residues after (window size = 2n+1). This was done for both the open and closed forms
and obtained two fragments to compare. After optimal rigid body superposition of only
these two set of coordinates, an average distance was calculated (RMSD). This RMSD
calculated in these conditions was called the “hinge score”. When this score is at a peak,
the “flanking” n number of Cα at both sides display a maximum change between the two
structures. For that reason, a hinge is detected. The bigger the window, the bigger the
domain movement is detected surrounding the hinge. To identify hinges that link small
and bigger domains, different window sizes can be scanned.

CHAPTER SIX
CONCLUSIONS
We analyzed the sequences of SucSases from divergent organisms, including
proteobacteria, cyanobacteria, and plants. The obtained phylogenetic tree shows that
sequences from proteobacteria (including the one from N. europaea) are clearly separated
from those present in cyanobacteria and plants. To the best of our knowledge, SucSases
from proteobacteria have never been characterized. In this work, we expressed, purified
the recombinant NeuSucSase, and solved its crystal structure. In addition, our analysis
provided evidence for a proposed “open” conformation for SucSases. Based on the
comparison with a previously published “closed” AthSucSase structure 84, a “hinge-latch”
combination was identified as critical features responsible for the open-close enzyme
actions.
We also mutated three highly conserved amino acids proposed to be critical for
catalysis. These mutations severely reduced the activity of NeuSucSase; therefore, we
conclude that the triad composed of residues R567, K572, and E663 (numbers according
to NeuSucSase) plays a key role for catalysis not only in SucSases, but probably also in
all the retaining GT-B glycosyltransferases 84, 94-97.
With both structural and kinetic results we propose that NeuSucSase has a
substrate preference in favor of ADP/ADP-Glc over UDP/UDP-Glc. This behavior is
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similar to the one observed for T. elongatus SucSase 77. It was proposed that the
difference in specificity towards the nucleotide substrate in the cyanobacterial enzyme
could be due to changes in two specific residues, R647 and S653 (Q648 and N654 in
AthSucSase). Interestingly, we found that NeuSucSase presents similar evolutionary
variances to those observed in T. elongatus SucSase: R636 (R647) and A642 (S653).
Residues Q648 and N654 from AthSucSase are strictly conserved in plants and the moss
P. patens, whereas they are more variable in cyanobacteria and proteobacteria. Based on
this finding and taking into account kinetic and structural data obtained for SucSases
from T. elongatus 77, AthSucSase 84 and NeuSucSase (this work), we hypothesize that
these residues may contribute to determining the specificity towards the nucleotide
substrate.
The evolutionary origin of enzymes from Suc metabolism in proteobacteria has
been previously discussed 65, 66, 69. The evolution of SucSases in cyanobacteria,
proteobacteria, and plants is not yet fully understood, but most likely it involved
horizontal gene transfers. On one hand, NeuSucSase is closer to plant enzymes in the
phylogenetic tree (Figure 35), but on the other hand, the specificity for nucleotides is
similar to several cyanobacterial enzymes examined 69, 77. It is possible that NeuSucSase
evolved from a protein already present in the common ancestor of proteobacteria and
cyanobacteria 71.
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